Novel strategies for enhancing tissue integration in cartilage repair by Davies, Lindsay
Novel Strategies for Enhancing Tissue 
Integration in Cartilage Repair 
Lindsay Davies
A thesis submitted to Cardiff University in 
accordance with the requirements for the degree 
of Doctor of Philosophy in the School of
Biosciences
June 2006
UMI Number: U584836
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U584836
Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
DECLARATION
This work has not previously been accepted in substance for any degree and is not being 
concurrently submitted in candidature for any degree.
Signed...< .(candidate)
Date.......
STATEMENT 1
This thesis is the result of my own investigations, except where otherwise stated.
Other sources are acknowledged by footnotes giving explicit references. A bibliography is 
appended.
Signed .£ 5 ^ ..............................................................(candidate)
Date ................................................................................
STATEMENT 2
I hereby give consent for my thesis, if accepted, to be available for photocopying and for 
inter-library loan, and for the title and summary to be made available to outside 
organisations.
Signed /. ..............................................................(candidate)
Date...............y . t f e : ...............................................................................
Dedicated to my family: 
Susan, Brian and Jo Davies
Thank you for your unconditional love, support and encouragement in
everything I  do
Special thanks to: 
Marc Richards
For his love, motivation and true belief in me
I  love you all, and could not have achieved this without you. Thank you.
Acknowledgements
Firstly I  would like to thank my supervisor, Professor Vic Duance, for all his advice and 
support during my PhD. Your door has always been open to me, thank you. It is very much 
appreciated. I  would also like to thank my co-supervisor, Professor Bruce Cater son for his 
help and advice during the setup o f  this project and advice about the proteoglycan work.
I  would like to acknowledge Dr. Debbie Mason for her help with the molecular biology and 
Dr. Tony Hayes fo r  all his expert advice regarding the confocal microscopy and 
immunohistochemistry. Thanks also to Dr. Sam Redman for her assistance with the design 
o f  the cartilage injury model, Dr. Ilyas Khan for the Sox 9 primer sequences and Dr. Anne 
Vaughan-Thomas fo r  the A VT-6E3 antibody.
A big thank you goes to all members, past and present, o f  lab C5.I1 and the newly 
Christened lab C4.12! Thanks to Drs. Sophie Gilbert and Emma Blain for their advice and 
discussing data when things needed clarifying and Yadan Zhang, Drs. Rhian Thomas, Sian 
Hancock, Phil Callender, Sophie Flood, Elaine Rees and Sarah Oldfield for their 
friendship and support. Girls, I  won’t forget the ‘Phili 4 7
Finally I  would like to acknowledge the EPSRC and Cardiff University for funding this 
project.
Abstract
Articular cartilage is found on the surface of opposing long bones within the synovial joint 
and aids to dissipate loads. Adult cartilage lacks the ability to initiate a repair response 
when injured due to its aneural and avascular nature.
Surgical techniques have been developed to enhance this repair process but none to date 
rival that of natural cartilage. Repair tissue is often of a fibrocartilaginous nature which 
does not have the biomechanical stability of articular cartilage. Integration between newly 
synthesised tissue and the endogenous cartilage is invariably poor as well, leading to 
degeneration of the repair tissue and surrounding cartilage with time.
The aim of this study was to develop strategies for the enhancement of integration between 
new and pre-existing articular cartilage to form a more biomechanically stable repair tissue. 
The migratory capacities of chondrocytes isolated from young and mature articular 
cartilage have been investigated using a Boyden chamber system, as well as the effects of 
different matrix substrates and chemoattractants on this process. Using this system the 
substrate dependent chemotactic effects of insulin-like growth factor 1 (IGF-1) and 
transforming growth factor beta 1 (TGFpl) were only seen if  the cells were seeded onto a 
fibronectin substrate. The inhibitory effect of chondroitin sulphate (CS) chains on 
chondrocyte migration was also demonstrated. Further experiments using an in vitro model 
of cartilage injury confirmed this, as it was demonstrated that chondrocytes migrated into 
chondroitinase ABC treated cartilage but not into untreated controls.
Biosynthesis studies were used to demonstrate the anabolic effects of IGF-1 and TGFf31 on 
chondrocytes. Radiolabelled sulphate and proline were used as a measure of sulphated 
glycosaminoglycan and collagen biosynthesis respectively. These experiments 
demonstrated increased biosynthesis of both matrix molecules by chondrocytes from both 
age groups in response to these growth factors. In addition, these results suggest that the 
newly synthesised molecules were assembled into an extracellular matrix by the cells.
The results from both the migration and biosynthesis experiments demonstrated the 
potential of IGF-1 and TGFpl for enhancing cartilage repair, but also illustrated the 
limitations of their short half lives. Constructs encoding the mature peptides of IGF-1 and 
TGFpi were therefore developed for transfection into chondrocytes. The ability of these 
transfected cells to migrate was investigated on a chondroitinase ABC treated aggrecan 
substrate. Here a constant trend of increased migration with the transfected cells was seen 
when compared to controls.
This study demonstrates the ability of chondrocytes from both young and mature articular 
cartilage to migrate. This is the first study to report this using skeletally mature articular 
cartilage. In addition, the inhibitory effects of CS chains in chondrocyte migration have 
been shown using both the Boyden chamber system and an in vitro model of cartilage 
injury. The over-expression of IGF-1 and TGFpl in articular chondrocytes demonstrated 
the possibility of increasing both the migration of cells into articular cartilage as well as up- 
regulating their capacity for matrix biosynthesis, thereby creating an integrated repair tissue 
improving on current repair strategies.
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1.1 The Synovial Joint
“...the narrowest hinge in my hand puts to scorn all machinery. ” Walt Whitman 1892
(Buckwalter and Mankin, 1998)
This statement by Walt Whitman in 1892 succinctly portrays the intricate design of the 
synovial joint and its composite materials. Even today with the modem technology 
available, no man-made substitute can rival that of nature’s creation. The synovial joint 
comprises two opposing long bones with a thin layer of articular cartilage at the interface 
region. This articular cartilage provides a functional surface for the frictionless movement 
needed within the joint and also helps aid the dissipation of loads, preventing excessive 
stress on the subchondral bone (see fig.1.1). Both the bones and associated ligaments are 
held together in a stable and secure manner by the fibrous joint capsule (Duance, 1998; 
Pacifici et al., 2005). Within the capsule, ligaments provide the strength to maintain the 
joint’s alignment and stability. Ligaments outside of the capsule help in articulation of the 
joint and in maintaining alignment. Both sets of ligaments allow free movement when 
relaxed but prevent unwanted movement that may damage the joint when tense.
The synovial membrane lines the inside of the fibrous capsule and consists of between 1 
and 3 layers of synoviocytes, which secrete and absorb synovial fluid (Benjamin, 1999; 
Nozawa-Inoue et al., 2003). This fluid provides both lubrication and nutrition to the joint. 
These cells are supported by vascular connective tissue and can be seen extending into the 
joint cavity as small villi or larger, fatty structures known as articular fat pads (Benjamin, 
1999).
All the structures of the joint interact and provide the support and strength needed during 
impact or mechanical loading. Together they are able to stabilise and prevent damage to the 
joint.
1.2 Articular Cartilage
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Articular cartilage forms the surface covering of opposing bones within the synovial joint 
cavity. Although functionally supported by numerous tissues such as ligaments and 
synovial tissue, articular cartilage centrally functions to aid the dissipation of loads. Its 
prevention of excessive stress on subchondral bone provides a surface for low friction 
movement. Differences in the composition and thickness of this tissue can be seen within 
the same joint as well as joints from the same and differing species. At most, articular 
cartilage is found to be a few millimetres thick, yet demonstrates impressive ability to resist 
compression and has phenomenal durability (Buckwalter et al., 2005).
Adult articular cartilage at a glance appears to be a simple and largely inactive tissue when 
compared to the metabolic activities of related connective tissues such as tendon. The 
chondrocyte is the sole cell type found within articular cartilage and is isolated from other 
cells by the dense matrix surrounding each chondrocyte. The tissue is avascular, aneural 
and alymphatic and relies on the diffusion of nutrients and the exchange of metabolites 
from the articular surface (Archer and Francis-West, 2003).
It is true that with skeletal maturity, cellular division and proliferation will decrease and 
within mature articular cartilage, chondrocytes most probably will never divide. In contrast 
to this rather simplistic view, detailed morphology has shown a highly organised structure 
with complex interactions between the chondrocytes and their surrounding matrix for the 
maintenance of the cartilage (Buckwalter and Mankin, 1998). The ability of isolated 
chondrocytes in vitro to proliferate demonstrates that they have not undergone terminal 
differentiation. It is therefore considered that in vivo, chondrocytes are within a ‘resting 
state’ of the cell cycle. The following section will describe the components of these cell- 
matrix interactions and look at their role in the maintenance of articular cartilage.
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1.3 Articular Cartilage Morphology
The highly ordered structure of cells and their matrix proteins form the basis of articular 
cartilage with the differing arrangements of these components separating the tissue into 
four main zones; these being the superficial, transitional, deep and calcified cartilage zones 
(see fig. 1.2). Cells within these layers appear to differ in size, shape and organisation as 
well as in metabolic activity (Aydelotte et al., 1988; Aydelotte and Kuettner, 1988; Bayliss 
et al., 1983; Buckwalter and Mankin, 1998; Ghadially et al., 1983; Kuettner et al., 1982). A 
decrease in cell number is seen with depth of cartilage, for example, it has been shown that 
in bovine articular cartilage a cell density of 54,000 cells/mm3 was seen in the superficial 
zone compared with 30,000 cells/mm3 in the deeper zones (Buckwalter and Hunziker, 
1999). Chondrocytes in the superficial zone demonstrate one tenth the metabolic activity of 
those in the deep zone as well as only having half the cell volume and surface area (Wong 
etal., 1996).
1.3.1 The Superficial Zone
This is the upper most and thinnest zone of articular cartilage. Consisting of two layers, the 
superficial zone covers the articular surface with an acellular sheet of thin fibrils with very 
few polysaccharides, known as the ‘lamina splendens* (Jurvelin et al., 1996). Beneath this 
clear film are layers of flattened chondrocytes arranged in rows with their axes parallel to 
the articular surface. They synthesise and secrete a matrix rich in collagen but with only 
small quantities of proteoglycans (Poole, 2003). This is thought to be due to the ability of 
these chondrocytes to degrade proteoglycans much more efficiently than chondrocytes 
within the deeper zones (Buckwalter, 1999). The collagen content of the superficial zone is 
the highest of all the articular cartilage zones. Studies by Aydelotte and Kuettner (1988) 
demonstrated that chondrocytes within this zone proliferate slower and have a less defined 
matrix than those chondrocytes in the deeper zones. Studies have shown that chondrocytes 
within the superficial zone are unequally distributed (Schumacher et al., 2002). A recent 
report has suggested that within the superficial zone cells will form pairs which are linked 
together, possibly by gap junctions due to the expression of connexin 43 at the adjoining 
cell surfaces (Chi et al., 2004). Superficial zone chondrocytes also have a more irregular 
shape with numerous large processes, more vacuoles associated with the Golgi region and
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small vesicles at the cell surface. This collagen fibril meshwork forms a barrier for 
molecules passing through the articular surface in either direction. Preventing the passage 
of large molecules, such as antibodies, through the superficial zone undoubtedly acts as an 
effective method of isolating healthy articular cartilage from the immune system 
(Buckwalter and Hunziker, 1999). Collagen fibrils contribute functionally to the resistance 
of shear and tensile forces at the articular surface from use of the joint (Buckwalter and 
Mankin, 1998).
13.2 The Transitional Zone
The transitional zone within articular cartilage lies directly beneath the superficial zone. 
This zone has a larger volume to that of the superficial zone and contains cells of a more 
spherical shape with greater amounts of endoplasmic reticulum (ER) and Golgi membranes, 
to the flattened cells previously described. The cells within this zone are more 
biosynthetically active (Poole et al., 2001). These cells appear to synthesise a higher 
concentration of proteoglycans but less collagen than those within the superficial zone. The 
collagen fibrils formed however are of a larger diameter. The water content in this zone is 
distinctly lower than seen in the superficial zone (Buckwalter and Hunziker, 1999).
1.3.3 The Deep/Radial Zone
The deep zone, also known as the radial zone, contains spherical chondrocytes as seen in 
the transitional layer, although here the cells tend to be organised into columns 
perpendicular to the articular surface (see fig. 1.2). Extracellular matrix (ECM) within this 
zone contains the highest concentration of proteoglycans as well as the lowest 
concentration of water (Buckwalter and Hunziker, 1999). Collagen fibrils here have the 
largest diameter compared to those seen in other zones (Poole et al., 2001). Fibrils from the 
deep zone are seen extending into the interface between uncalcified and calcified cartilage. 
This region is known as the tidemark (Buckwalter and Hunziker, 1999).
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1.3.4 Calcified Cartilage Zone
The calcified cartilage zone forms an interface between the articular cartilage and the 
underlying subchondral bone. It is the point of attachment for cartilage to bone and 
functions to transmit force generated by mechanical loading (Oegema et al., 1997). Cells 
within this region have a much smaller volume and contain less synthetic organelles than in 
the upper layers of cartilage (Buckwalter and Hunziker, 1999). The relative size of the 
calcified zone is regulated by the conversion rate of cartilage into bone by the process of 
endochondral ossification. During development and growth, chondrocytes within this zone 
have very similar characteristics to cells within the growth plate, however during adulthood 
chondrocytes within the zone of calcification are seen to be quiescent although not inactive 
(Oegema et al., 1997).
1.3.5 Subchondral Bone
Underlying the calcified cartilage zone is the subchondral bone made from the interfacing 
subchondral bone plate and the supporting trabecular bone. This interface region between 
cartilage and bone provides support to the articular surface during mechanical loading, 
preventing excessive forces on the subchondral bone plate. It has previously been shown 
that articular cartilage can withstand great forces and load when attached to its underlying 
subchondral bone (Jeffrey et al., 1995). This junction between cartilage and bone is a site of 
active remodelling exhibiting extensive collagenase activity. This turnover process is 
required for a healthy interface region (Poole, 2003). The shape and curvature of the bone 
also provides a stable scaffold optimally designed for mechanical loading and also for the 
provision of smooth movement during articulation (Kawcak et al., 2001).
1.4 Components of Articular Cartilage
1.4.1 The Chondrocyte
As previously mentioned in section 1.2, the chondrocyte is the only cell type found within 
articular cartilage and comprises as little as 1% of the total tissue volume within adult 
cartilage (van Sickle and Evander, 1997). Isolated and surrounded by the ECM that they
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synthesise and maintain, chondrocytes contain all the necessary organelles needed to 
perform this function, such as ER and Golgi apparatus (Archer and Francis-West, 2003). 
These cells are also characterised by the intracellular deposition of glycogen and the 
possession of short cilia protruding from the cell into the matrix, possibly with the role of 
detecting any minute changes within the matrix (Buckwalter and Mankin, 1998).
Within different zones of the cartilage, chondrocytes will exhibit differing morphology, 
changing their size, shape and organisation, with an accompanying change in metabolic 
activity. Mature chondrocytes are normally round in shape and are characterised by the 
synthesis of type II collagen, large aggregating proteoglycans and non-collagenous 
proteins. Ultimately it is the interaction of these components which forms the ECM 
(Buckwalter and Hunziker, 1999).
As articular cartilage is avascular, cellular metabolism is designed to function at a low 
oxygen tension, with levels between 10% at the articular surface to less than 1% in the 
deeper zones of the cartilage. This consequently means that the majority of the cell’s 
energy requirements come from glycolysis (Archer and Francis-West, 2003; Grimshaw and 
Mason, 2000). Studies by Lane et al. (1977) showed that this was the preferred method of 
metabolism even in aerobic conditions.
1.4.2 The Extracellular Matrix
The ECM found surrounding the chondrocytes within articular cartilage is composed of 
tissue fluid and an array of structural macromolecules. Visualisation of the ECM sees its 
division into three circumferential sections found surrounding individual chondrocytes (see 
fig.1.3).
1.4.2.1 The Pericellular Matrix
Collectively, the chondrocyte and its pericellular matrix are known as the chondron. The 
pericellular matrix is closest to the cell, linked by a transparent glycocalyx enclosed by the 
fibrillar pericellular capsule. This thin matrix provides protection to the chondrocyte during 
mechanical loading as well as preventing deformation of the cell (Huber et al., 2000). Type
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IX collagen is found concentrated here, tightly regulating the fibril diameter of type II 
collagen. The presence of type VI collagen is thought to mediate interactions for 
pericellular architecture and receptor-mediated anchorage and signalling between the 
chondrocyte and its micro-environment. Type VI collagen is normally found located with 
the matrix glycoprotein fibronectin (Poole et al., 2001). These networks of collagen fibrils 
form a ‘basket’ around the contained cell.
High concentrations of the monomeric form of the proteoglycan aggrecan, hyaluronan 
(HA) and link protein (LP) in this region suggests the assembly of these components into 
aggregates within the pericellular capsule before moving into the outer two matrices. Other 
small proteoglycans such as decorin and biglycan may have roles in modulating the 
collagen-proteoglycan interactions here (Poole, 1997).
1.4.2.2 The Territorial Matrix
Cytoplasmic extensions from the chondrocyte, project into the pericellular matrix and also 
as far as the territorial matrix. The territorial region is well defined within all zones of 
articular cartilage. A reduced quantity of type IX collagen within this domain allows the 
development of thicker type II collagen fibrils. Collagen fibres arrange themselves into 
bundles and thereby forming a distinct border between the territorial and interterritorial 
matrices (Huber et al., 2000). The glycosaminoglycan (GAG), chondroitin sulphate (CS), is 
also more concentrated in this layer (Buckwalter and Hunziker, 1999; Poole, 1997).
1.4.2.3 The Interterritorial Matrix
The interterritorial matrix is furthest away from the cell, and contains the largest type II 
collagen fibrils (Hagg et al., 1998). This is accompanied by the low abundance of type IX 
collagen and the lowest concentration of type VI collagen within the 3 regions. Collagen 
fibres within this region arrange into vertical columns radiating up through the zones of 
cartilage, previously described as ‘column arcades’ by Benninghoff (Benninghoff, 1925), 
until they reach the superficial zone where they arrange parallel to the articular surface 
(Huber et al., 2000). The GAG keratan sulphate (KS) is concentrated in this region
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(Aydelotte and Kuettner, 1988; Poole, 1997). These components work in co-operation to 
form a tissue able to withstand strong tensile and compressive forces.
1.43 Tissue Fluid
Tissue fluid within the ECM is primarily composed of water, making up 80% of the wet 
weight. Water is of huge importance in the role of maintaining the form of the tissue as well 
as in its mechanical properties. Most water is trapped by the proteoglycans within the 
matrix, but some is able to move freely in and out of the tissue. Negatively charged 
sulphate and carboxylate groups found on the GAGs, attached to the large aggregating 
proteoglycans, contribute to the high negative fixed charged density (FCD), which controls 
the equilibrium within the matrix. The FCD of the proteoglycans in the extrafibrillar matrix 
is one factor controlling an osmotic pressure differential. These negatively charged 
proteoglycans also contribute to changes in hydrogen ion concentration and therefore the 
pH of the matrix, with pHs varying from 7.1-7.3 in the superficial zone to 6.9 in the deep 
zone (Hall et al., 1996). The interstitial fluid exhibits a higher concentration of cations than 
neighbouring fluids such as synovial fluid, generating osmotic pressure (Urban et al., 1993; 
Wachtel and Maroudas, 1998). Intrafibrillar water plays an important role in the 
maintenance of the natural conformation of the collagen fibril (Wachtel and Maroudas,
1998). Within the tissue fluid a variety of gases, small proteins, metabolites and ions can 
also be found (Buckwalter and Mankin, 1998). Ions found within the interstitial fluid tend 
to be dissolved electrolytes, mainly cations such as sodium and calcium ions, attracted by 
the negative FCD. Chloride ions are also found though and collectively these ions are 
required to neutralise the charges fixed to the solid matrix (Mow et al., 1999).
The gaps between collagen fibres are relatively large, lOOnm, and are filled with a fine, 
porous GAG-water gel (Maroudas, 1976). Movement of molecules from the synovial fluid 
into the ECM is regulated by this gel. The shear presence of the collagen fibrils and 
aggregating proteoglycans makes the flow of fluid difficult, resulting in a frictional 
resistance and therefore further decreasing the permeability of cartilage (Mow et al., 1999). 
Negatively charged GAGs within the gel restrict the flow of certain ions by their respective 
charges. The small pore sizes within the gel also discriminate against movement of large 
molecules. Proteins such as serum albumin are often excluded from the matrix, however
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work by Maroudas (1976) suggests that some larger pores may be present for the regulated 
movement of these molecules. This would explain the ability of large aggregating 
proteoglycans to leave the matrix in normal ECM turnover. The observation further extends 
to that of degradative enzymes, some of which are smaller than 50KDa, and can freely 
diffuse in and out of the matrix. Their large inhibitors, such as alpha-2-macroglobulin 
(a2M), present within the joint fluid (Chu et al., 1994; Hadler et al., 1981) cannot enter the 
matrix though. Excessive degradation of the proteoglycans by proteolytic enzymes will 
increase these pore sizes though and diffusion of a2M molecules will be possible. Presence 
of a2M  within the matrix will inhibit further proteolytic degradation of proteoglycans 
allowing their restoration. At this point a2M  will once again be restricted from entering the 
matrix (Maroudas, 1976).
1.4.4 Extracellular Matrix Constituents
1.4.4.1 Proteoglycans
Proteoglycans provide compressive resistance to articular cartilage as well as enhancing 
and maintaining its durability. The specificity and concentration of proteoglycans varies 
between sites and zones of articular cartilage and are also affected by age, injury and 
disease (Buckwalter and Mankin, 1998). Generally proteoglycans consist of a core protein, 
to which numerous negatively charged GAG side chains are linked. These GAG chains 
attract water in order for the proteoglycan to carry out its function. The proteoglycans 
within cartilage can be divided into two subfamilies, namely the large aggregating 
proteoglycans and the small leucine-rich repeat proteoglycans (SLRPs). The function and 
distribution of these proteins are described below.
1.4.4.1.1 Large Aggregating Proteoglycans
There are four members of this family, namely aggrecan, versican, brevican and neurocan, 
although only the foremost three are found in articular cartilage. All members of the family 
have an amino terminal globular domain (Gl) and a carboxyl terminal globular domain 
(G3) demonstrating lectin-like homology (Roughley, 2001).
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Aggrecan is by far the most abundant of the aggregating proteoglycans composing 90% of 
the total cartilage proteoglycan mass (Buckwalter and Hunziker, 1999). It is secreted as a 
monomer and forms aggregates with the GAG, HA. On aggregation, aggrecan becomes 
immobilised within the matrix due to the size of the complexes it forms. Each aggrecan: 
HA interaction is stabilised by one molecule of LP (Dudhia, 2005; Hascall and Heinegard, 
1974; Poole, 1986). The length of HA restricts how many aggrecan monomers can bind to 
it, as does the abundance of HA molecules. The size of aggregates can therefore range from 
2-5 aggrecan molecules where there is an excess of HA, to large aggregates of 400-800 
aggrecan monomers where HA abundance is low (Hardingham and Fosang, 1995). Due to 
the large numbers of negatively charged GAG chains on aggrecan, these aggregates are 
hydrated providing cartilage with an exceedingly high water content aiding aggrecan’s role 
in resisting compressive forces (Maroudas et al., 1969; Venn and Maroudas, 1977).
Aggrecan consists of a core protein which has an additional globular domain (G2) inserted 
between the amino terminal and carboxyl terminus (see fig. 1.4). Located between the first 
and second globular domain is an interglobular domain (IGD), which is unique to aggrecan 
(Hardingham and Fosang, 1995). At the N-terminal the G1 domain is approximately 
65KDa and contains 25% carbohydrate and some KS chains as well as oligosaccharides. 
This domain interacts specifically with HA in the formation of aggregates. In addition, the 
G1 domain may also play a role in regulating aggrecan biosynthesis by inhibiting GAG 
chain attachment to the core protein (Yang et al., 2000). The G2 domain is approximately
1 lOKDa and contains more KS than G l. The G2 domain is separated from G3 by a KS and
2 CS attachment domains. There are over 110 CS and 30 KS attachments here which aid in 
aggrecan’s function in resisting compression (Dudhia, 2005). The exact function of the G2 
domain still remains unknown, but it is thought to inhibit the secretion of aggrecan prior to 
GAG modification in the Golgi (Luo et al., 1996). The G3 domain has lectin-like homology 
suggesting that it may interact with other ECM components and may also be involved in 
intracellular trafficking during aggrecan synthesis. Aggrecan molecules within cartilage 
often appear to have lost part of their C-terminal structure including the G3 domain due to 
proteolysis (Hardingham and Fosang, 1995; Roughley, 2001).
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Fig.1.4 A schematic representation of the large aggregating proteoglycan, aggrecan
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Versican, so named because of its highly interactive and versatile nature, encodes two 
exons for CS attachment within its core protein and is thought to have roles in cell 
adhesion, proliferation, migration and ECM assembly. It is found in mature articular 
cartilage, although only as a minor constituent and is found mainly within a variety of soft 
tissues. With increasing passage, chondrocytes expanded in monolayer culture for use in 
cartilage grafts express versican within the deep zone of the graft, suggesting 
dedifferentiation of the chondrocytes (personal communication with Dr. Anthony Hayes). 
Although, still controversial, versican is therefore considered by some to be a marker of 
fibrocartilage. Increased levels of versican are also seen in osteoarthritic cartilage (Nishida 
et al., 1994). Within developing cartilage, versican is a major macromolecule expressed 
during condensation. The true role of versican in cartilage development is unknown but a 
recent study has demonstrated the positive effect of versican on mesenchymal condensation 
and ensuing chondrocyte differentiation (Kamiya et al., 2006). The authors of this study 
hypothesise that the CS chains on versican interact with cell surface receptors or provide 
the cells with suitable enviromental conditions to aid the migration and/or change in shape 
of those cells directly involved in chondrogenesis. Brevican can also be found in small 
quantities in cartilage, but is primarily located in neuronal tissues like neurocan (Wight, 
2002).
1.4.4.1.2 Small Leucine-Rich Repeat Proteoglycans
The SLRPs interact with the fibrillar collagens of the ECM and are characterised by a 
central domain composed of a series of adjacent leucine-rich repeats bordered at each end 
by disulphide bonded domains. These repeats provide an ideal conformation for binding to 
other matrix proteins. The SLRPs are unique in that they flank their leucine-rich repeats 
with cysteine residues. These non-aggregating proteoglycans do not contribute a great deal 
to the volume of the tissue or its mechanical function. It is thought that these molecules are 
present to regulate cellular behaviour through interactions with other matrix 
macromolecules (Buckwalter and Hunziker, 1999). This family of proteoglycans can be 
subdivided into three classes (Iozzo, 1998).
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This class of SLRPs comprises two members within cartilage, namely decorin and 
biglycan. They exist with one or two dermatan sulphate (DS) or CS chains in the N- 
terminus of their core protein respectively (Iozzo, 1998; Roughley, 2001). Despite their 
structural similarities they are thought to have dissimilar functions due to their differing 
expression patterns (Hocking et al., 1998). Decorin is found normally in association with 
type II collagen regulating fibril diameter and also interacting with adjacent proteoglycan 
molecules. Biglycan may also regulate type II collagen interactions but can be found most 
concentrated within the pericellular matrix interacting with type VI collagen (Buckwalter 
and Mankin, 1998). Biglycan possesses the unique ability to organise type VI collagen 
fibrils into hexagonal-like networks (Wiberg et al., 2003). Both decorin and biglycan bind 
to the N-terminus of type VI collagen through the formation of complexes with matrilins 1, 
3 and 4. Complexes between these SLRPs and matrilin-1 can also link them to aggrecan 
and LP (Wiberg et al., 2003). Both these SLRPs have growth factor binding capabilities, 
especially to transforming growth factor beta 1 (TGFpi). Decorin and biglycan have both 
been shown to bind TGFpi through their core protein, and that their GAG attachments 
hinder this process (Hildebrand et al., 1994). Decorin’s interaction with TGFpi occurs 
independently of the SLRP binding to collagen and it is hypothesised that the TGFpi-SLRP 
interaction may be a means of storing the growth factor within the ECM, thereby 
modulating the interactions with its receptor (Schonherr et al., 1998).
Class n  SLRPs
This group is further divided into 2 subfamilies. Fibromodulin and lumican comprise the 
first subfamily and keratocan, Proline Arginine-Rich End Leucine-Rich Repeat Protein 
(PRELP) and chondroadherin the second (Hocking et al., 1998; Iozzo, 1998). All members 
of this family have distinct structural homology and are therefore also classified as the KS 
proteoglycans. Within cartilage the more important members of this group are 
fibromodulin, which is found within articular cartilage throughout life but only contains KS 
chains in embryonic and juvenile tissues and lumican, which is only found in adult cartilage 
as a glycoprotein (Roughley, 2001). Both however are up-regulated in cartilage with 
ageing. Both fibromodulin and lumican have been shown to interact with fibrillar collagens
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and inhibit fibrillogenesis (Rada et al., 1993). Proteins in this family can be distinguished 
from the class I SLRPs due to the tyrosine sulphation seen at the N-terminal. Tyrosine 
sulphation has been implicated in protein-protein interactions during intracellular 
transporting and secretion. It has also been suggested to play a role in ligand recognition 
and proteolytic processing (Hocking et al., 1998).
PRELP was first isolated from articular cartilage and has been shown to encode a 382 
amino acid protein (Bengtsson et al., 1995). PRELP is unique in that its N-terminal is rich 
in arginine and proline. This proteoglycan has been shown to promote chondrocyte 
attachment but does not enhance spreading. This function was similarly described for the 
36KDa protein, chondroadherin (Hocking et al., 1998). Chondroadherin’s protein structure 
consists of ten leucine-rich repeats and nine cysteine residues and has been shown to 
interact with chondrocytes via their a 5 p l integrin receptor (Camper et al., 1997).
Class III SLRPs
This class consists of the proteoglycans epiphycan and osteoglycin. The former is found 
exclusively within epiphyseal cartilage and has therefore been implicated in cartilage 
differentiation (Iozzo, 1998). Osteoglycin was first isolated from bone (Bentz et al., 1989) 
and has subsequently been shown to play a major role in the regulation of collagen 
fibrillogenesis in many connective tissues, but is especially present within the cornea 
(Tasheva et al., 2002). Both these SLRPs have a core protein containing 6 leucine-rich 
repeats flanked by cysteine residues (Hocking et al., 1998).
1.4.4.2 Glycosaminoglycans
Many of the functional properties of proteoglycans are as a result of their GAG 
attachments. GAGs are divided into categories dependent on their saccharide composition 
(see fig. 1.5). Within each category they are then further sub-divided according to their 
sulphation pattern and chain length. Within cartilage the major sulphated GAG (sGAG) 
chains are CS and KS, with a small quantity of DS, as well as the non-sulphated GAG, HA 
(Bayliss et al., 1999). Their acidic and hydrophilic nature provides a net negative charge 
thereby attracting water molecules and providing compressive strength to the tissue. They
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are also involved in binding to growth factors, enzymes, cell surface receptors and ECM 
associated proteins (Gallagher, 1989).
1.4.4.2.1 Hyaluronan
HA is the simplest of the GAGs, composed of alternating N-acetylglucosamine and 
glucuronic acid molecules with no sulphation (see fig. 1.5). Unlike other GAGs within 
cartilage, HA is not attached to a core protein (Day and Prestwich, 2002). Due to its large 
molecular weight and high concentrations of glucuronic acid within its structure, HA will 
form a stiff and kinked coiled structure within solution occupying a large hydrodynamic 
volume (Laurent et al., 1996). HA will attach to other molecules through non-covalent 
linkage. In the case of aggrecan, this interaction is stabilised by LP. HA has diverse 
biological functions, playing major roles in intracellular signalling, providing a matrix for 
cell adhesion and migration as well as being a major component of cartilage (Tammi et al., 
2002; Toole et al., 2002; Turley et al., 2002).
1.4.4.2.2 Chondroitin and Dermatan Sulphate
CS GAG chains have a very similar structure to HA in that they are constructed from 
(l->3) links between D-glucuronic acid to N-acetylgalactosamine (see fig. 1.5). The 
galactosamine replacement for HA’s glucosamine residues are differentially sulphated in 
either position 4 (C-4-S) or 6 (C-6-S). The sulphate groups on the galactosamine residues 
and the carboxyl groups on the glucuronic acid are ionised and therefore result in a net 
negative charge. Within some cells of the body some of the carboxyl groups found on the 
glucuronic acids will be epimerised, converting D-glucuronic acid to L-iduronic acid. This 
results in a conformational change of the GAG and is now referred to as DS. In tissues such 
as cartilage, on average 100 CS chains each containing 50-60 disaccharide units are 
covalently bonded through serine residues to the core protein of aggrecan (Bali et al., 2001; 
Roden, 1980).
The pattern of sulphation of CS found within articular cartilage is dependent on age, 
topography of the joint and the zone of the cartilage. Immature cartilage contains high 
concentrations of C-4-S cartilage, but as the joint and therefore cartilage matures, C-6-S
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will become the predominant form. This change in sulphation coincides with the time that 
the chondrocyte is most actively synthesising GAG chains. Concentrations of this GAG 
will also be much higher within the deeper zones of articular cartilage than those closer to 
the articular surface (Bayliss et al., 1999). CS can be catabolised within the ECM by 
chondroitinases and glycosidases. The former is able to destroy the osidic bond between the 
N-acetylgalactosamine and glucuronic acid (Bali et al., 2001).
1.4.4.2.3 Keratan Sulphate
Two main classes of KS have been characterised, originally named KSI and KSII 
dependent on their distribution in cornea and cartilage respectively. Both consist of a 
repeated disaccharide of N-acetylglucosamine and galactose (see fig. 1.5), although KSI is 
linked to asparagine residues in the attached core protein, whereas this linkage occurs 
through serine and threonine residues in the case of KSII (Funderburgh, 2000). These 
linkages are not specific to individual tissues however, and therefore all asparagine linked 
KS chains are termed KSI and those linked through serine and threonine residues are 
termed KSII. In addition, a third class of KS, KSIII has been discovered based on its 
linkage through mannose (Krusius et al., 1986).
Within cartilage KSI can be found attached to fibromodulin, PRELP and osteoadherin 
(Antonsson et al., 1991; Bengtsson et al., 1995; Sommarin et al., 1998). A small number of 
KSI chains can also be found attached to the aggrecan core protein (Barry et al., 1995).KSII 
is more highly sulphated than KSI and the chains are shorter (Nieduszynski et al., 1990). 
As seen with CS, KS distribution is dependent on the articular cartilage zone, with much 
higher concentrations of the GAG seen in deeper regions of the tissue (Zanetti et al., 1985). 
The authors from this study demonstrated that chondrocytes found residing within the 
different cartilage zones had varying capabilities to synthesis KS thereby explaining the 
defined zonal distribution.
1.4.4.2.4 Heparin / Heparan Sulphate
Heparan sulphate (HS) is the most complex of the GAG’s, composed of alternating 
hexuronic acid and glucosamine residues (see fig. 1.5). Various sulphations along this
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polymer convey the GAG’s biological function (Lindahl et al., 1998). The closely related 
GAG heparin is considered to be an over-sulphated and intracellular HS variant. Heparin is 
specifically produced by mast cells and is found on the surface of the proteoglycan 
serglycin (Humphries and Stevens, 1992).
HS has been demonstrated to have numerous interactions with cytokines such as 
interleukin-6 (IL-6) (Mummery and Rider, 2000) and tumour necrosis factor a  (TNFa) 
(Menart et al., 2002), growth factors such as members of the fibroblast growth factor (FGF) 
family (Ashikari-Hada et al., 2004), lipases, proteases and protease inhibitors (van 
Barlingen et al., 1997; Whitelock et al., 1996) as well as ECM proteins. HS has been 
demonstrated to associate with a number of the major ECM proteins found within articular 
cartilage such as fibronectin (Walker and Gallagher, 1996) and type II collagen (Keller and 
Furthmayr, 1986).
1.4.4.3 Collagens
Collagens within the ECM of articular cartilage provide tensile strength and stability to the 
tissue and protection for the encased chondrocytes. To date 27 collagens have been 
characterised within vertebrates. Within the collagen superfamily there are four subgroups, 
namely the fibrillar collagens, microfibrillar, short chain non-fibrillar and FACITs (fibril 
associated collagens with an interrupted triple helix). All collagens are characterised by the 
presence of continuous or interrupted triple helices composed of the amino acid repeat 
sequence Gly-X-Y where the latter two residues are often proline or hydroxyproline (Pace 
et al., 2003; Ricard-Blum and Ruggiero, 2005; Sandell et al., 1999). Glycine is the smallest 
amino acid, and the alpha (a) chains of collagens arrange themselves so that these residues 
are always positioned in the centre of the triple helix, allowing the larger amino acids to fall 
on the outside of the helix. This allows close packing of the molecule. The presence of 4- 
hydroxyproline is essential for the formation o f intramolecular hydrogen bonds which 
contribute towards the thermal stability of the triple helix (Gelse et al., 2003).
The arrangement of the collagen molecules into a fibrillar structure provides collagen with 
the ability to resist tensile forces. Post-translational modification of collagens such as cross- 
linking confers greater stability and strength to the tissue. The process of collagen fibril
C h a p t e r  1
formation occurs extracellularly through the cleavage of pro-collagen peptides by pro­
collagen metalloproteinases. The C-propeptide is considered to be involved in the initiation 
of fibril formation, whereas the N-propeptide is considered to have a role in regulating 
fibril diameter (Bateman et al., 1996).
Within cartilage the main collagen is the fibrillar triple helical type II, making up 90% of 
the total collagen content. The type II collagen triple helix consists of 3 al(II) chains 
(Bruckner and van der Rest, 1994). Type II collagen a  chains show high levels of 
hydroxyproline as well as glucosyl and galactosyl residues which aid in the interaction of 
the collagen molecule with proteoglycans within the ECM (Mayne, 1989). Alternative 
splicing can occur in the type II collagen pre-messenger ribonucleic acid (mRNA) which 
results in the generation of 2 forms of the al(II) chain -  splice variants IIA and IIB. IIB is 
the most predominant form in mature articular cartilage. This variant lacks exon 2 encoding 
for a cysteine rich domain. The splice variant IIA maintains this exon and is generally 
expressed in development, and is seen in pre-chondrogenic mesenchyme and 
perichondrium (Ryan and Sandell, 1990).
Fibrils of the FACIT type IX collagen and fibrillar type XI can normally be found 
associated with type II collagen (see fig. 1.6). These minor collagens are thought to have 
roles in regulating fibril diameters of the type II component. Type IX collagen can be found 
covalently attached to the surface of the type II fibril and cross-linking between multiple 
type II and IX molecules. The presence of a CS chain on some type IX molecules suggests 
a role in interaction with other matrix components and also possible targeting of the 
molecule to the correct sites for cross-linking (Eyre et al., 1987). The NC4 (non- 
collagenous 4) domain of the type IX fibril may also help in maintaining matrix integrity 
(Morrison et al., 1996). Type XI collagen can be found within the type II/IX/XI heterofibril 
and is primarily concerned with regulating fibril diameter, although has also been suggested 
to interact with matrix proteoglycans and the chondrocytes (Eyre, 2002; Vaughan-Thomas 
et al., 2001; Wardale and Duance, 1993). It is generally accepted that this collagen type is 
required for maintaining the integrity and cohesion of the tissue. Other minor collagens 
such as types I, III, V, VI, X, XII and XIV have also been found in cartilage, although are 
normally specific to one area. For example, type VI collagen is found most concentrated
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23
Chapter 1
within the pericellular matrix surrounding the chondrocyte and acting to stabilise fibrillar 
structures and the linkage of matrix molecules (Chang and Poole, 1996; Hing et al., 2002; 
Morrison et al., 1996). Type VI collagen has been shown to interact with components of the 
ECM through SLRPs such as decorin and biglycan, which in turn complex with the 
oligomeric matrix proteins, matrilins (Wiberg et al., 2003). Matrilin-1 has previously been 
shown to interact directly with both aggrecan and type II collagen (Hauser et al., 1996; 
Paulsson and Heinegard, 1979; Winterbottom et al., 1992). Type X collagen is found 
associated with type II collagen and is expressed exclusively within the hypertrophic zone 
of the growth plate and is thought to be involved in the calcification of the surrounding 
matrix (Wardale and Duance, 1993).
1.4.4.4 Non-collagenous Proteins and Glycoproteins
In general this group constitutes mainly proteins with a few mono or oligosaccharides 
attached to them. A broad function that they appear to have is the organisation and 
maintenance of the matrix structure.
1.4.4.4.1 Link Protein
The LPs are a family of glycoproteins involved in the stabilisation of aggregates of 
proteoglycans and HA (Comper and Laurent, 1978). At least three forms of LP have been 
described, namely LP1, LP2 and LP3, and range in size from 45-50KDa (Baker and 
Caterson, 1979). LP3 is the most prominent isoform within mature articular cartilage 
(Roughley et al., 1982).
Studies isolating LP from rat chondrosarcoma have identified it as a 339 amino acid single 
peptide. Differences in the molecular weights of LP isoforms arise from glycosylation 
patterns. The protein core of LP3 is 37.406KDa and there is just one N-linked 
oligosaccharide. Disulphide bonds within the structure generate loops are separated by 
short sequences of 27 amino acids. It is thought that these loops are the important structures 
in the interaction between LP and HA, as they are known to be highly conserved within 
different species (Neame et al., 1986).
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1.4.4.4.2 Superficial Zone Protein (SZP)
SZP, an approximately 345KDa proteoglycan, also know as proteoglycan-4 (PRG4), is 
homologous to the megakaryote-stimulating factor and is specifically localised in the 
superficial zone of cartilage. The majority of the proteoglycan is released into the synovial 
fluid, although some is retained within the local matrix. SZP contains large and small 
mucin-like O-linked oligosaccharide repeat domains flanked by cysteine-rich N and C- 
terminal domains and can be classified as a proteoglycan due to the CS and KS 
substitutions. It has growth promoting, cytoprotective, lubricating and matrix binding 
properties (Flannery et al., 1999a; Schumacher et al., 1994).
1.4.4.4.3 Cartilage Intermediate Layer Protein (CILP)
This 91.5KDa protein is found specifically within cartilage and is most abundantly found 
within the transitional zone. Its defined location suggests a role for CILP in maintaining the 
structural integrity of the cartilage. Synthesised by the chondrocytes it encompasses, this 
protein has been demonstrated to have between 3 and 5 N-glycosidically linked 
oligosaccharides (Lorenzo et al., 1998) and has also been shown to be up-regulated in the 
early stages of osteoarthritis (OA) (Bayliss et al., 1983). Like aggrecan, this protein also 
accumulates within cartilage with age and although exactly why this occurs is not known, it 
has been speculated that this is the result of decreased turnover of the protein (Lorenzo et 
al., 1998).
1.4.4.4.4 Cartilage Oligomeric Matrix Protein (COMP)
This pentameric glycoprotein, composed of 5 identical llOKDa monomeric subunits, is a 
member of the thrombospondin (TSP) gene family. Specific to this family, COMP 
possesses type 3 calmodulin-like repeats, which bind calcium ions with high affinity (Chen 
et al., 2000). Calcium will also bind to the type II epidermal growth factor (EGF)-like 
repeats present, helping COMP to assume a more compact unit.
It has been suggested that this glycoprotein may have roles in tissue development and 
homeostasis through interactions directly with cells (DiCesare et al., 1994) via an integrin-
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mediated mechanism and with ECM components such as types II (Rosenberg et al., 1998) 
and IX collagen (Holden et al., 2001). These interactions with ECM constituents are zinc 
dependent and are mediated by the C-terminal of COMP. The ability of COMP to bind 
several matrix components at once suggests roles in fibrillogenesis or chaperoning, 
bringing individual fibrils together to create a heterotypic fibril (Chapman et al., 2003).
1.4.4.4.5 Annexin V / Anchorin II
Annexin V is a membrane-associated collagen binding glycoprotein with a molecular 
weight of 31KDa. This hydrophobic molecule has an affinity for native type II collagen 
fibrils and has been localised to the chondrocyte-matrix interface (Mollenhauer et al., 
1984). Binding to native type II collagen is decreased after pepsinisation signifying binding 
to the telopeptide portion of type II collagen (Kirsch and Pfaffle, 1992). Expression of 
annexin V was found to be decreased on the surfaces of flattened chondrocytes and this 
expression has been shown to decrease further with culture time (Mollenhauer et al., 1984). 
Annexin V has been suggested to play a role in the calcification of cartilage. It has been 
shown to be expressed in both the growth plate (especially within the zone of calcification) 
and bone and is a constituent of matrix vesicles. It does bind to type X collagen, although to 
a lesser extent than type II collagen and therefore is thought to play a role in the process of 
attachment of the matrix vesicles to the collagenous matrix surrounding them. Within 
calcifying tissue annexin V also takes on the form of a calcium ion channel, which it has 
been hypothesised, creates a calcium rich environment inside the matrix vesicles for 
crystallisation (Kirsch and Pfaffle, 1992).
1.4.4.4.6 Tenascin-C
Tenascin-C is a high molecular weight glycoprotein composed of 6 subunits ranging 
between 190 and 300KDa in size, joined at their N-terminal by disulphide bonds. This N- 
terminal, which is cysteine rich, is involved in oligomerisation and contains EGF-like 
repeats, fibronectin type Ill-like repeats and a fibrinogen-like globular domain (Jinnin et al., 
2004). This correlates with the ability of tenascin-C to bind to ECM proteins such as 
fibronectin and aggrecan as well as cell surface receptors. This glycoprotein also has the 
ability to interact with proteases such as the matrix metalloproteinases (MMPs) (Jones and
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Jones, 2000). Tenascin-C has been visualised by rotary shadowing and has been shown to 
form a symmetrical structure termed a hexabrachion (Erickson and Inglesias, 1984).
During chondrogenesis, tenascin-C is selectively associated with mesenchymal 
condensations. With the process of endochondral ossification and the development of bone, 
expression becomes restricted to the epiphyseal cartilage (Mackie and Murphy, 1998). 
Within normal adult cartilage tenascin-C expression has been demonstrated in the territorial 
and interterritorial matrices of the deeper zones. Within diseased or fibrillated cartilage 
tenascin-C expression is up-regulated though, especially within the pericellular matrix and 
surface lining of the cartilage (Pfander et al., 1999). This is most probably due to a tissue 
repair response.
1.4.4.4.7 Fibronectin
Fibronectin is an ECM dimeric glycoprotein with 5% carbohydrate content. It is made from 
large, 250KDa subunits. The subunits are held together by a pair of disulphide bonds at the 
C-terminal of the dimer (see fig. 1.7). Once in a dimeric form the polypeptide can fold itself 
into functional domains, which are lined up along the length of the protein. Each functional 
domain contains either type I, II or III repeats of between 45-90 amino acids forming 
separate mini-domains (Hynes, 1990).
Fibronectin can be found in two forms -  plasma (pFN) and cellular (cFN). pFN acts as a 
disulphide bonded dimer and has been shown to bind with a Kd (dissociation constant) of 
lpM  to the actin binding protein (ABP), gelsolin (Lind and Janmey, 1984). While cFN can 
be found as a dimer, it can also associate to form a high molecular weight disulphide 
bonded polymer or aggregate after secretion from the cell (Hynes, 1990).
Fibronectin, although encoded by a single gene product exists as many isoforms due to 
extensive post-translational modifications and splice variation at the pre-mRNA stage. One 
of these isoforms is found exclusively within cartilage and is derived from a pattern of 
alternative splicing (MacLeod et al., 1996). Isoforms of fibronectin expressed, change 
dramatically during development. Within articular cartilage a definite increase in 
fibronectin protein levels is seen during the process of pre-chondrocyte condensation in
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limb development (Downie and Newman, 1994; Downie and Newman, 1995; Kulyk et al., 
1989). Within mature cartilage studies by Brown and Jones (1999) and Hayashi et al. 
(1996) fibronectin biosynthesis is localised to only the surface and deep zones of cartilage.
The functions of fibronectin are diverse although definite roles in cell differentiation, 
adhesion and migration have been documented (Hynes, 1990). Fibronectin is able to bind to 
a wide variety of ECM molecules as well as to the chondrocytes via their integrin receptors. 
Fibronectin can bind to several integrins, in particular a5(31, which is specific for 
fibronectin and one of the principal integrins expressed by chondrocytes. It is the arginine- 
glycine-aspartic acid (RGD) of the type III repeats which is essential for binding to this 
integrin (Loeser, 1993; Loeser et al., 1995; Salter et al., 1995; Salter et al., 1992; Sommarin 
et al., 1989). Cells are unable to bind to fibronectin when it is in solution, suggesting that 
when fibronectin binds to a substrate its conformation must change (Grinnell, 1976; 
Pearlstein, 1978; Schwarz and Juliano, 1984). Cell binding to fibronectin requires the 
presences of divalent cations (Edwards et al., 1988; Edwards et al., 1987; Grinnell, 1976; 
Klebe, 1974; Klebe, 1975; Klebe et al., 1977; Pearlstein, 1978) and metabolic energy 
(Grinnell and Hays, 1978; Grinnell and Minter, 1978).
Structural studies by Kleinman et al. (1981) demonstrated that a single region between 
positions 690-800 on collagen chains a l  (I), a2  (I), a l  (II) and a l  (III) is required for 
binding to fibronectin. Recent findings also demonstrate an interaction between the NC4 
domain of type IX collagen and fibronectin (Callender, 2004). Fibronectin also binds 
strongly to highly sulphated HS, heparin and dextran sulphate chains. Binding of these 
proteoglycans strengthens the binding affinity to the a  chains of the described collagens. 
Fragmentation studies have demonstrated 3-4 heparin-binding sites on the fibronectin 
molecule each with its own defined specificities and affinities for divalent cations (Gold et 
al., 1983; Hayashi and Yamada, 1982; Sekiguchi et al., 1982).
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Fig.1.7 Fibronectin structure
The sequence of fibronectin is made up of type I, II and III 
repeats separated by introns. EIIIA and B can be included or 
spliced out during processing giving rise to the many isoforms 
of fibronectin. Splice variants can also occur within the V 
(variable) region.
(Adapted from Hynes, 1990)
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1.5 Age Related Changes in the Morphology and Composition of Articular Cartilage
Age related changes in articular cartilage have been widely reported and primarily relate to 
alterations in matrix macromolecule distribution (Bobacz et al., 2004). Changes in the 
physical ‘make-up’ of articular cartilage can ultimately affect the mechanical and 
functional properties of the tissue leading to degenerative diseases such as OA.
Age related decreases in proteoglycan synthesis have been reported (DeGroot et al., 1999; 
Schafer et al., 1993; Verbruggen et al., 2000), but the question of whether this is a result of 
decreased cellularity of the tissue or a decrease in biosynthetic activity of the cells is 
currently debatable. It is widely accepted that there is a decrease in cellularity of articular 
cartilage with skeletal development and maturity, although conflicting reports have been 
made as to whether this decrease continues to progress after maturation (Huch et al., 2001; 
Meachim and Collins, 1962; Mitrovic et al., 1983; Vignon et al., 1976). Decline in cell 
density occurs primarily within the superficial zone (Kobayashi et al., 2003) and this cell 
death has recently been attributed to apoptosis (Kim et al., 2000; Kim et al., 2001) after 
years of thinking the decrease in cell number was a result of necrosis (Roy and Meachim, 
1968). Analysis of aged chondrocytes has also demonstrated high level expression of pro- 
apoptotic genes such as Fas and caspase-8 (Todd Allen et al., 2004).
The initially high cell density seen within immature cartilage may contribute to the anabolic 
state of the tissue resulting in growth. Quinn et al. (1999) demonstrated that with increasing 
distances between cells there is decreased matrix metabolism. Deposition of matrix 
molecules and their turnover in bovine cartilage occurs within 8pm of the cell membrane 
(Quinn et al., 1999). In the case of mature cartilage, where cells are sparsely distributed, 
regions of the ECM will be prone to degradation.
1.6 Articular Cartilage Development
The formation of skeletal elements is under the regulation and control of transcription 
factors such as the homeobox (Hox) genes as well as signalling molecules and growth 
factors such as the bone morphogenic proteins (BMPs). The Hox genes have fundamental 
roles in the patterning of vertebrate embryos (Nowicki and Burke, 2000) and Hox 9-13
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have definite roles in limb development and patterning (Pacifici et al., 2005). The process 
o f joint development is divided into two phases, the first being mesenchymal condensation 
and the differentiation of the pluripotent cells into a cartilaginous skeleton. Within the 
developing limb, condensations form as a result of aggregation of uniform populations of 
cells (Hinchliffe and Johnson, 1980). An increase in cell-cell contact and gap junctions 
facilitate intracellular communication and the transport of molecules between them (Kelley 
and Fallon, 1978; Kelley and Fallon, 1983; Zimmermann, 1984; Zimmermann et al., 1982). 
The process of chondrogenesis follows directly on from the formation of condensations and 
it is the shape and number of these condensations that define the skeleton (Morris et al.,
2002). The clustering of these cells is under the control of cell-cell adhesion molecules such 
as neural cell adhesion molecules (N-CAMs) (Widelitz et al., 1993) and N-cadherin 
(Oberlender and Tuan, 1994) as well as matrix receptors such as CD44 (Toole, 1991). The 
constituents of the ECM change during development with increasing levels of fibronectin, 
syndecan-3, versican and tenascin seen during condensation and decreases in HA. As 
chondrogenesis begins and the multipotent cells begin to develop into chondrocytes, levels 
of the characteristic type II collagen and aggrecan increase with type I collagen levels 
decreasing (Kosher et al., 1986a; Kosher et al., 1986b).
The second phase of joint development involves the formation of the joint structures and 
space. Chondrocytes within the destined joint space undergo a phenotypic change from a 
round to a flattened fibroblastic morphology and are interconnected by gap junctions. This 
non-chondrogenic region is known as the interzone, an important signalling centre within 
the joint (Archer et al., 2003). Cells within the interzone will express BMPs and their 
antagonists, for example noggin, regulating chondrocyte proliferation and differentiation 
(Hartmann and Tabin, 2000). Signals from the joint, such as those provided by growth and 
differentiation factor 5 (Gdf5), control proliferation and prevent terminal differentiation of 
the developing cells. The interzone itself has been shown, in a study looking at the 
development of rat knee joints (Ito and Kida, 2000), to be composed of 2 outer layers 
associated with the epiphyseal ends and a thin intermediate area. Cells within the outer 
zones have been shown to become later incorporated into the epiphyses, whereas those 
within the intermediate zone are destined to become part of the articular cartilage.
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After the formation of the interzone, the cartilage anlagen will separate and undergo a 
process of cavitation to form the synovial cavity (Pacifici et al., 2005). The strongest 
evidence regarding the mechanism by which this occurs involves HA synthesis, regulated 
by mechanical loading. Both HA and its receptor, CD44, are expressed at the interzone and 
opposing cartilage surfaces (Archer et al., 1994; Dowthwaite et al., 1998; Edwards et al., 
1994; Pitsillides et al., 1995). HA synthesis is up-regulated during the formation of the 
synovial cavity. This is coupled by the increased expression of HA synthase due to 
mechanical stimulation (Dowthwaite et al., 1998). Increasing concentrations of HA result in 
cell separation and loss of tissue integrity facilitating cavitation (Toole, 1991). In addition 
to the increased synthesis and accumulation of HA, there is a change in the orientation of 
collagen fibrils along the future joint line, together facilitating the process of cavitation 
(Pacifici et al., 2005). It is also important to consider the potential role of SZP is facilitating 
cavitation. This anti-adhesive glycoprotein may, when increased in production, aid 
cavitation by reducing association between the epiphyses (Pacifici et al., 2005).
1.7 The Chondrocyte Cytoskeleton
Cytoskeletal elements form a dynamic network of microfilaments, intermediate filaments 
(IFs) and microtubules within the chondrocyte. Collectively cytoskeletal constituents play 
important roles in the interactions between the chondrocyte and its ECM. They are 
fundamentally involved in the cellular processes of motility, division and plasticity. The 
cytoskeleton also contributes to the biomechanical properties of the cell and interactions as 
a result of mechanical loading.
1.7.1 Actin Microfilaments
Actin proteins are a highly conserved family found solely in eukaryotic cells. They have 
been classified into 3 isoforms, namely a , beta (p) and gamma (y). Actin is primarily 
located within the cytoplasm, although it has been localised to the nucleus suggesting non­
trafficking functions as well. Actin filaments are constructed from individual, uniformly 
orientated globular actin molecules (G-actin) forming a tight helix with a diameter of 
approximately 8nm. These filaments (F-actin) rarely occur in isolation but rather form 
cross-linked aggregates or bundles of fibrils providing strength. These microfilaments have
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been implicated in processes such as cell adhesion (Turner and Burridge, 1991), migration 
(Heath and Holifield, 1991), ECM assembly (Hayes et al., 1999) and regulation of 
chondrocyte hypertrophy (Hirsch et al., 1996; Hirsch et al., 1997). Importantly actin has 
both active roles in movement as well as passive roles in maintaining structural integrity of 
the cell and providing an anchor for other cytoskeletal proteins.
Within chondrocytes Langelier et al. (2000) showed, by actin labelling, that the 
predominant location of actin is just beneath the cell membrane, suggesting roles in 
secretion and endocytosis. Focal points of actin at the cell membrane however were shown 
to co-localise with vinculin and therefore may also have important functions in adhesion to 
the ECM. Actin expression was seen throughout the different zones of the articular 
cartilage uniformly, in contrast to the expression of vimentin, which was concentrated 
within the superficial zones, especially in weight bearing regions.
1.7.1.1 Actin Binding Proteins
To date 162 ABPs have been identified and many are known to bind to the same site on the 
actin surface and are therefore thought to compete. These proteins have been classified into 
seven families and include the actin-monomer binding proteins, thymosin and profilin. 
Actin-monomer binding proteins associate directly with the monomer and inhibit its 
addition to the end of a forming filament. Profilin is located within the plasma membrane 
and regulates actin polymerisation in response to extracellular stimuli (Goldschmidt- 
Clermont et al., 1992), and thymosin has been shown to be mechanically regulated 
suggesting a role for actin in mechanotransduction (Blain et al., 2002; Blain et al., 2003). 
Other ABPs include the filament depolymerising proteins CapZ and actin depolymerising 
factor (ADF)/cofilin which convert F-actin to G-actin, and gelsolin which slices filaments 
by binding to either side of the F-actin cutting it into two pieces. Tropomyosin conversely 
stabilises F-actin filaments and prevents their depolymerisation, while Arp 2/3 (actin 
related peptide 2/3) act as a cross-linking protein aiding the formation of filament bundles 
(dos Remedios et al., 2003).
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Microtubules are polar structures derived from a /p  tubulin heterodimers and are considered 
highly dynamic in their ability to switch between growing and shrinking phases by the 
binding and hydrolysis of guanidine triphosphate (GTP) by individual tubulin subunits. The 
plus end of the microtubule is capable of rapid growth and shrinkage while the minus end is 
normally stabilised by the centrosome, which in most cells is next to the nucleus. In order 
to form heterodimers, tubulin needs chaperoning co-factors to be present. These co-factors 
also regulate the a /p  tubulin ratios. There are many isotypes of both a  and p tubulin 
subunits and each has a different stability within the cell. Microtubules are formed by the 
binding of polymers of tubulin dimers in a head to tail conformation. The positively 
charged C-terminal end of the isoform confers its ability to associate with microtubule- 
associate proteins (MAPs), suggesting that isoform type may be of relevance to not only the 
stability but also the functionality of the microtubule within the cell. Extensive post- 
translational modifications can also occur at the C-terminal of both tubulin subunits. These 
modifications alter the ability of the subunit to interact with cellular factors, suggesting 
importance in signal transduction pathways and cytoskeletal interactions (Nogales, 2001). 
Within chondrocytes microtubules are constantly renewing and have been demonstrated to 
play a crucial role in the process of hypertrophy (Farquharson et al., 1999) and in regulating 
the phenotype of the cell (Brown and Benya, 1988; Martin et al., 1999).
1.7.2.1 Microtubule-Associated Proteins and Motors
1.7.2.1.1 Kinesin
The microtubule-associated motor protein, kinesin, is a dimer (Hirose and Amos, 1999) of 
2 identical 120-130KDa heavy chains. Two light chains of 60-70KDa are associated with 
the dimer (Kull, 2000) and are involved in the binding of kinesin to organelles but not cell 
motility (Howard, 1997). The heavy chains both contain an N-terminal globular motor 
domain with a microtubule-binding site and an adenosine triphosphatase (ATPase)-active 
centre, a stalk region for heavy chain dimerisation and a C-terminal tail domain for cargo 
binding. Kinesin is able to bind to the surface of the microtubules and use them as tracks
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for the transportation of cargo (Vale, 2003; Woehlke and Schliwa, 2000). The preferred 
model of how kinesin performs this function is the “hand-over-hand” model where two 
kinesin heads bind to the microtubule, stepping along its surface by the hydrolysis of 
adenosine triphosphate (ATP) (Coy et al., 1999; Schnitzer and Block, 1997; Vale and 
Milligan, 2000). Kinesin directs its force towards the plus-ends of the microtubules for 
anterograde movement. Kinesin has also been documented to be involved in the movement 
of vimentin particles. Interactions between kinesin and IFs have been shown to occur 
within the tail region of kinesin’s heavy chain and within a specific 62KDa region of its 
light chain (Liao and Gundersen, 1998).
1.7.2.1.2 Dynein
Retrograde movement of cargo towards the minus-ends of microtubules, is controlled by 
the dynein-dynactin motor complex (Cross, 2004). Dynein, a large enzyme complex of the 
cytoplasm, has two heavy chains to which light chains can bind. Dynein is a much larger 
and more complex molecule than kinesin. Dyneins have a molecular mass of between 
1000-2000KDa and have 2-3 heads through which they bind the microtubules (Johnson and 
Wall, 1983; Sale et al., 1985; Vallee et al., 1988). The heads are derived from the heavy 
chains and contain large polypeptides involved in ATP hydrolysis (Vallee, 1993). The head 
of the molecule binds to the dynactin complex, which connects the complete motor 
complex to the microtubules. In addition to cargo transport, dynein is also thought to have 
roles in the movement and distribution of intracellular organelles such as elements of the 
Golgi apparatus (Vallee, 1993).
1.7.3 Intermediate Filaments
IFs derived from individual vimentin particles are an extensive family with over 65 
different genes characterised and sub-classified into 5 families -  4 of which are cytoplasmic 
(I-IV) and 1 which is nuclear (lamins / V).
Vimentin particles are elongated, thin rod-shaped dimers and can passively assemble into 
10pm diameter filaments with a polymeric coiled-coil configuration (Strelkov et al., 2003). 
Each dimer, normally homodimers, forms alignments to each other parallel to the filament
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axis. All IFs exhibit ‘tripartite’ structures with a helical domain, the rod, and flanking this 
region two non-helical domains (Fuchs and Weber, 1994; Geisler and Weber, 1982). They 
display a tight meshwork that traverses from the cytoplasm to the nucleus, suggesting 
functions in mRNA transport and targeting (Langelier et al., 2000). Their location overlaps 
with the microtubules suggesting that these systems may interact in some way (Prahlad et 
al., 1998; Yoon et al., 1998). Preparations of polymerised IFs demonstrate the unique 
ability of these filaments to resist deformation and breakage due to mechanical loading 
because of their viscoelastic nature (Janmey et al., 1991; Janmey et al., 1998). Time-lapse 
studies have demonstrated the dynamic nature of these filaments and their ability to change 
shape and configuration continuously through assembly, disassembly, shortening and 
elongation through the cytoplasm (Martys et al., 1999; Yoon et al., 1998). IFs have no 
polarity, unlike the previously discussed microtubules and actin microfilaments, due to 
their ability to orientate in both directions along the filament (Strelkov et al., 2003). 
Experiments by Yoon et al. (1998) have shown the active bi-directional movement of IFs 
within the cytoplasm with speeds of 1-2 pm/s being demonstrated by one group (Prahlad et 
al., 1998). Prahlad’s group also described the movement of individual vimentin particles 
along microtubules with the majority (*65-70%) of movement being anterograde.
Increased expression of IFs have been shown in load bearing regions of articular cartilage 
(Eggli et al., 1988) supporting the theory that IFs play a crucial role in the coordination of 
mechanical events (Lazarides, 1980). Langelier et al. (2000) showed vimentin IFs to be 
most concentrated in the superficial zones of articular cartilage with expression patterns 
being even clearer in peripheral loading bearing regions of the cartilage. Traub et al. (1995) 
have also suggested a role in signal transduction. Recent studies have demonstrated 
significant cytoskeleton disruption in osteoarthritic cartilage. Changes in both the content 
and distribution of vimentin, tubulin and actin have been visualised. A reduction in all three 
cytoskeleton components was demonstrated, with highly significant losses of vimentin and 
tubulin seen in the OA cartilage suggesting their involvement in OA pathogenesis (Capin- 
Gutierrez et al., 2004; Fioravanti et al., 2003).
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1.8 Chondrocyte Cell Surface Receptors
1.8.1 CD44
CD44 is a single-pass transmembrane glycoprotein acting as a receptor on the surface of 
many cell types including chondrocytes (Chow et al., 1995; Knudson et al., 1996). This is 
the main receptor involved in the binding of HA and therefore its associated aggrecan 
aggregates. CD44 is of crucial importance in the formation of pericellular matrices during 
the process of chondrogenesis. This receptor contains a hydrophobic transmembrane 
domain and an intracellular domain of 70 amino acids, which has the ability to transduce 
signals and control receptor expression within the plasma membrane (Knudson et al.,
1999). Changes within the HA rich ECM, to which CD44 is attached, results in alteration to 
the phosphorylation of the receptor. The intracellular domain of CD44 has binding domains 
allowing the attachment of ABPs, namely from both the ‘ERM’ (ezrin, radixin and moesin) 
and ‘ankyrin’ families. These ABPs allow the linking of the cytoskeleton to the 
cytoplasmic domain of CD44 and in turn the HA ECM. Chondrocytes have been shown to 
express both moesin and ankyrin concurrently. Chondrocytes can therefore respond to 
changes sensed in their extracellular environment through the association of their 
cytoskeleton and receptors. The association of CD44 with the discussed ABPs is just one 
example of this. These interactions have also been shown to alter chondrocyte metabolism 
(Knudson and Loeser, 2002). CD44 has also been shown to be responsible for the 
internalisation of HA for its catabolism. Mutations within the cytoplasmic tail of CD44 
have demonstrated that this domain is required for the binding and internalisation of HA. 
However, only HA located within the cell’s pericellular matrix can be processed in this 
way, perhaps contributing to the accumulation of HA and its associated G1 domain of 
aggrecan with age in the interterritorial matrix of articular cartilage (Embry and Knudson,
2003).
1.8.2 Integrins
Integrins are a heterodimeric ( l a  and lp-subunit) family of transmembrane receptors. By 
definition they are glycoproteins with large globular extracellular domains, which are able 
to bind and interact with ECM proteins as well as other cell bound surface receptors
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(‘outside-in’ signalling). Their cytoplasmic domains are able to interact with cytoskeletal 
components and through alterations in signalling pathways, mediate changes in cell 
morphology, gene expression and matrix proteins (‘inside-out’ signalling) (Camper et al., 
1998; Yamada, 1997). Intracellular signals can also be propagated through integrins and 
regulate integrin ligand-binding affinity and cell adhesion (Hynes, 1992; Schwartz et al., 
1995). Through such interactions research has elucidated roles for cell surface integrins in 
cell survival, differentiation, migration, growth and matrix remodelling. The direct 
interaction of chondrocytes with their external environment allows their response to change 
in order to maintain the composition and mechanical properties of the cartilage. On the 
surface of chondrocytes the major integrin subfamilies mediating cell-matrix interactions 
are the p i and aV-subunits. Integrin expression patterns change during development as 
well as in response to their intracellular and extracellular environments. Chondrocyte 
integrin expression has also been shown to alter in response to ECM damage or removal as 
well as by the differentiation state of the cell (Knudson and Loeser, 2002); however it is 
known that adult articular chondrocytes express a lp l ,  a2 p l (weakly), a 3 p l, a5 p l, a6 p l, 
a lO pl, aVp3 and aVP5 (Loeser et al., 1995; Salter et al., 1992; Woods et al., 1994). The 
most prominent integrin in adult chondrocytes being a5 p l (Salter et al., 1992). This has 
been summarised in fig. 1.8.
The a-subunits of integrins consist of a short cytoplasmic tail, a transmembrane domain 
and a large extracellular domain of approximately 1000 amino acids. The extracellular 
domain contains distinct cation binding regions, which regulate integrin mediated 
attachment to matrix proteins (Longhurst and Jennings, 1998). Integrins normally exist in a 
low-affinity state (Faull et al., 1994; Lollo et al., 1993) and cannot bind to its ligand 
without an energy dependent activation process involving intracellular signal transduction 
and mediation by the cytoplasmic tail. Within the P-subunits the terminal aspartic acid 
residue is necessary for the regulation of integrin activation (Hughes et al., 1996). Upon 
adhesion to ECM ligands, integrins will cluster within the cell membrane for their 
activation. Integrin signalling requires the binding of cytoskeletal elements and the 
reorganisation of cytoskeletal complexes for the activation of signalling molecules, which 
for many involves phosphorylation of tyrosine or serine and threonine residues. A study by 
Clancy et al. (1999) demonstrated such a signalling complex on integrin binding to
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fibronectin and the resulting recruitment of F-actin, the small GTPase (guanosine 
triphosphatase) RhoA and focal adhesion kinase (FAK).
Integrin receptors have also been shown to cooperate with growth factors and their 
receptors to regulate matrix production and other functions. Growth factors, such as insulin­
like growth factor-1 (IGF-1), have demonstrated potential synergy between its receptor and 
the p i integrin subunit by activation of cell signalling proteins such as She (Shakibaei et 
al., 1999). Integrins generally recognise ligand amino acid sequences containing an acidic 
residue required for ligand binding, for example RGD. TGFpi and IGF-1 have been shown 
to increase a5 p l integrin expression and in doing so increase adhesion to type II collagen 
and fibronectin. IGF-1 also increased the expression of a lp  1 integrin resulting in enhanced 
adhesion to type VI collagen (Loeser, 1997).
The cytoplasmic tails have a crucial role in the transduction of intracellular signalling 
pathways. The importance of this domain has been demonstrated by experiments lacking p 
tails which fail to localise to focal adhesions, decrease ligand binding and impair the 
activation of downstream signalling molecules (Hayashi et al., 1990; Marcantonio et al., 
1990; O’Toole et al., 1994). Isolated p tails are also the only requirement for the activation 
of downstream signalling molecules such as FAK, and can regulate cell cycle progression 
and actin cytoskeleton assembly (Belkin and Retta, 1998; David et al., 1999; Tahiliani et 
al., 1997). At least 21 proteins are known to bind to these tails including ABPs such as 
filamin and signalling proteins such as FAK. ABPs provide the connection between the 
cytoskeleton and the integrin receptors. This connection provides the basis for the 
formation of focal adhesions and the initiation of cell adhesion, spreading and migration.
1.8.3 Syndecans
Syndecans are type I membrane proteoglycans with a single transmembrane sequence and a 
short cytoplasmic tail. The extracellular domain has GAGs attached which are normally HS 
(see fig. 1.9), although some of the four members of this family possess CS or DS chains, 
for example syndecan-4 (Bemfield et al., 1992). These extracellular domains are 
heterogeneous and sequence conservation is only seen at the sites of attachment to the GAG
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Fig. 1.9 Schematic representation of the structure of syndecans (adapted from Zimmerman and David, 1999)
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side chains. The syndecan core proteins contain 4 conserved tyrosine residues, which can 
be modified by phosphorylation. The transmembrane domain is conserved between all 
members and the cytoplasmic domain can be separated into three regions with two constant 
regions (Cl and C2) flanking a variable (V) region, giving the individual syndecan its 
specificity.
These glycoproteins have been demonstrated to have roles in cell proliferation, migration, 
adhesion, cytoskeletal organisation and growth factor signalling (Woods, 2001). Syndecans 
appear to carry out their functions by binding growth factors and/or their receptors as well 
as ECM molecules. This occurs via their GAG chains which interact with signal 
transducers and directly with the cytoskeleton via their cytoplasmic domain. They have also 
been shown to bind protease inhibitors and degradative enzymes (Bemfield et al., 1992). 
Chondrocytes have been shown to highly express syndecan-3 during limb development and 
chondrogenesis (Gould et al., 1992; Mackie et al., 1987), and while levels are maintained in 
the proliferative chondrocytes of the growth plate, expression profiles change to syndecan-4 
in the developed articular chondrocytes. Although at much lower levels, syndecan-2 has 
been shown to be expressed in mature chondrocytes. Barre et al. (2000) has shown that 
although syndecan-1 (a syndecan normally associated with epithelial cells) is not expressed 
in normal chondrocytes it is with cultured chondrocytes from OA patients. Syndecan-2 has 
been demonstrated to interact with matrix proteins, including fibronectin (Kusano et al., 
2000), and its V region is able to control matrix assembly at the cell surface (Klass et al., 
2000). As discussed above, syndecans are known to act as co-receptors for growth factors 
and this is primarily thought to occur through their GAG chains. A recent report looking at 
the interaction of syndecan-2 and TGFpl has discovered that this syndecan can act directly 
with TGFpl through its core protein (Chen et al., 2004) regulating expression of this 
growth factor.
Syndecan-3 has been shown to associate with tenascin-C in chondrogenesis (Gould et al., 
1992; Mackie et al., 1987) with particular emphasis to mesenchymal cell condensations. By 
facilitating cell-cell and cell-matrix interactions syndecan-3 promotes the formation of 
these condensations (Seghatoleslami and Kosher, 1996). During differentiation into 
chondrocytes expression decreases suggesting a role for this syndecan, and its association, 
in promoting differentiation and proliferation (Hoffman et al., 1988). Syndecan-4 is the
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most highly expressed of the family within chondrocytes. It has been shown in a number of 
cell types to have a definite role in focal adhesion formation. Within fibroblasts coated on 
fibronectin, syndecan-4 has been shown to co-localise with vinculin in focal adhesions 
(Woods and Couchman, 1994) and recruit the cytoskeletal protein to the cell-binding 
domain of fibronectin. The important role in cell adhesion and migration of syndecan-4 is 
demonstrated in a study by Bloom et al. (1999) where cells plated on fibronectin mutated 
for the heparin-binding site fail to form filopodia and stress fibres and consequently spread 
slowly. It has been suggested that syndecan-4 may stimulate these processes by acting via 
the Rho-family of GTPases and also protein kinase C (PKC) (Keum et al., 2004; Koo et al., 
2006). Syndecan-4 has also been shown to co-localise with integrins within focal adhesion 
complexes (Humphries et al., 2005; Woods and Couchman, 1994). It has been hypothesised 
that syndecans may act as organising centres within focal adhesion complexes. By binding 
to intracellular scaffold proteins, such as systenin, additional transmembrane receptors 
including integrins can be recruited to the adhesion. Clustering of syndecan-4 is also 
required for focal adhesion formation within cells adhering via the a5 p l integrin (Bass and 
Humphries, 2002).
The interactions between the chondrocyte and its ECM through the discussed receptors 
have been summarised in fig. 1.10.
1.9 Focal Adhesion Formation and Cell Migration
Migration of cells occurs in response to changes or signals from the extracellular 
environment. Any changes are sensed by transmembrane receptors initiating the activation 
of signalling pathways, which result in changes in cytoskeletal organisation and the 
formation of focal adhesion complexes. It is the actin microfilament system specifically 
that is thought to be the main centre for cellular migration initiation. By rearranging the 
microfilament organisation, cells are able to form membrane protrusions and generate 
intracellular forces, which ultimately culminate in translocation of the cell.
There are two main features associated with the process of cell migration, the formation of 
lamellipodia and filopodia (see fig. 1.11). Lamellipodia have been described as veil-like
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sheets containing highly branched actin filaments (Small, 1994). Filopodia are in contrast, 
long, thin structures which project beyond the leading edge of the lamellipodium and are 
characterised by their parallel organisation of actin filament bundles (Small et al., 1999; 
Svitkina et al., 2003).
The actual process of translocation requires the cell to attach to its substrate at the leading 
edge and also regulate its detachment from the rear (Lauffenburger and Horwitz, 1996; 
Mitchison and Cramer, 1996). Focal adhesions form at the site of attachment (see section 
1.9.1) and the resulting movement and activation of signalling molecules within the cell 
connect these contact points with the actin cytoskeleton. Focal adhesions at the rear of the 
cell are released to allow the cell to be actively pulled forward. Within a resting, non-motile 
cell there is little or no turnover of actin filaments. In the presence of growth factors or 
chemoattractants, filaments are uncapped and/or severed to allow the conversion of G-actin 
to F-actin. This cycle of cell polarisation, protrusion of lamellipodia (due to actin 
polymerisation), formation of focal adhesions and detachment of the rear of the cell allows 
complete translocation of the cell in response to stimuli.
Specifically within chondrocytes, the adhesion of the cell to a matrix substrate is directly 
affected by the surface chemistry and topography. One group have previously demonstrated 
that primary chondrocytes respond well to deep grooves, demonstrating increased levels of 
cell migration (Hamilton et al., 2005). In addition, the mechanisms by which they do this 
are not typical to other cell types, with no rearrangement of the F-actin cytoskeleton seen 
(Curtis and Wilkinson, 1998).
1.9.1 Focal Adhesion Formation
Focal adhesions form at points of contact between a cell and its ECM (see fig. 1.12). 
Transmembrane receptors such as the integrins mediate this attachment and initiate an 
intracellular response, resulting in the accumulation of signal transduction molecules at the 
point of contact. The complete adhesion complex contains cytoskeletal, enzymatic and 
adaptor proteins for mediation between the matrix and the intracellular cytoskeleton. 
Attachment of matrix proteins to integrins is not sufficient enough however to initiate such
4 5
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a response. Studies by Couchman et al. (2001) demonstrated that adhesion of fibronectin to 
a 5 p l is not sufficient for focal adhesion formation. Interactions o f fibronectin with the 
membrane bound glycoprotein, syndecan-4, via its heparin binding domains did however 
result in the formation of focal adhesions. Within fibroblasts it has been shown that the V 
region of syndecan-4 mediates PKCa localisation and activation of focal adhesions (Oh et 
al., 1997a; Oh et al., 1997b; Oh et al., 1998).
FAK is recruited and activated upon clustering and ligation of integrins (Brakebusch et al., 
1997; Howe and Juliano, 1998; Schoenwaelder and Burridge, 1999) and this is also 
mediated by syndecan-4 in some way (Jeong et al., 2001). FAK is also known to be 
activated in response to IGF-1, initiating a signalling cascade resulting in phosphoinositide 
3 kinase (PI3K) activation (Cheng et al., 2000).
In general, FAK links transmembrane glycoproteins to the actin cytoskeleton. FAK is 
composed of a central catalytic domain with a non-catalytic domain at either end (Parsons, 
2003). The N-terminal of FAK has a FERM (band four point one, ezrin, radixin, moesin) 
homology domain and the C-terminal region contains 2 proline-rich regions that serve as 
binding sites for a variety of SH3 containing proteins, for example, the GTPase activating 
protein (GAP). The C-terminal region also contains the focal adhesion targeting (FAT) 
domain, which contains binding sites for the integrin-associated proteins talin and paxillin. 
Paxillin has been implicated in acting as a docking partner for FAK as it binds to the 
cytoplasmic domains of integrin receptors (Liu et al., 1999; Schaller et al., 1995). 
Autophosphorylation of FAK on its Tyr397 residue initiates the binding of Src and PI3K via 
its Src homology domain (SH2) (Miyamoto et al., 1995). The association between FAK 
and Src results in further phosphorylation of FAK and signalling to downstream effectors, 
as well as the incorporation of talin and paxillin and the recruitment of vinculin, paxillin, 
tensin and zyxin. Regulation of FAK activity is also modulated by inhibitory proteins 
binding to the FAK kinase domain (Abbi et al., 2002) and by the actions of protein-tyrosine 
phosphatases in either a positive (Zeng et al., 2003) or negative (Chiarugi et al., 2003) 
fashion.
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1.9.2 Signal Transduction Mechanisms
Signal transduction pathways link the ECM to the cytoskeleton. There are a number of 
pathways, which have been implicated as having roles in this information transfer, but the 
main pathway involves the Rho family of small GTPases.
1.9.2.1 Small GTPases
This family include Rho A-H, Rac and cdc42. In the process of cell migration the main 
contributors are Rho A, Rac and cdc42. All three promote the assembly of integrin-based 
matrix adhesion complexes (Nobes and Hall, 1995; Ridley and Hall, 1992; Ridley et al., 
1992). These GTPases cycle between an active GTP bound state and an inactive guanidine 
diphosphate (GDP) bound state. This cycle is regulated by GAPs and guanidine exchange 
factors (GEFs) that enhance the GTPase activity and stimulate the exchange of GDP for 
GTP. Guanidine protein inhibitors (GPIs) prevent this exchange and thereby activation. In 
their GTP state, Rho GTPases interact with downstream effectors to initiate intracellular 
responses. The main role of interest is in the regulation of the actin cytoskeleton. Each 
GTPase has its own function with relation to its role in actin cytoskeletal organisation. Rho 
regulates the assembly of the actin: myosin filaments, while Rac and cdc42 activation 
results in filopodia and lamellipodia formation due to its ability to activate Wiskott-Aldrich 
Syndrome protein (WASP) family verprolin homolgous (WAVE) proteins and 
subsequently Arp 2/3 complexes. This ultimately leads to an increase in actin 
polymerisation and protrusion of the cell membrane (Ridley and Hall, 1992; Ridley et al.,
1992). Cdc42 is also required for the cell polarity needed for actin polymerisation (Etienne- 
Manneville and Hall, 2002). Cdc42 plays a crucial role at the front of the cell in controlling 
the direction of migration. Rac has a similar function but is involved exclusively in the 
formation of lamellipodia. It is needed at the leading edge of the cell to regulate actin 
polymerisation and control membrane protrusion (Raftopoulou and Hall, 2004). It has the 
ability to activate the PIP2 (phosphatidylinositol 3,4 bisphosphate) pathway and regulate 
adenosine diphosphate (ADP). The production of PI(3,4,5)P3 leads to an increase in the 
expression of GTP-Rac. Rho has crucial roles in cell adhesion, actomyosin assembly and 
stress fibre formation. It acts primarily via the ROCK myosin-light-chain or ROCK-LIMK 
pathway and diaphanous (mDIA)-profilin and regulates the contraction of the cell body and
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retraction of the rear of the cell (Raftopoulou and Hall, 2004; Ridley and Hall, 1992; Ridley 
et al., 1992). Rho GTPases can also modulate microtubule organisation and structure 
(Wittmann and Waterman-Storer, 2001), reorganising the cytoskeleton towards the leading 
edge, directing the transport pathways there (Ma and Chisholm, 2002). These GTPases are 
also able to regulate each other’s activities. For example, activation of Rac inhibits the 
GTPase Rho, which is thought to be behind the mechanism for cell detachment (Sander et 
al., 1999).
1.10 Proteolysis of Extracellular Matrix Components
Following joint injury a sustained increase in aggrecan metabolites can be detected within 
the synovial fluid as well as the damaged tissue of patients (Lohmander et al., 1999). 
Degradation of the large aggregating proteoglycan, aggrecan, is one of the first indications 
of joint injury and is thought to be primarily due to the up-regulation of aggrecanases and 
secondarily the MMPs (Amer et al., 1999).
1.10.1 Aggrecanases
Three aggrecanases have been isolated from articular cartilage. These are also known as the 
zinc metalloproteinases ADAMTS (A Disintegrin and a Metalloproteinase domain with 
Thrombospondin Motifs) 1, 4 and 5 (Nagase and Kashiwagi, 2003). All members of this 
family have an N-terminal pro-peptide domain, a metalloproteinase and a disintegrin-like 
domain resembling the ADAM (A Disintegrin and a Metalloproteinase) proteins, which are 
membrane-anchored and have a transmembrane and cytoplasmic domain in the C-terminal 
region (see fig. 1.13). The C-terminal of ADAMTS proteins contain a number of TSP-1 
motifs (Tortorella et al., 2000a). These enzymes are synthesised as pre-proteins and are 
targeted to the secretory pathway. All members possess a furin cleavage site just before the 
proteinase domain, and therefore are most probably activated intracellularly by a pro­
protein convertase and secreted as active enzymes (Jones and Riley, 2005).
ADAMTS-1 has been shown to be ineffective in cleaving aggrecan. It has been suggested 
that this ADAMTS may be acting as a natural inhibitor by competing for the binding sites 
on the aggrecan molecule (Tortorella et al., 2000a). Aggrecanase 1 and 2 (ADAMTS 4 and
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5 respectively) were first cloned in 1999 from the conditioned media of IL-1 stimulated 
bovine nasal cartilage (Abbaszade et al., 1999; Tortorella et al., 1999). The possession of 
TSP-1 motifs at the C-terminus allows the anchorage of the enzyme to extracellular GAG 
side chains. This may target the protein to distinct regions of the ECM and may serve to 
modulate the specificity and/or activity on the metalloproteinase domain by binding to 
selective sites on substrate molecules (Flannery et al., 1999b). This has been confirmed by 
research by Tortorella et al (2000b) illustrating that ADAMTS-4 will not bind to aggrecan 
if there are no glycosylation sites or if  its C-terminal is lacking.
Cleavage of aggrecan primarily occurs within the highly conserved IGD region between the 
G1 and G2 domains. Within this region there are 2 known cleavage sites between Asn341-
^  i  a  l '7'l A
Phe and Glu -Ala . The foremost has become known as the MMP site and the latter, 
the aggrecanase site (Caterson et al., 2000). Cleavage by at either site results in G1 domains 
remaining bound to HA and LP, accumulating in the tissue with age (Roughley, 2001). The 
C-terminal fragment is free to diffuse out of the tissue where it will move to the liver to be 
broken down (Ilic et al., 1992).
Monoclonal antibodies raised against N-terminal neo-epitopes of degraded aggrecan have 
allowed the quantification of these products within synovial fluid. The antibody BC-3 
recognises the N-terminal ARGSV sequence of aggrecan metabolites generated by 
ADAMTS-4 and 5 action and BC-14 recognises the FFGVG N-terminal generated by 
MMPs. Development of these antibodies has elucidated that the major catabolite in 
cytokine-mediated cartilage degradation is the ARGSV fragment, suggesting the more 
efficient aggrecanases to have the predominant role in aggrecan degradation (Amer et al., 
1999; Hughes et al., 1998). Cleavage at the MMP site however does seem to be up- 
regulated as a later event in cartilage degradation when collagenolysis has begun (Caterson 
et al., 2000).
ADAMTS-4 and 5 have been shown to cleave bovine aggrecan at 4 additional sites outside 
of the IGD in the CS rich region between G2 and G3 more readily than the site previously 
described, resulting in the formation of at least 8 aggrecan fragments (Tortorella et al., 
2002). MMPs have also been shown to cleave preferentially in the GAG binding region 
rather than the IGD (Little et al., 2002). Furthermore, the inducible expression by pro-
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inflammatory cytokines of ADAMTS-4 seems to be more active in young than the 
constitutively expressed ADAMTS-5, which is found predominantly in older tissue 
(Tortorella et al., 2002). Recent reports have demonstrated that ADAMTS-5 is the main 
aggrecanase within murine cartilage and that this enzyme is primarily responsible for 
aggrecan degradation in mouse OA and inflammatory arthritis (Glasson et al., 2005; 
Stanton et al., 2005)
1.10.2 Matrix Metalloproteinases
The first MMP was discovered by Gross and Lapiere (1962) in the tadpole tail. The 
collagenase was postulated to have a role in tissue remodelling and development in 
maturation of the frog. This family of proteolytic enzymes are now known to have 
important roles in normal tissue remodelling and wound healing as well as in many 
diseases such as OA, rheumatoid arthritis and cancers (Woessner, 1991).
The MMPs can be divided into four main groups, the collagenases, stromelysins, 
gelatinases and membrane-type MMPs (MT-MMPs), differing in their size and substrate 
specificity. Regardless of subclass, the MMPs comprise a multi-domain structure with 
additional protein elements to help with functions such as substrate binding (see fig. 1.14).
Each MMP consists of: -
(i) a signal peptide -  this signals to direct the translated product to the ER.
(ii) a pro-peptide domain (approximately 80 amino acids) which contains the 
conserved PRCG (V/N) PD sequence located at the site of an unpaired cysteine 
residue, which is lost during activation.
(iii) a catalytic domain (approximately 170 amino acids), which contains the 
thermolysin-type zinc binding domain and a conserved methionine residue. 
Structural zinc and calcium ions are also present to maintain enzyme stability 
and expression of enzyme activity.
(iv) a C-terminal hemopexin-like domain (approximately 210 amino acids) showing 
homology to vitronectin, which is a necessity for collagenases to cleave the a l  
chains of collagen and for activation from pro-form to active in MMP 2. It has 
been noted that this domain is not essential in collagenases for non-collagen
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substrate activity and for action by stromelysins. Mutation studies have shown 
this domain to be important in conveying specificity to substrate and also 
associations with tissue inhibitors of metalloproteinases (TIMPs) 1 and 2.
The MT-MMPs have a similar domain structure but in addition have a transmembrane 
domain within their C-terminal. The gelatinases also have 3 repeats of fibronectin type II 
domains composed of 58-59 amino acid repeats inserted into the catalytic domain which 
interact with collagens and gelatins. They also help to bind to their substrates and enable 
the enzyme to attach to other components of the ECM (Cawston, 1996; Kleiner and Stetler- 
Stevenson, 1993; Nagase and Woessner, 1999). MMPs are known to be able to degrade all 
components of the ECM and the family are made up of conserved domains and have a 
number of common properties.
• MMPs contain common sequences of amino acids making up to 7 distinct domains.
•  They are secreted as inactive pro-enzyme forms (excluding MT-MMPs).
• Activation of the pro-enzyme is achieved by proteolysis.
• Activation results in the loss of a pro-peptide domain and a resultant fall in
molecular weight.
•  All MMPs have a zinc containing domain within their active site.
•  All MMPs are inhibited by the naturally occurring TIMPs.
• Activity of the enzymes requires the presence of calcium ions and a neutral pH.
(Cawston, 1996)
MMPs are synthesised as pre-pro-enzymes and are secreted as inactive zymogens (Nagase 
and Woessner, 1999). Their activity is regulated at transcriptional and translational levels, 
and by their activators and inhibitors upon secretion (Stemlicht and Werb, 2001). All are 
synthesised in response to cytokines such as IL-1 and their activation is rate limited to 
proteolysis of their pro-peptide domain at the N-terminus (Saito et al., 1998).
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1.10.2.1 Collagenases
There are three distinct collagenases MMPs 1 (interstitial collagenase), 8 (neutrophil 
collagenase) and 13 (collagenase 3). Collagenases have the ability to cleave all three of the 
a  chains in collagens I, II and III. Cleavage occurs at a single site resulting in the formation 
of characteristic 1/4 and 3/4 length fragments. Unravelling of the triple helix and cleavage 
by the collagenases exposes sites for subsequent degradation by the gelatinases, MMPs 2 
and 9, for removal of degraded fragments from the matrix (Mort and Billington, 2001). 
Experiments by Fosang et al. (1996) suggest MMP 13 may also be involved in aggrecan 
degradation.
1.10.2.2 Stromelysins
The stromelysins 1 and 2 (MMPs 3 and 10 respectively) have a broad substrate specificity. 
Stromelysin 1 is not widely expressed but is inducible by growth factors and cytokines. The 
other stromelysin (MMP 7), known as matrilysin is the only MMP to have no C-terminal 
region. These enzymes have the ability to cleave aggrecan, type VI collagen, LP, 
fibronectin, laminin, vitronectin and gelatin amongst other substrates (Cawston, 1996).
1.10.23 Gelatinases
MMPs 2 and 9 are often secreted in complexes associated with TIMPs 2 and 1 respectively. 
Activation of gelatinases usually takes place on the cell surface in association with MT- 
MMPs. The carboxyl terminal domain is need for activation if taking place via a cell 
surface receptor in this way (Kleiner and Stetler-Stevenson, 1993).
1.10.2.4 Membrane-type MMPs
These enzymes are found on the cell surface of cells. The six members of the subfamily 
(MT-MMPs 1-6) contain a furin recognition site, which is involved in their activation 
within the cell (Somerville et al., 2003). On secretion these MMPs are in their active state. 
There is a 10 amino acid insert between the pro-peptide and amino terminal domain. This
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sequence GLSARNRQKR is recognised by a golgi associated serine proteinase furin, 
which activates these MMPs (Cawston, 1996).
1.10.3 The Cysteine Switch Model of Activation
Activation of the inactive form of MMPs was shown using a cysteine switch model by van 
Wart and Birkedal-Hansen (1990). This model involves a conserved cysteine residue in the 
pro-domain attached to the zinc atom found within the catalytic domain of the enzyme. 
This association appears to maintain latency of the enzyme. It was suggested that physical 
reagents such as sodium dodecyl sulphate (SDS) may be able to degrade the peptide 
containing the cysteine, causing it to fold back and break the bond between the cysteine and 
zinc atom. Reagents such as aminophenylmercuric acetate (APMA) are then free to react 
with the sulphydryl group to inactivate the cysteine and render the enzyme active. 
Alternatively it is possible that proteases could cleave the pro-peptide upstream of the 
cysteine, also breaking the cysteine-zinc bond leaving the active enzyme to autolytically 
remove its pro-peptide conferring permanent activation (Springman et al., 1990; Woessner, 
1991). Salowe et al. (1992) demonstrated that this cysteine residue co-ordinates with a zinc 
atom in the latent form of stromelysin. This was the first direct evidence supporting the 
cysteine switch mechanism (Kleiner and Stetler-Stevenson, 1993).
1.11 Natural Inhibitors of Metalloproteinases
1.11.1 Tissue Inhibitors of Metalloproteinases
TIMPs are the naturally occurring inhibitors of the MMPs. To date four members of the 
family have been characterised, TIMPs 1-4. All four TIMPs have 12 conserved cysteine 
residues paired into 6 disulphide bonds. The bonds divide TIMPs into 2 distinct domains 
each with 3 internal disulphide-bonded loops (Kleiner and Stetler-Stevenson, 1993). TIMPs 
1 and 2 have been found to be constitutively expressed and act against the MMPs in 
regulating degradation processes (Kashiwagi et al., 2001). It is currently thought that it is 
the balance in expression of MMPs and TIMPs that regulates cartilage homeostasis and it is 
the disruption of this balance that results in the onset of joint destruction.
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TIM P-l’s constitutive expression in adult and embryonic tissues suggests a role in animal 
development (Zafarullah et al., 1996). TIMP-1 is a 184 amino acid, 28KDa glycoprotein. 
Both domains of the inhibitor are thought to contribute to the MMP: TIMP interaction, the 
main residues conferring inhibitory activity appear to reside in the N-terminal domain. The 
presence of the C-terminal as well appears to tighten this binding (Cawston, 1996). TIMP-2 
shows 38% sequence homology to TIMP-1 but has a much smaller size due to its lack of 
glycosylated residues (Woessner, 1991). Differences within the promoter region of the 
inhibitors suggests that TIMP-2 may protect the integrity of the ECM by MMPs as opposed 
to TIMP-1 ’s role in acute protection (Zafarullah et al., 1996). The critical residues involved 
in MMP inhibition are located around the disulphide bond between Cys3 and Cys13 (Kleiner 
and Stetler-Stevenson, 1993; Nagase and Woessner, 1999). Both enzymes have been shown 
to share common activities in vitro including erythroid-potentiation, MMP inhibition and 
growth promotion (Wang and Soloway, 1999). They also both bind reversibly to their 
substrates with 1:1 stoichiometry with the active enzyme. They show a high degree of 
stability against high temperatures and low pH but are susceptible to reducing and 
alkylating agents (Cawston, 1996).
Recent work suggests a role for TIMPs in the regulation of ADAMTS expression. After 
secretion, TIMP-3 is bound within the matrix by negatively charged polysaccharides 
(Nagase and Kashiwagi, 2003). TIMP-3 has been shown to be a potent inhibitor of 
ADAMTS-4 and 5 with higher kD values than for MMPs (Kashiwagi et al., 2001) TIMP-1 
has also been shown to inhibit the aggrecanases at very high concentrations in vitro but this 
would not occur in vivo. TIMP-2 has been shown to have no affinity for the aggrecanases 
(Hughes et al., 1998).
1.12 Articular Cartilage Injuries
Injuries to the articular surface are frequently the result of damage to other tissues within 
the synovial joint such as the meniscus or synovium. Trauma due to repetitive impact and 
sudden movements such as twisting of the joint, as seen in high impact sports, can cause 
damage to the joint, normally resulting in swelling and pain (Buckwalter, 2002). Due to the 
inability of cartilage to effectively repair itself, these injuries can in a number of cases
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result in degeneration of the articular surface, resulting in conditions such as OA later in 
life.
A number of studies looking at the events subsequent to wounding have been performed in 
cartilage from both bovine (Tew et al., 2000) and chick cartilage (Walker et al., 2000). The 
initial events which appear to follow wounding are a zone of cell death adjacent to the 
wound edge, termed the ‘zone of necrosis’ (Stockwell, 1979), characterised by shrunken 
chondrocytes containing condensed nuclei as well as empty lacunae (Tew et al., 2000; 
Zhang et al., 2005). Work by Tew et al. (2000) demonstrated by TUNEL (terminal 
deoxynucleotidyl-mediated dUTP-biotin nick end-labelling) analysis and ultrastructural 
observations that a number of cells within this zone had died through the apoptotic 
pathway. The resulting area of acellularity is a limiting factor of integration in cartilage 
repair strategies. As a zone of mechanical weakness, it is often the area in which fissures or 
fractures occur, leading to subsequent degeneration of the repair tissue. Immediately behind 
this ‘zone of necrosis’ is a zone of cellular proliferation and increased matrix production. 
This response occurs later than the initiation of cell death and the reason for this increase in 
proliferation is not known. It has been hypothesised however, that chondrocytes adjacent to 
the ‘zone of necrosis’ may have been exposed to increased concentrations of ‘survival 
factors’ causing their proliferative response (Walker et al., 2000). In addition, cells within 
this zone of proliferation appear to up-regulate their expression of the integrin subunits, a5 
and a6. This may be as a result of alterations in the matrix composition (Walker et al., 
2000). These subunits, if bound to the pi-subunits would be able to form interactions with 
matrix molecules such as fibronectin and laminin respectively (Hall et al., 1990; Pytela et 
al., 1985).
In vitro studies investigating the reaction of bovine articular cartilage to experimental 
wounding demonstrated damage to the type II collagen fibrils, as well as loss of 
proteoglycans from the wound edge rapidly after wounding had occurred (Tew et al.,
2000). In addition, aggrecan within the ‘zone of necrosis’ adjacent to the wound edge 
undergoes proteolytic cleavage by the invading macrophages and mesenchymal stem cells 
(MSCs) as well as those live chondrocytes within the cartilage which form clusters as part 
of the repair response (Hembry et al., 2001). Taken together, the cell death and damage to 
the tissue as a result of wounding, as well as that caused by proteolytic cleavage seriously
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compromises the mechanical stability of the remaining tissue, a factor likely to play a huge 
role in the reason why regions o f integration between endogenous and repair tissue are so 
poor.
Injuries to articular cartilage are normally classified into two broad groups, namely damage 
that does not cause mechanical disruption of the articular surface and those that do. The 
latter can be further divided into chondral (where only the cartilage has been damaged) and 
osteochondral (where the subchondral bone has also been penetrated) injuries. A schematic 
illustration of both chondral and osteochondral injuries can be seen in fig. 1.15 (Buckwalter, 
2002).
1.12.1 Cell and Matrix Injuries
This form of injury to the cartilage is possible to repair. Repetitive trauma to the cartilage 
may result in damage to the proteoglycans resulting in either an up-regulation of their 
degradation or a down-regulation of their synthesis. Proteoglycans within the ECM of 
articular cartilage are the first macromolecules to respond to impact trauma. Changes in 
proteoglycan and collagen degradation are altered within days of injury and remain like that 
for a substantial time (Patwari et al., 2001). A decrease in proteoglycan concentration faster 
than replenishment by new synthesis is thought to be the point at which this form of injury 
cannot be repaired and further impact will result in extra strain on other components of the 
ECM such as the collagen fibrils, resulting in degeneration of the articular cartilage 
(Buckwalter, 2002).
1.12.2 Chondral Injuries
This form of injury involves mechanical disruption of the articular cartilage but does not 
extend to the subchondral bone (see fig. 1.15). Mechanical disruption of such a kind 
normally results in the development of fissures and chondral flaps to the articular surface 
(Buckwalter et al., 1994). This kind of injury mostly occurs in young and middle-aged 
adults who are active. The severity of this injury will be dependent on the size of the lesion, 
but invariably due to the avascular nature of the cartilage, no fibrin clot will be formed in a
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repair response and any attempt by local chondrocytes to up-regulate matrix synthesis will 
only be short term and will not result in filling of the defect (Beris et al., 2005; Buckwalter, 
2002). Injury to cartilage alone is sufficient to cause OA and such injuries can result in 
progressive degeneration of the joint (Buckwalter et al., 1994; Patwari et al., 2001).
1.12.3 Osteochondral Injuries
Injuries classified into this bracket involve damage to the articular cartilage and further 
penetration into the subchondral bone. Many injuries within this group occur as a result of 
osteochondrosis dessicans (OCD) and within the adolescent and young adult age groups. 
OCD is defined as a disorder in which an osteochondral fragment is separated from the 
articular surface. This fragment will become loose and eventually dislocate from the lesion 
site (Peterson et al., 2003).
Penetration of the bone results in blood flow and the formation of a fibrin clot, which will 
fill the defect site. Platelets within the invading blood contain the necessary growth factors 
and cytokines, for example, TGF-pl and platelet derived growth factor (PDGF) to stimulate 
the migration of undifferentiated MSCs into the defect and their differentiation into 
chondrocytes to synthesis a new matrix (Buckwalter, 2002). This is followed by an 
inflammatory response. Repair tissue tends to be of a fibrocartilaginous (containing a mix 
of both type II and I collagens) nature and with time degenerates with fragmentation and 
fibrillation of the articular surface. Spontaneous repair responses are associated with the 
development of necrotic tissue adjacent to the wound edge and little remodelling of the 
cartilage at the centre of the defect (Shapiro et al., 1993). A loss of proteoglycans and cells 
is normally seen within 6-12 months. This decrease in proteoglycans, and associated 
damage to the collagen network, results in an increased amount of water, increasing the 
tissue’s permeability and decreasing stiffness. In effect, this impairs the loading 
characteristics of healthy cartilage (Buckwalter et al., 1994). Disruption of this kind also 
normally leads to damage of the synovial membrane and exposure of the cartilage to the 
synovial fluid leading to enzymatic degradation of the cartilage (Buckwalter et al., 1994). 
Ultimately this results in diseases such as OA (Hunziker, 1999).
61
Chapter 1
Fig.1.15 Illustrated differences between chondral and osteochondral defects within 
articular cartilage (reproduced from Woodfield et al., 2002)
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1.13 Articular Cartilage Repair
In 1743, the British scientist William Hunter, stated, “from Hippocrates to the present age it 
is universally allowed that ulcerated cartilage is a troublesome thing and that, once 
destroyed, it is not repaired” (Hunter, 1743). This statement has largely remained true to 
this day due to the low intrinsic properties of cartilage to initiate a repair response 
following injury. This inability of self-renewal has been attributed to the avascular, 
alymphatic and aneural properties o f articular cartilage. The low density and isolation of 
chondrocytes within their ECM furthers this problem as cells cannot migrate to the site of 
injury and up-regulate their synthesis. Today orthopaedic surgery is developing techniques 
to enhance this repair process with the aim of producing as near a replicate of natural, 
hyaline cartilage as possible.
1.13.1 Surgical Repair Strategies
Depending on the nature of the injury there are a number of surgical therapies available 
with the aim of relieving symptoms and increasing joint mobility and function. These 
include the well establishment methods of debridement and arthroscopic lavage (Bert,
1993). Such methods do not repair the damage or instigate intrinsic repair responses. A 
number of these techniques aim to initiate repair within the native tissue by inducing an 
inflammatory response and fibrin clot development by drilling through the subchondral 
bone into the vasculature (microfracture). The outcome of these techniques is highly 
variable between patients due to differences in the repair tissue formed, and the age and 
mobility of the patient (Akizuki et al., 1997; Steadman et al., 2003). More recently methods 
involve tissue transplantation. Such techniques include osteochondral transplantation 
(mosaicplasty), perichondral and periosteal grafts. Methods such as autologous chondrocyte 
transplantation (ACT) involve the insertion of isolated autologous chondrocytes into the 
defect to stimulate the formation of repair tissue to fill the defect. All these techniques do 
initiate a repair response, although repair tissue is invariably fibrocartilaginous and 
integrates poorly with the pre-existing tissue. Long term studies on the durability of this 
repair tissue remain to be done in many cases but results from Peterson et al. (2003) for the 
use of ACT in OCD patients suggests this tissue can last for up to 10 years. Improving the 
durability and stability of this repair tissue is now the goal of orthopaedic researchers and a
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tissue resembling natural hyaline articular cartilage with good integration would surely 
provide these answers.
1.13.1.1 Autologous Chondrocyte Transplantation
Treatment of cartilage defects using the isolation and re-implantation of autologous 
chondrocytes was first demonstrated in a study by Grande et al. (1989) using rabbit 
chondrocytes isolated from healthy cartilage, and their subsequent transplantation into focal 
patellar defects within the animal. The study was declared successful, however integration 
was reported to be poor and the repair tissue brittle leading ultimately to its degeneration 
(Brittberg et al., 1996).
The first reported use in humans was in 1994 when 16 patients with femoral condyle 
defects were treated. The procedure, as summarised in fig. 1.16, was used initially for full 
thickness defects ranging from 1.6-6.5 cm2. Healthy chondrocytes were isolated from 
biopsies (300-500mg of tissue) taken from minimal weight bearing areas of healthy 
cartilage by arthroscopy. The cells were cultured for 14-21 days in autologous serum to 
increase cell number by 20-50 fold. The relationship between the number of implanted 
chondrocytes and biosynthetic activity is linear (Chen et al., 1997). In a second procedure 
the lesion is debrided back to healthy cartilage before the expanded chondrocytes are 
injected at a concentration of 2.5-5 million cells per 50-100pl into the defect covered with a 
sutured periosteal flap isolated from the proximal medial tibia (Brittberg et al., 1994).
Histology taken from biopsies of the repair tissue generated at various points after surgery 
show any attempts at integration were vertical not lateral. In general, a fibrocartilaginous 
tissue was seen with some of the periosteum remaining incorporated into the repair tissue. 
Studies investigating the molecular mechanisms behind the ACT technique have 
demonstrated the low expression of type II collagen mRNA, as well as transcriptional 
factors Sox-9 and aggrecan (Grigolo et al., 2005), thus explaining the fibrocartilaginous 
nature of the repair tissue. Studies looking at methods to encourage the re-expression of the 
chondrocytic phenotype after monolayer expansion of the cells have focussed on the 
development of a defined chondrogenic medium. A recent report by Goldberg et al. (2005) 
suggests that culturing monolayer expanded chondrocytes in media containing ITS (insulin,
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transferrin and selenium) and TGFpl enhances the re-expression of the chondrocytic 
phenotype as characterised by the production of type II collagen. The fibrocartilaginous 
nature of ACT repair tissue raises the question as to the source of the cells generating the 
repair tissue. Are the cells contributing to the repair tissue the autologous chondrocytes 
injected into the defect, the periosteal cells or stem cells entering the defect from the 
damaged subchondral bone (Redman et al., 2005)? A recent study by Dell’Accio et al. 
(2003) used a goat model to look at the contribution of fluorescently labelled transplanted 
cells. This group demonstrated that the implanted chondrocytes do participate in the 
formation of repair tissue.
For the patient, a reduction in locking, swelling and pain was seen with this surgical 
technique, but failures were due to lack of integration and insufficient filling of the defect 
(Peterson et al., 2002). Clinical findings by Minas (1998) 12-24 months post-ACT suggest, 
72% of patients had improved function and quality of life. Micheli (2001) reported overall 
improvement in the knee condition and functional outcome in 84% of patients.
Concerns with the method currently being addressed are (i) the phenotype of the cells- 
dedifferentiated cells being introduced into the defect lose their plasticity after numerous 
passages in culture; (ii) unequal distribution of the cells leading to an uneven repair tissue. 
This uneven distribution may be due to weight bearing and ‘clumping’ of the cells within 
one area of the defect; (iii) leakage of cells - weight bearing of the joint may result in 
leakage of the cells from under the sutured periosteum, which is acting as a cover, and 
supply of natural growth factors to stimulate their redifferentiation.
One newly developed technique to address some of these issues is matrix-induced 
chondrocyte implantation (MACI) (Bachmann et al., 2004). This technique involves the 
implantation of chondrocytes using a collagen based scaffold. This scaffold can be used 
instead of a periosteal graft (Behrens et al., 1999).
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Fig. 1.16 Overview of the process of ACT for treatment of full thickness defects 
(reproduced from Brittberg et al., 1994)
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1.13.2 Adhesion and Integration
Surgical techniques designed to initiate a cartilage repair response in situ have the main 
goals of relieving symptoms of the patient and increasing the function and mobility of the 
joint. The repair tissue generated is invariably fibrocartilaginous and does not have the 
correct biomechanical characteristics to withstand loading and preventing excessive 
shearing forces, which leads to ultimate degeneration of the repair tissue and surrounding 
tissues (Ghadially et al., 1977; Shapiro et al., 1993). Unfortunately these techniques do not 
really answer the question of quality integration between the native cartilage and the repair 
tissue. Studies of cartilage-cartilage interface regions have demonstrated the importance of 
cell density and phenotype as well as the matrix synthesised within this defined region for 
integration (Bos et al., 2002; Obradovic et al., 2001; Peretti et al., 2003; Spangenberg et al., 
2002). The process of integration appears to be a culmination of a number of interactions 
between new and existing tissue and involves the cross-over of both collagen and 
proteoglycan fibres over the interface region (Moretti et al., 2005). It is well known that 
proteoglycans have anti-adhesive properties, especially the small CS/DS proteoglycans 
decorin and biglycan (Rosenberg and Hunziker, 1995). This is thought primarily to occur 
through their GAG chains which block the cell binding domain of fibronectin 
(Lewandowska et al., 1987). Recent research suggests that removal of the proteoglycans at 
the wound edges by enzymatic treatment may act to improve adhesion of transplanted 
chondrocytes and integration (Giurea et al., 2002; Hunziker and Rosenberg, 1996; Lee et 
al., 2000; van de Breevaart Bravenboer et al., 2004). Specifically a number of studies have 
used the enzyme chondroitinase ABC to pre-treat the wound edge (Hunziker and 
Kapfinger, 1998; Lee et al., 2000). This enzyme, at pH 8.0, specifically targets the CS GAG 
chains attached to the aggrecan core protein as well as the SLRPs (Yamagata et al., 1968). 
The removal of proteoglycans at the wound edge may then expose pro-adhesive matrix 
macromolecules such as fibronectin or collagen. The presence of SLRPs also tightly 
regulates the development of collagen fibrils and is known to inhibit fibrillogenesis 
(Roughley, 2001). Removal of these macromolecules by digestive enzymes may encourage 
the development of stronger cross-links within the interface region and enhance collagen 
synthesis. Interestingly, the role of GAGs in inhibiting integration would also explain why 
newly formed cartilage integrates more successfully with adjacent bone. Bone contains, 
relative to cartilage, very little GAG content and exhibits a higher adhesive strength than
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native cartilage (Tognana et al., 2005). In addition, this group have also shown the negative 
effects of GAG on GAG synthesis and deposition within constructs (Freed et al., 1998).
The integration seen within mature articular cartilage is directly correlated to collagen 
cross-linking and remodelling. During cartilage maturation collagen content as well as the 
amount of non-reducible collagen cross-links increases (Verzijl et al., 2000). This in turn 
increases the mechanical stability of the cartilage. DiMicco and Sah (2001) state that it is 
the deposition of newly synthesised collagen and the process of lysyl-oxidase mediated 
cross-linking that defines the adhesive strength between opposing cartilage explants. The 
importance of these cross-links was demonstrated by Ahsan et al. (1999) when explants 
were exposed to the lysyl oxidase inhibitor p-aminopropionitrile (BAPN), which inhibits 
cross-linking and consequently integration. Recent research demonstrated that pre­
treatment of cartilage with BAPN allows the accumulation of hydroxyproline residues on 
collagen molecules, and after removal of the inhibitor, the rapid development of cross­
links. The authors hypothesise that the use of BAPN in this manner at a cartilage-cartilage 
interface would allow the rapid formation of cross-links for greater integrative strength 
(McGowan and Sah, 2005).
Chondrocytes in mature cartilage are trapped within their matrix and are unable to move 
through the tissue to the site of an injury. Removal of limited GAGs may also increase the 
permeability of the tissue, temporarily improving chances for local cell migration. Treated 
matrix also has less water so it is easier for newly synthesised matrix to infiltrate the tissue. 
Interestingly, in addition to the effects of GAG chains in inhibiting chondrocyte adhesion to 
the wound edge, a recent report has highlighted the effects of the micro-geography of the 
wound edge on chondrocyte adhesion. The authors demonstrated that the tightness of 
attachment was dependent on the smoothness of the cartilage to which the cells were to 
adhere (Zhang et al., 2005). In addition, in vivo, poor integration has been attributed to the 
presence of PRG4 in synovial fluid. PRG4, also known as lubricin or SZP is a lubricant 
found in the synovial fluid as well as the articular cartilage surface zone and is synthesised 
by both synoviocytes and superficial zone chondrocytes. Recently it has been shown that 
integration within in vivo models of cartilage repair is likely to be hindered by the presence 
of PRG4 (Englert et al., 2005, Schaefer et al., 2004).
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Work by Shapiro et al. (1993) demonstrated that tissue at the defect site becomes necrotic 
and there is no suggestion of resorption or remodelling. Injury or surgical intervention 
results in cell death at wound edges resulting in an acellular wound edge next to a zone of 
proliferating cells (Hunter and Levenston, 2004; Tew et al., 2000). Integration needs the 
presence of proliferating cells as well as deposition of ECM not just the latter alone. The 
proliferating cells will also be affected by the age of the tissue as older tissue has less active 
cells and are not capable of repairing damage to the cartilage. Removal of the ECM is 
known to trigger deoxyribonucleic acid (DNA) synthesis and cell proliferation (Giurea et 
al., 2002). Combining these factors with the introduction of proliferating cells and 
mitogenic factors into the interface region may be the key to initiating hyaline repair 
responses.
Of course an important factor in the process of repair and integration is the actual adhesion 
of cells to the injured tissue. Studies have demonstrated that native cartilage will adhere to 
both native (Reindel et al., 1995) and engineered cartilage (Silverman et al., 2000). The 
levels of adherence are poor however, and with use of the joint, fissures inevitably develop. 
The boundary between the definitions of integration and adhesion are slim but it is 
important to consider the factors involved in the attachment of chondrocytes to their 
extracellular matrices. It is the initial adhesion of transplanted cells within a cell-based 
method of repair, which may retain them within a defect. The adhesion of chondrocytes to 
articular cartilage is time dependent and with increasing seeding durations the level of 
adhesion and the stability of the interaction increases (Lee et al., 2000). The authors 
hypothesised that this increase in adherence may be due to the development of chondrocyte 
receptors for HA, collagen and/or fibronectin, and the interaction of these newly formed 
receptors with their ligands. This is likely to be integrin mediated. The level of adhesion 
may be affected by ligand density, which will invariably differ between interterritorial and 
territorial regions and also with depth from the articular surface (Hayashi et al., 1996; 
Pfander et al., 1999). As previously discussed in section 1.13.2, proteoglycans such as the 
SLRPs, especially decorin and biglycan, as well as aggrecan are anti-adhesive molecules 
and inhibit cell adhesion. In the case of decorin it is able to modulate the adhesiveness of 
cells to fibronectin through interactions of its GAG chain and protein core with the cell 
adhesive domain of fibronectin (Bidanset et al., 1992; Winnemoller et al., 1991). However, 
adhesion is not solely the answer to good integration. A study by Silverman et al. (2000)
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showed that when chondrocytes were attached to articular cartilage using fibrin glue then 
cells were retained within a defect and adhered well to the surface, but still a clear line 
between repair and endogenous tissue was seen and integration was poor. Although 
numerous reports have been published emphasising the enhancement of tissue integration 
by seeding chondrocytes between cartilage interfaces, it is obvious that a balance between 
adhesion and migration of chondrocytes into injured cartilage, and the subsequent 
generation of a biomechanically stable repair tissue is required for good integration (Bos et 
al., 2002; Obradovic et al., 2001).
1.14 Mesenchymal Stem Cells
This pluripotent cell lineage arises from the bone marrow and can be cultured in vitro to 
induce osteogenic, chondrogenic or adipogenic differentiation (Barry, 2003). Around 1 in 
every 105 cells isolated from bone marrow are stem cells and these are mixed with 
endothelial and stromal cells (Tuan et al., 2003). Protocols for MSC usage in cartilage 
repair have been previously described (Wakitani et al., 1994; Wakitani and Yamamoto, 
2002) as well as in a number of other connective tissues such as bone and tendon. The 
advantages of using MSCs as opposed to mature chondrocytes is their higher proliferative 
capacity and also that no biopsy needs to be taken from healthy cartilage in order to isolate 
the cells (Tuan et al., 2003). This reduces the risk of further degeneration in healthy 
cartilage areas. A large number of cells can further be obtained from bone marrow 
aspirations as opposed to isolation from tissue as the cells within cartilage are so sparse 
(Cancedda et al., 2003). There is also the possibility of introducing viral vectors into these 
pluripotent cells in a gene therapy attempt to improve the characteristics of the cell. 
However further research is required as the experiments by Wakitani et al. (1994; 2002) 
show no integration between the differentiated cells and the pre-existing tissue when using 
rabbit MSCs in full thickness cartilage defects.
1.15 Growth Factors
Growth factors are soluble proteins of small molecular weight and are rapidly absorbed and 
degraded in vivo (Hickey et al., 2003). Their use in therapeutics therefore needs to consider 
delivery methods in order to be effective. Growth factors can be used in conjunction with
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pre-existing technology to enhance or stabilise chondrocyte proliferation in vitro. Within 
spontaneous repair processes growth factors are seen to be differentially expressed and play 
an active role in the process of regeneration. A study by Bos et al. (2001) using injured 
articular cartilage demonstrated an up-regulation of the growth factors TGFpi, IGF-1/2 and 
FGF after injury and their subsequent return to normal expression on restoration of 
proteoglycan levels. Knowledge of this suggests that the expression of growth factors 
indicates an autocrine and/or paracrine response after injury to restore the pericellular 
matrix (Bos et al., 2001). Manipulation of growth factor expression levels therefore in 
conjunction with current repair strategies may be of use in finding the answer to the process 
of enhancing effective cartilage repair.
Within this study, the major growth factors considered are IGF-1 and TGFpi. The 
following sections give a detailed description of the structure and mechanisms of action by 
these growth factors.
1.15.1 Insulin-like Growth Factor 1
IGF-1, originally known as somatomedin C, is a 70 amino acid polypeptide with a 
molecular weight of 7.5KDa, first isolated from the liver (Humbel, 1990). IGF-1 comprises 
a 4-domain structure, with 2 domains demonstrating homology to the A and B chains of 
insulin. A third domain is similar to the pro-peptide of pro-insulin, but the fourth is unique 
to IGF-1. The mature protein is folded and stabilised by 3 intra-chain disulphide bridges 
held between 6 cysteine residues (Rotwein et al., 1987). IGF-1 is expressed from a gene 
consisting of 6 exons (exons 1-6) and spans more than 80 kilobases (Kb) of genomic DNA 
(Dickson et al., 1991; Kajimoto and Rotwein, 1991; Rotwein et al., 1986; Shimatsu and 
Rotwein, 1987). The growth factor is produced by most cells of the body and is therefore 
thought to work on its target tissues through autocrine, paracrine and endocrine 
mechanisms. Within cartilage, IGF-1 is accepted as being the major stimulatory factor 
found in the synovial fluid. Here it is found at concentrations of approximately 50ng/ml and 
is synthesised by chondrocytes and stored in the ECM at concentrations of approximately 
lOng/ml. In OA patients this concentration is normally seen to increase 5 fold 
(Schneiderman et al., 1995).
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IGF-1 has been defined as anabolic in its actions and specifically, within articular cartilage, 
has strongly been implicated in the maintenance of matrix homeostasis (Luyten et al., 1988; 
McQuillan et al., 1986). Its anabolic effects are demonstrated through its ability to increase 
both proteoglycan and collagen synthesis in vitro, and inhibit the rate of matrix degradation 
by regulating the transcription of degradative enzymes such as the MMPs and up-regulating 
the expression of TIMPs (Hui et al., 2001a; Hui et al., 2001b). IGF-1 has been 
demonstrated to reverse the effects of IL-1 and TNFa on the degradation of proteoglycans 
(Fosang et al., 1991; Tyler, 1989). IGF-1 increases cellular proliferation and differentiation 
with an increase in DNA synthesis (Trippel, 1997). In addition to its mitogenic effects, 
IGF-1 has been suggested to act as a chemoattractant. Chang et al. (2003) showed that in 
chondrocytes from newborn calves, IGF-1 can act as a chemoattractant enhancing the 
migration of these cells. A study by Gentilini et al. (2000) using hepatic stellate cells 
suggested that the chemotactic and mitogenic effects of IGF-1 are regulated through the 
PI3K pathway discussed later in this section.
The receptor for IGF-1 is heterotetrameric with 2 a  and 2 P-subunits held together 
covalently. The IGF-1 receptor (IGF-1R) is synthesised as a single precursor polypeptide 
with a molecular weight of approximately 180,000. This chain is cleaved, yielding 2 
polypeptide chains with apparent molecular weights of 135,000 (a chain) and 95,000 (p 
chain) (Jacobs et al., 1983). The extracellular a-subunit contains a cysteine-rich domain that 
is involved in the IGF-1 ligand binding to its receptor. The p-subunits anchor the receptor 
to the membrane and contains within its cytoplasmic region tyrosine kinase activity which 
is enhanced on IGF-1 binding to the a-subunit (LeRoith et al., 1995). Binding of the ligand 
to the a-subunit promotes autophosphorylation of the ligand at Tyr950, Tyr1131 and Tyr1136 
(Hongo et al., 1996). This leads to activation of the tyrosine kinase in the cytoplasmic p- 
subunit, recruiting ATP and initiating autophosphorylation of the receptor (Kato et al., 
1994). This phosphorylation also extends to other cellular substrates such as insulin 
receptor substrate 1 (IRS-1), and She. These substrates can then function as docking 
proteins for adaptor proteins such as growth factor receptor bound protein 2 (Grb2).
IRS-1, a 160-190KDa phosphoprotein, is the most characterised of these exogenous 
substrates (Sun et al., 1991; White, 1994; White et al., 1985). This protein contains at least 
20 potential tyrosine phosphorylation sites and is predicted to bind to the SH2 domains of
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the regulatory subunit of PI3K (see fig. 1.17). Yamamoto et al. (1992) demonstrated that the 
phosphorylated IGF receptor can also interact directly with PI3K’s regulatory subunit 
without IRS-1. Activation of IRS-1 is a signal to many SH2 containing proteins including 
Grb2, which is involved in Ras regulation (White, 1994). Activation of PI3K’s regulatory 
subunit and Grb2 results in activation of both the PI3K and MAPK pathways. In addition to 
this role, IRS-1 contains over 30 phosphorylation sites for serine/threonine kinases (Sun et 
al., 1991). Although the role of IRS-1 in IGF-1 signalling has not yet been well 
characterised it is known to have a crucial role in the control of cell cycle progression in 
response to IGF-1 (Chuang et al., 1993).
Independent of the IRS-1 protein, other docking proteins such as She have been implicated 
in IGF-1 signalling pathways. She is also tyrosine phosphorylated by the P receptor subunit 
and is thought to be involved in Ras signalling downstream (Rozakis-Adcock et al., 1992). 
Activation of Ras can lead to the downstream activation of the MAPK signalling cascade 
ultimately leading to MEK and RSK (ribosomal S6 kinase) translocation to the nucleus 
where transcription factors such as c-jun, c-fos and c-myc will be activated (Blenis, 1993).
Expression and activity of IGF-1 is controlled primarily through the IGF-binding proteins 
(IGFBPs). These binding proteins are a group of 6 highly versatile proteins which can 
differentially regulate IGF signalling in addition to acting independently of the growth 
factor (Shimasaki and Ling, 1991). Independently IGFBPs are involved in the regulation of 
processes such as growth, differentiation and apoptosis. IGFBPs are located within the 
ECM and exert their effects by binding to cell surface receptors. IGFBP3 and 5 have also 
been shown to be internalised by endocytotic pathways (Lee et al., 2004; Singh et al.,
2004). Together IGFBPs act to prolong the half life of IGFs-up to 12 fold (Baxter and Dai, 
1994)- while inhibiting their availability and activity. Understanding of the mechanism of 
action of these binding proteins is still slim and is thought to be cell-type specific.
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1.15.1.1 Insulin-like Growth Factor Binding Proteins 
IGFBP1 and 2
These binding proteins contain an RGD repeat and have been demonstrated to bind to the 
a5pi integrin (Jones et al., 1993). Binding to this integrin has implicated IGFBP1 in 
modulating the activity of FAK downstream and stimulating cell migration. IGFBP2 also 
contains an RGD sequence and has been hypothesised to bind to the same integrin, 
although there is no evidence for this to date. It has however been shown to bind to the cell 
surface in rat brain but the nature and role of this binding protein has still to be elucidated 
(Hoeflich et al., 2002).
IGFBP3 and 5
The functions of both these binding proteins remain unknown. IGFBP3 is the most 
abundant binding protein and the largest in circulation. Whereas IGFBP1, 2, 4 and 6 act 
exclusively as growth inhibitors to IGF induced cell proliferation, the role of IGFBP3 is 
complex. IGFBP3 can have an anti-proliferative effect but this is independent of IGF. It can 
also inhibit IGF dependent proliferation if the 2 molecules are co-incubated. In addition, 
IGFBP3 can also enhance the responsiveness of growth plate chondrocytes to IGF-1 by its 
ability to associate with the cell membrane, aiding in ligand-receptor binding (Kiepe et al., 
2002). IGFBP3 contains a number of basic amino acids and is therefore a particularly 
‘sticky’ molecule in nature. Unsurprisingly this protein has been found to bind to a number 
of receptors including the type V TGFP receptor (Leal et al., 1999; Leal et al., 1997). 
IGFBP5 has been demonstrated to bind to a membrane protein with high affinity although 
this protein remains to be characterised. High affinity binding may suggest that this 
membrane protein may be a specific IGFBP5 receptor (Andress, 1998).
Evidence from the structural analysis of both these IGFBPs suggests that may also 
translocate to the nucleus. Nuclear localisation signals (NLS) within the C-terminal 
domains of IGFBP3 and 5 support this theory (Radulescu, 1994). Internalisation of IGFBP3 
is dependent on binding to either caveolae (Lee et al., 2004; Singh et al., 2004) or the 
transferrin receptor via the metal binding domain within the C-terminus of IGFBP3 (Singh
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et al., 2004). The mechanisms o f these interactions remain unknown. Numerous studies 
have localised IGFBP3 to the nucleus and its transportation from the cytosol possibly by 
association with importin-(3. Importin-p is a protein with known roles in the transportation 
of other proteins from the cytosol into the nucleus. The translocation of IGFBP5 has been 
shown to be controlled by importin-p (Schedlich et al., 2000). The functions of these 
binding proteins on translocation to the nucleus are not well characterised but appear to 
involve regulation of transcription and therefore could lead to IGFBP dependent cellular 
effects such as apoptosis (Ricort, 2004).
1.15.2 Transforming Growth Factor Beta
TGFPs are members of the TGF superfamily, which includes the BMPs, Gdfs, activins, 
inhibins and Mullerian inhibitory factor (MIF). In total there are over 100 proteins within 
this family, all with at least one region of homology, normally occurring within the C- 
terminus (Burt and Law, 1994).
TGFpi was first identified from human platelets as a homodimeric peptide with a 
molecular weight of 25KDa (Assoian et al., 1983). In addition, a heterodimer of TGFpi 
and TGFp2 has been demonstrated (Cheifetz et al., 1988). The cloned, human sequence 
suggests that the monomer form of TGFpi (112 amino acids) is encoded at the C-terminus 
of a larger 390 amino acid precursor molecule (Derynck et al., 1986). The three mammalian 
isoforms (TGFpi-3) of the growth factor are secreted from virtually all cell types, including 
the chondrocyte, as the precursor form, preventing its attachment to the TGFp receptor 
(TGFPR) and rendering the molecule inactive (Wakefield et al., 1987). This latent 
precursor is the major point of control for TGFp activity. A fourth isoform of TGFp, 
TGFp4 is found only in avian tissues and is thought to have the same role as TGFpi within 
mammalian cells (Jakowlew et al., 1991; Pan and Halper, 2003).
The small latent complex (SLC) to which TGFp is attached on secretion consists of an N- 
terminal latency associated peptide (LAP) non-covalently associated with the mature 
peptide (Munger et al., 1997). In some cases this SLC is associated with the latent TGFp 
binding protein forming the large latent complex (Young and Murphy-Ullrich, 2004). LAP 
association with the mature peptide is critical for latency and also for expression of the
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mature domain. Mutations within the LAP-mature domain binding region result in 
diminished mature domain secretion (Sha et al., 1991). The mechanism by which LAP is 
able to confer latency is largely unknown, however a recent paper by Young and Murphy- 
Ullrich (2004) elucidated the sequence RKPK as the binding site of LAP to TGFp and a 
molecular basis for dissociation and activation of the mature TGFP through TSP-1.
Nine membrane receptors for TGFp have been identified to date and they all bind to TGFp 
with different affinities (Fanger et al., 1986). They are classified as either type I (7 
identified) or type II (2 identified) transmembrane serine/threonine receptors which form a 
functional complex of two type I and two type II. When not bound to a ligand the receptors 
exist as homodimers at the cell surface (Itoh et al., 2001).
Ligand binding results in the formation of these receptor complexes within the membrane. 
The type II receptors are known to induce the phosphorylation of their type I counterparts 
within the GS domain, an area rich in glycine and serine residues. The activation of the type 
I receptor kinase results in the downstream phosphorylation of receptor regulated Smads 
(R-Smads 1, 2, 3, 5 and 8) at 2 serine residues within their C-terminus (see fig. 1.18). 
Auxiliary proteins such as Smad anchor for receptor activation (SARA) provide access of 
the R-Smads to the phosphorylated receptor (Shi and Massague, 2003). It is believed that 
phosphorylated R-Smads form complexes with co-Smad 4 which translocate and 
accumulate in the cell’s nucleus and control gene expression in a cell type and ligand 
specific manner by interacting with various transcription factors, co-activators and co­
repressors (Zhu and Burgess, 2001). The TGFpR will remain activated for 3-4 hours after 
initial phosphorylation and continuous receptor activation by ligand binding will maintain 
the accumulating Smad complexes within the nucleus, regulating gene expression (Inman et 
al., 2002). This mechanism has recently been shown to actually involve continuous 
shuttling of the Smad proteins between the nucleus and cytoplasm via an interaction of the 
Smad MH2 (MAD homology 2) domain binding to the nuclear pore complex (Shi and 
Massague, 2003) and is importin independent (Chen et al., 2005).
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1.15.2.1 Regulation of Smad Function
The localisation and activity of Smads is controlled by their binding to adaptor molecules 
such as chaperones (Wurthner et al., 2001), microtubules (Dong et al., 2000) or SARA 
(Tsukazaki et al., 1998). Inhibitory Smads (I-Smads), 6 and 7, can interfere with receptor 
regulated Smad signalling by controlling access to the receptor. Kaiser et al. (2004) were 
the first to demonstrate the expression of both these I-Smads in normal and OA 
chondrocytes. Cytoplasmic localisation of the I-Smads within chondrocytes suggests that 
these inhibitors are permanently activated in vivo. Inactive I-Smads are generally thought to 
be localised within the nucleus. Their expression is induced by TGFp (Hata et al., 1998; 
Hayashi et al., 1997) (Imamura et al., 1997; Nakao et al., 1997). I-Smads can bind to 
TGFpRs blocking R-Smad phosphorylation (Hayashi et al., 1997; Imamura et al., 1997; 
Nakao et al., 1997). Smad 6 can also compete directly with Smad 4 for binding to 
phosphorylated Smad 1 (Hata et al., 1998).
Smad signalling is also controlled by a number of other pathways independent of type I 
receptor phosphorylation. R-Smads are targeted by the Erk MAPK pathways with or 
without the stimulation of Ras. Activation of this pathway results in inhibition of Smad 
translocation to the nucleus and signalling (Kretzschmar et al., 1999). Smads also contain 
phosphorylation sites for calcium/calmodulin dependent protein kinase II (CamKII) (Wicks 
et al., 2000) and PKC (Yakymovych et al., 2001) inhibiting TGFP induced Smad 
transcriptional activity. TGFpi activity is also controlled via a number of non-Smad 
pathways such as Erk, c-jun N-terminal kinase (JNK), MAPK and PI3K as well as Rho 
GTPase family (Derynck and Zhang, 2003). Activation of the PI3K pathway requires a 
functional type II receptor (Yi et al., 2005).
The effects of matrix metabolism by TGFpi in chondrocytes are controversial. Conflicting 
reports have demonstrated both increases and decreases in proteoglycan synthesis with 
chondrocytes in monolayer culture as well as enhanced differentiation and proliferation 
versus inhibition of growth (Trippel, 1995). These differing effects are dependent on the 
chondrocyte’s cell cycle stage. TGFp will enhance proliferation of those cells within S 
phase, whereas those dividing slowly within G1 will be inhibited (Trippel, 1995; Vivien et 
al., 1992; Vivien et al., 1990).
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Fig. 1.18 Smad activation by TGFP 
(adapted from ten Dijke and Hill, 2004)
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The anabolic effects of TGFpi have also been shown to be influenced by the presence of 
collagen, bound to the cell through an integrin interaction (Lee et al., 2002). Stimulation of 
JJ012 cells, a human chondrosarcoma cell line, with TGFpi and collagen demonstrated a 
synergistic effect on Smad 2 phosphorylation (Schneiderbauer et al., 2004). In addition, this 
synergistic interaction was seen when analysing DNA synthesis and mRNA levels of 
aggrecan (Qi and Scully, 1997; Qi and Scully, 1998). A number of studies have suggested 
that the proliferative effects of TGFP 1 are seen when in conjunction with other cytokines or 
serum factors (Bradham and Horton, 1998; Inoue et al., 1989). TGFpi has also been shown 
to have differential effects on degradative enzymes within chondrocytes. One study 
demonstrated the ability of TGFpi to up-regulate message levels of MMP9 while 
maintaining levels of the constitutively expressed MMP2 (Thompson et al., 2001). Levels 
of the aggrecanases, ADAMTS-4 and 5 showed a similar pattern, with ADAMTS-4 levels 
increasing with exposure to TGFpi, but no differences in ADAMTS-5 expression being 
seen (Moulharat et al., 2004). Recent research using the manipulation of growth factors to 
enhance cartilage repair have seen encouraging results. In one study, IGF-1 was seen to 
enhance chondrogenesis of the transplanted chondrocytes within an equine model of 
cartilage injury and resulted in a repair tissue with a higher proportion of type II collagen 
staining than those cells not supplemented with the growth factor (Fortier et al., 2002).
1.15.3 Bone Morphogenic Proteins
BMPs are a subset of the TGF-P superfamily and are known inducers of chondrogenesis 
within MSCs. BMP 2, 4 and 7 are expressed in the mesenchyme and are necessary for the 
formation of condensations and the differentiation of stem cells into chondrocytes (Pizette 
and Niswander, 2000). They also can maintain steady state proteoglycan synthesis within 
developed chondrocytes (Rosier and O'Keefe, 1998). Similar to TGFpi (see section 1.15.2) 
BMPs transduce their signals through serine/threonine kinase receptors, resulting in the 
activation of Smads (Kawabata et al., 1998; ten Dijke et al., 1994).
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1.15.4 Fibroblast Growth Factor
At least 22 members of the FGF family have been identified to date (Eswarakumar et al.,
2005). During development FGFs play crucial roles in regulating cell proliferation, 
differentiation and migration. Within the adult, FGFs play a part in both tissue repair and 
wound healing. FGF2, also known as basic FGF, exhibits anabolic effects which can be 
enhanced synergistically in conjunction with IGF-1, stimulating TGFpi release (Hickey et 
al., 2003). The response to FGFs is age and concentration dependent. At low concentrations 
in young cartilage, FGF2 is mitogenic and increases proteoglycan synthesis. However at 
high concentrations these responses become catabolic. Within adult cartilage FGF2 is 
anabolic and in a dose dependent manner (Sah et al., 1994). Over-expression studies in 
chondrocytes suggest that this growth factor may decrease type II collagen production and 
induce dedifferentiation of chondrocytes (Schmal et al., 2005).
FGFs mediate their responses by binding to their tyrosine kinase receptors. Four FGF 
receptors have been characterised (FGFR1-4). Point mutations occurring within FGFR1-3 
have been linked to a number of skeletal dysplasias, with obvious impairment to skeletal, 
digital and cranial development (reviewed in Webster and Donoghue, 1997). Specifically, 
point mutations within FGFR3 have been linked to achondroplasia, hypochondroplasia and 
thanatophoric dysplasia type I and II (Deng et al., 1996; Eswarakumar et al., 2005).
1.15.5 Hepatocyte Growth Factor
Hepatocyte growth factor (HGF), also known as scatter factor, is a regulator of cartilage 
development in embryogenesis and is up-regulated after injury (Hickey et al., 2003; 
Takebayashi et al., 1995). Conflicting reports have been documented regarding the effects 
of HGF on chondrocyte matrix turnover (Bau et al., 2004; Hickey et al., 2003). A detailed 
investigation into the effects of HGF on chondrocyte catabolic and anabolic gene 
expression suggests that this growth factor is not a major regulator in cartilage matrix 
turnover (Bau et al., 2004). Studies suggest that HGF does stimulate motility and 
proliferation within chondrocytes however (Hickey et al., 2003). This growth factor may be 
important in the induction of chondrogenesis as it is expressed prior to the formation of 
condensations (Takebayashi et al., 1995).
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1.15.6 Connective Tissue Growth Factor
Connective tissue growth factor (CTGF) is 1 of 6 members of the CCN (cyr61, ctgf, nov) 
family. Within cartilage, CTGF is predominantly expressed within the chondrocytes of the 
hypertrophic and calcifying cartilage zones (Nakanishi et al., 1997). This growth factor has 
regulatory roles in the process o f endochondral ossification, including angiogenesis 
(Takigawa, 2000). CTGF has also been demonstrated to play roles in cell proliferation, 
migration and wound healing (Oemar and Luscher, 1997). CTGF has been found to be up- 
regulated in OA chondrocytes. Clustering chondrocytes at the damaged articular surface in 
OA sufferers highly express CTGF in addition to those within the hypertrophic zone 
(Omoto et al., 2004).
CTGF is thought to be a downstream mediator of TGFpi due to the induction of CTGF 
expression in response to TGFpi stimulation (Nakanishi et al., 1997), and also because of 
the presence of a TGFpi response element within the CTGF promoter sequence 
(Grotendorst et al., 1996).
1.15.7 Platelet Derived Growth Factor
PDGF is a wound healing growth factor and is secreted by chondrocytes at the site of 
injuries (Hickey et al., 2003). This growth factor is a powerful mitogen and chemoattractant 
for all cells derived from MSCs including chondrocytes. A recent study has demonstrated 
that exposing resting zone chondrocytes to PDGF encourages cell proliferation and 
proteoglycan production whilst inhibiting their progression into endochondral ossification 
(Schmidt et al., 2006). PDGF is involved in matrix homeostasis as it can increase 
proteoglycan synthesis alone, without an associated increase in DNA synthesis (Schafer et 
al., 1993), or interact with IL-1 to induce matrix degradation (Hickey et al., 2003).
1.15.8 Ageing and Sensitivity to Growth Factors
With age the ability of chondrocytes within articular cartilage to synthesise and maintain 
their ECM becomes diminished, a factor illustrated by the increased prevalence of 
degenerative joint diseases such as OA. The biosynthetic abilities of chondrocytes are in
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part regulated by their response to anabolic growth factors such as IGF-1 and TGFpi. 
Studies have demonstrated that the response of chondrocytes to growth factors such as 
these becomes diminished with age and OA. Despite higher concentrations of IGF-1 and its 
associated receptor within osteoarthritic joints, chondrocytes are less responsive to the 
anabolic growth factor (Dore et al., 1994; Middleton et al., 1996; Tavera et al., 1996). The 
reason for this decrease in responsiveness has been partly attributed to the increased 
number of IGFBPs found within older and OA cells (Dore et al., 1994; Martin et al., 
1997). These binding proteins may associate with the cell surface and compete with IGF-1 
for its receptor. Messai et al. (2000) have also suggested that chondrocytes may exhibit 
decreased sensitivity to IGF-1 with age due to an altered signalling pathway. The authors 
addressed the activation of adenylcyclase for cAMP production required for the PKC 
pathway. They demonstrated that aged chondrocytes produced lower levels of cAMP, 
ultimately affecting the ability of the chondrocytes to produce matrix macromolecules. The 
role of cAMP in stimulating DNA synthesis and matrix production is well documented 
(Leipold et al., 1992; Stack and Brandt, 1980).
The responsiveness to other growth factors such as TGFpi and PDGF have also been 
investigated (Gueme et al., 1994). In this study the only growth factor able to stimulate a 
proliferative response in old chondrocytes was TGFpi. These findings are supported in a 
number of publications. A study by Hickery et al. (2003) illustrated the ability of TGFpi to 
increase total GAG synthesis in immature but not mature cartilage. The findings from this 
study are supported by Blaney Davidson et al. (2005) who demonstrated decreased 
expression of TGFpRI and II in old when compared to young mice. These results also 
correlated with decreased Smad 2 phosphorylation. In addition, the authors also observed 
an increase in the I-Smads 6 and 7, further supporting a decreased sensitivity to TGFpi in 
old chondrocytes. Within humans a similar observation has been made, with anabolic 
effects of TGFpi only observed in donors of less than 40 years of age (Barbero et al.,
2004).
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In summary, once injured articular cartilage will not spontaneously repair. This 
phenomenon has been attributed to its avascular nature and the entrapment of chondrocytes 
within an extensive ECM. Surgical attempts at repairing cartilage have seen the 
development of fibrocartilaginous repair tissue that integrates poorly with native cartilage. 
This study aims to address the issue of integration for cartilage repair. As discussed in 
section 1.13.2, integration is dependent on the interactions of newly synthesised matrix 
with the pre-existing cartilage as well as the migration of chondrocytes into wounded 
cartilage in order to induce a synthetic response.
Experiments outlined in the following chapters address factors influencing the migration 
and adhesion of chondrocytes, their integration into a wounded cartilage matrix as well as 
their biosynthetic responses with growth factor stimulation.
1.17 Hypothesis
Integration between injured articular cartilage surfaces can be enhanced by the addition and 
stimulation of isolated chondrocytes to the interface regions.
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The overall objective of this project is to define novel strategies for enhancing the 
integration of newly synthesised repair tissue and pre-existing cartilage in articular cartilage 
repair. The aims to be addressed to achieve the main objective are outlined below:
•  Compare the migratory capacities of chondrocytes isolated from young and 
skeletally mature articular cartilage.
• Establish an in vitro model for investigating articular cartilage repair.
• Investigate the migration and integration of chondrocytes isolated from young and
skeletally mature cartilage into wounded articular cartilage.
• Elucidate the effects of the growth factors IGF-1 and TGFpi on matrix
macromolecule biosynthesis using chondrocytes isolated from young and skeletally 
mature articular cartilage.
• Evaluate the effects of over-expressing IGF-1 and TGFpi on the migration of 
articular chondrocytes.
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Chapter 2
Investigating the Migration 
of Articular Chondrocytes
2.1 Background
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In situ it is generally accepted that chondrocytes are a non-motile cell type. Entrapped 
within the extensive ECM that they synthesise, their static nature is thought to be one of 
the major reasons why articular cartilage does not spontaneously repair.
Frenkel et al. (1996) were the first group to demonstrate directed migration of 
chondrocytes. They revealed the effects of nitric oxide on the chondrocyte’s 
cytoskeleton and how this directly affected the migration of these cells. Despite the fact 
that chondrocytes have been shown to possess the components required for cell 
movement, their migratory capacities have not been investigated in detail. A more 
recent study has shown that chondrocyte migration is an active process and involves the 
formation of pseudopodia and lamellipodia at the leading edge with ruffled borders seen 
at the posterior o f the moving cell (Chao et al., 2000). The development o f cell-based 
methods o f articular cartilage repair, such as ACT, require more detailed knowledge of 
the migratory abilities o f chondrocytes once removed from their constraining ECM.
Studies that have been carried out to date do not consider in detail the fragility of the 
chondrocyte phenotype and the well known fact that once plated and passaged, 
chondrocytes will dedifferentiate into fibroblast-like cells (Kuettner et al., 1982; 
Kuroda, 1964). A recent report on the effects o f passage number on the adhesion, 
migration and cytoskeletal organisation o f articular chondrocytes has highlighted the 
changes in F-actin arrangements between primary and passaged cells (Hamilton et al.,
2005). This is associated with the loss of the chondrocyte’s characterising spherical 
shape. The authors in this study question how passaging o f chondrocytes and the 
rearrangement of the cytoskeleton will lead to internal changes in signal transduction 
pathways and gene expression profiles. A study by Chang et al. (2003) has recently 
addressed this issue of phenotype and documented that chondrocytes isolated from 
newborn calves do have the capacity to migrate on fibronectin. To date no groups have 
looked at the ability of chondrocytes from skeletally mature articular cartilage to 
migrate. This is o f particular importance now as cell-based methods of repair generally 
use autologous chondrocytes isolated from adult articular cartilage.
Groups studying the migratory capacities o f chondrocytes have focussed on their ability 
to move on different ECM substrates and also their response to different growth factors
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in enhancing this migratory process. The glycoprotein, fibronectin (see section 
1.4.4.4.7) is generally considered to be pro-migratory and the previously discussed 
study by Chang et al. (2003) demonstrated that chondrocytes can bind to this ECM 
molecule and migrate on its surface. The chemotactic and haptotactic effects of 
fibronectin as well as type I and II collagen on chondrocyte migration have been shown 
by Shimizu et al. (1997). The group furthered this work by demonstrating that this 
migration was mediated through protein tyrosine phosphorylation initiated by the cross- 
linking or clustering o f p i integrins. Other studies have used time-lapse video­
microscopy to show that chondrocytes can bind to the surface o f collagen fibrils and 
pull themselves along the fibres like tracks. Work by Maniwa et al. (2001) using 
monolayer expanded chondrocytes also demonstrated migration by time-lapse 
microscopy on HA. No investigations have been documented on the effects of aggrecan, 
a major component of the articular cartilage ECM, on chondrocyte migration. As 
previously discussed in section 1.13.2, proteoglycans including aggrecan and the SLRPs 
are generally considered to be anti-adhesive due to the presence of their negatively 
charged GAG side chains (Culp et al., 1979; Lewandowska et al., 1987; Merle et al., 
1997; Winnemoller et al., 1991; Winnemoller et al., 1992; Yamagata et al., 1989) and 
are therefore also thought to be anti-migratory (Merle et al., 1999).
A small amount o f research has also been documented looking at the chemotactic effect 
of growth factors including IGF-1 (Chang et al., 2003) and FGF2 (Maniwa et al., 2001) 
to enhance the migration o f chondrocytes in vitro. The chondrocytes used in these 
experiments had been isolated from young animals though and it is generally accepted 
that chondrocyte responsiveness to growth factors decreases with age (Hickery et al., 
2003; Martin and Buckwalter, 2000; Martin et al., 1997). No groups have looked at the 
response of chondrocytes to growth factors with age in respect to migration. The 
chondrocytes from the Martin and Buckwalter study (Martin and Buckwalter, 2000) had 
also been expanded in monolayer culture, altering the native integrin pattern on the 
surface of the cell as seen in freshly isolated chondrocytes.
The objective of this study was to compare the migratory capacities o f both 
chondrocytes derived from young and skeletally mature animals. The cells were freshly 
isolated from the tissue and not expanded in monolayer so as to preserve their 
chondrocytic phenotype and cause as little alteration to their integrin expression pattern 
as possible. The chondrocytes were seeded onto different ECM macromolecules
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including type II collagen, fibronectin and aggrecan to investigate the effects of these 
substrates on the migration o f chondrocytes from both age groups. The chemotactic 
effects of IGF-1 and TGFpi on chondrocyte migration were also investigated. The 
effects of the CS side chains, linked to the aggrecan core protein, on chondrocyte 
migration are also addressed within this chapter.
Aims
1. Compare and contrast the migratory capacities o f chondrocytes isolated from 
both young and skeletally mature bovine articular cartilage on a variety of ECM 
macromolecules using an in vitro model for cellular migration.
2. Investigate the chemotactic effect of IGF-1 and TGFpi on chondrocytes 
migrating on a variety o f ECM macromolecules.
3. To investigate the role o f the GAG, CS, in modulating chondrocyte migration on 
monomeric aggrecan.
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2.2 Materials
All materials were obtained from Sigma Chemical Company, UK unless otherwise 
stated within the protocol.
2.3 Methods
2.3.1 Harvesting o f  Bovine Articular Cartilage Explants
Feet from both 7 day old (young) and 18 month old (skeletally mature) cattle were 
washed and skinned before being sprayed with 70% ethanol (Fisher Scientific UK Ltd., 
UK) and dissected. Upon opening o f the metacarpophalangeal or metatarsophalangeal 
joint, full depth slices o f articular cartilage were removed from the medial and lateral 
condyles of the joint using a sharp, size 10 scalpel blade (Swann Morton Ltd., UK) (see 
fig.2.1). Harvested explants o f cartilage were serially washed in Hanks balanced salt 
solution (HBSS) with 400U/ml penicillin, 400pg/ml streptomycin, lOpg/ml Fungizone 
and 200pg/ml Gentamicin twice and lOOU/ml penicillin, lOOpg/ml streptomycin, 
2.5pg/ml Fungizone and 50pg/ml Gentamicin once (Invitrogen Ltd., UK). Washed 
explants were maintained overnight in Dulbecco’s modified Eagle’s medium 
(DMEM)/Glutamax™ 1, 10% foetal bovine serum (FBS), lOOU/ml penicillin and 
lOOpg/ml streptomycin (Invitrogen Ltd., UK).
2.3.2 Isolation o f  Chondrocytes from Bovine Articular Cartilage Explants
Pronase (15U/ml) was made up in DMEM/Glutamax™ 1, 10% FBS, lOOU/ml 
penicillin, 1 OOpg/ml streptomycin and filter sterilised using a 0.2pm pore size serum 
Acrodisc® syringe filter (Pall Corporation, USA). Explants, isolated as previously 
described, were digested in pronase for 30 minutes at 37°C with gentle agitation. 
Digested explants were transferred to filter sterilised type II collagenase (llU /m l) and 
digested in the above conditions. Isolated cells were removed at 30 minute intervals and 
spun down at 1000 RPM (revolutions per minute) for 10 minutes. The collagenase 
supernatant was removed and pipetted back onto the explants and the pelleted cells were 
resuspended in DMEM:Ham’s F-12 (l:l)/Glutamax™  1, 1 X ITS (insulin, transferrin 
and selenium) supplement, lOOU/ml penicillin, lOOpg/ml streptomycin (Invitrogen Ltd., 
UK) for counting. This was the basal media used for subsequent experiments.
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Fig.2.1 Comparing the anatomy of (a) 7 day and (b) 18 month old bovine 
metacarpophalangeal/metatarsophalangeal j oints
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A cell count was performed using a haemocytometer and the trypan blue exclusion 
assay as a measure o f cell viability.
2.3.3 Assessing Cell Viability Using the Trypan Blue Exclusion Assay
The trypan blue exclusion assay was used to ascertain the quality o f the cells extracted 
before they were used for experimentation. Trypan blue is an acidic dye and can only be 
taken up by cells which have a compromised cell membrane and, are therefore, 
considered to be dead. Within the cell, trypan blue can bind to intracellular proteins and 
therefore turns the cell blue. An aliquot of isolated cells (suspended in basal media), at 
an appropriate dilution, was incubated with a working concentration o f 0.08% trypan 
blue for 5 minutes before counting. Three aliquots of cells were prepared and an 
average 3 counts were taken from each aliquot in order to obtain an accurate measure of 
chondrocyte viability. Cells were counted using a haemocytometer. Total and dead cell 
counts (those cells which stained blue after incubation with trypan blue) were calculated 
in order to obtain a percentage cell death figure.
2.3.4 Using General Histology to Investigate the Morphological Differences between 
Young and Skeletally Mature Articular Cartilage
Fig.2.1 illustrates that articular cartilage becomes thinner during development. Full 
thickness cartilage isolated from young bovine (7 day old) metacarpophalangeal and 
metatarsophalangeal joints is on average 4-5mm thick, whereas that obtained from 
skeletally mature joints (18 month old) tends only to be, at maximum, 1mm in depth. 
Here general histological methods have been employed to investigate the differences 
between the age groups o f cartilage at a microscopic level.
2.3.4.1 Haematoxylin and Eosin Staining
Haematoxylin and eosin staining was used to look at the arrangement o f chondrocytes 
within the different zones of articular cartilage and also demonstrate the profound 
differences between young and skeletally mature articular cartilage. Haematoxylin is a 
basic dye that will bind to acidic components such as DNA and therefore will stain cell 
nuclei. Typically this dye is combined with eosin, a bromine derivative of fluorescein 
which will stain both cell nuclei and the cytoplasm (Masson, 1929).
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Cryosections of 10 pm thickness from explants taken from both young and skeletally 
mature bovine metacarpophalangeal/metatarsophalangeal joints were stained. Slides 
were washed in running water for 2 minutes to hydrate them before staining in Mayer’s 
haematoxylin for 30 seconds. Slides were then transferred back to the running water and 
washed until the sections turned blue (a period of approximately 5 minutes). The 
sections were then stained in 1% aqueous eosin for 4 minutes before again washing in 
running tap water. Slides were then dehydrated in a series o f increasing alcohol 
concentrations (Fisher Scientific UK Ltd., UK) before fixing in xylene (Fisher Scientific 
UK Ltd., UK) for 4 minutes. Sections were then mounted under a coverslip using DPX 
mountant (Agar Scientific Ltd., UK). Sections were visualised using an upright light 
microscope (Leitz DMRB, Leica, Germany) at x 40 magnification and 
photomicrographs recorded using the Image Grabber PCI software, Version 2.5 
(Neotech Ltd., UK).
2.3,4.2 Masson *s Trichrome Staining
Masson’s trichrome staining procedure was used for the localisation of collagen within 
the ECM. In this method cell nuclei are stained blue/black, collagen and 
polysaccharides green and any cytoplasmic granules red (Flint, 1975). As described 
above, 10pm cryosections o f cartilage were used. Sections were hydrated in running tap 
water for 2 minutes before staining with Celestine blue for 5 minutes. Slides were then 
washed in running tap water until sections appeared clear. Sections were stained in 
Mayer’s haematoxylin for a further 5 minutes before again washing in running tap water 
until the sections appeared to turn blue. A further staining step in acid fuchsin was used 
for 5 minutes to stain any cytoplasmic granules present. The sections were again washed 
in running water for 30 seconds before differentiating in 1% phosphomolybdic acid for 
5 minutes. The slides were transferred directly to light green stain for 2 minutes before 
washing in 1% acetic acid for an extra 2 minutes. The sections were briefly washed in 
running tap water before dehydrating in increasing concentrations of alcohol, and fixing 
in xylene. Slides were allowed to air dry before mounting under a coverslip using DPX.
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2.3.43 Safranin O Staining
Safranin O is a basic dye which in the context of cartilage is used to stain for the 
presence of GAG chains (Rosenberg, 1971). In this method it has been combined with a 
Mayer’s haematoxylin stain in order to visualise cell nuclei at the same time. As for the 
haematoxylin and eosin staining and Masson’s trichrome staining, 10pm cryosections of 
full depth cartilage were used. The sections were hydrated in running tap water for 2 
minutes, before staining as previously described with Mayer’s haematoxylin. Slides 
were then washed in running water until sections appeared blue, before staining with 
1% fast green for 1 minute. Sections were subsequently rinsed in 1% acetic acid before 
staining in 0.1% Safranin O for 4 minutes. The slides were then rinsed in 1% acetic acid 
before the sections were dehydrated in alcohol and mounted under a coverslip using 
DPX mountant. Sections were visualised as per the method described for haematoxylin 
and eosin staining.
2.3.5 Measuring Cell Migration Using Boy den Chambers
2.3.5.1 Generating a Chondroitinase ABC Treated Aggrecan Substrate
Monomeric, A1D1 fraction, aggrecan purified from bovine nasal cartilage (courtesy of 
Professor Bruce Caterson, Cardiff University, UK) was digested with chondroitinase 
ABC at a concentration of O.OOlU/lOpg o f sGAG, as assessed by Dimethylmethylene 
blue assay (DMMB), for 24 hours at 37°C on a roller. Loss o f the CS side chains was 
assessed by both the DMMB colorimetric assay and slot blotting.
2.3.5.1.1 Assessment o f  Sulphated Glycosaminoglycan Content Using the 
Dimethylmethylene Blue Assay
This plate assay uses the ability of the metachromatic dye, dimethylmethylene blue to 
detect sGAGs through a colour change from blue to pink which can be read at 540nm 
(Famdale et al., 1986).
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The 1,9-dimethylmethylene blue dye (32mg) was dissolved overnight on a roller at 
room temperature in 20ml o f 100% ethanol. The vial containing the reagent was 
wrapped in foil to prevent exposure to light. The dissolved dye was added to 1.5 litres of 
distilled water, 59ml of 1M sodium hydroxide (Fisher Scientific UK Ltd., UK) and 7ml 
of 98% (v/v) formic acid (Fisher Scientific UK Ltd., UK), mixed and made up to 2 litres 
with distilled water. The complete reagent was stirred for 2 hours at room temperature. 
Absorbance readings were taken at 525 and 595nm using a multi-well plate reader 
(Labsystems Multiskan MS, Thermo Electron Corporation, UK) with respective 
absorbencies of 0.3 and 1.4 recorded if  the correct amount of dye had successfully been 
dissolved.
The DMMB Plate Assay
A standard curve was calculated from dilutions of a 0.5mg/ml stock of CS C (C-6-S) 
derived from shark cartilage, within the range o f 0-40pg/ml using distilled water. 
Standards and samples (40pl/well) were added to the 96 well plate (Greiner Bio-One 
Ltd., UK) in triplicate followed by 200pl of DMMB reagent before being read 
immediately at 525nm. Complete digestion of the A1D1 aggrecan was assessed by the 
loss of the sGAG chains.
2,3,5.2 Detection o f  Chondroitinase ABC Generated Neo-epitopes by Slot Blotting
Slot blotting principally involves the transfer o f proteins within a sample onto transfer 
membrane (Towbin et al., 1979). A primary antibody raised against the specific antigen 
required (the chondroitinase ABC generated C-O-S and C-4-S stubs in this case) will 
attach specifically to this immobilised antigen upon incubation. An appropriate species 
specific secondary antibody conjugated with a reporter enzyme such as horseradish 
peroxidase (HRP) is subsequently used and the location of the reporter enzyme tracked 
using chemiluminescence detection reagents.
Native, non-digested and chondroitinase ABC digested A1D1 aggrecan samples were 
loaded onto a slot blot system. Using this method for blotting, samples are loaded 
directly onto Immobilon-P polyvinylidene fluoride (PVDF) transfer membrane
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(Millipore Ltd., UK) pre-soaked in transfer buffer (lx  Laemmli buffer [see appendix 
5.1.3], 20% (v/v) methanol) sandwiched between the slots and filter paper and held 
under vacuum. Samples were pulled into the membrane by the vacuum over a period of 
10 minutes. On completion o f transfer, the membrane was washed 3 times over 30 
minutes in blocking buffer (1 x Tris-buffered saline (TBS) [see appendix 5.1.4], 0.05% 
(v/v) Tween 20™) with 3% (w/v) skimmed milk powder (CWS Ltd., UK) to block any 
remaining binding sites before incubation with the primary antibody.
23,5,2,1 Primary Antibodies -  IBS and 2B6
The murine monoclonal antibodies, 2B6 and 1B5, have been developed to specifically 
recognise chondroitinase ABC generated CS-stub epitopes o f the CS GAG chains 
projecting out from the aggrecan core protein (see fig.2.2). 2B6 recognises C-4-S stubs, 
specifically an unsaturated glucuronic acid residue at the non-reducing end o f the chain 
adjacent to a 4-sulphated N-acetylgalactosamine residue o f the CS unsaturated 
disaccharide (Caterson et al., 1985). 1B5 is designed to recognise unsulphated 
chondroitin-stubs. This antibody is raised against an unsaturated uronic acid residue 
linked to a N-acetylgalactosamine residue (Couchman et al., 1984).
Membranes were exposed to either 2B6 (1:100) or 1B5 (1:1000) for 2 hours at room 
temperature on a roller. Primary antibodies were diluted in blocking buffer. Primary 
antibody negative controls were exposed to just blocking buffer for the incubation 
period. On removal o f the primary antibody, the membrane was washed in blocking 
buffer 3 times over 30 minutes. All membranes including the negative controls were 
exposed to the secondary antibody (sheep anti-mouse) conjugated to HRP for 2 hours 
with agitation at room temperature. This antibody was diluted to 1:10,000 in blocking 
buffer. The membranes were again washed in blocking buffer for 30 minutes with 3 
changes before detection.
2,3,5,2.2 Detection o f Antibody Binding Using Enhanced Chemiluminescence 
(ECL™)
Excess buffer was removed before ECL™ reagent (GE Healthcare UK Ltd., UK) was 
added to the membranes. The ECL™ method allows detection o f immobilised antigens
Chondroitinase ABC Digestion
Chondroitin Stubs
CS Stubs
Fig.2.2 Schematic representation of the chondroitinase ABC generated CS-stubs 
recognised by monoclonal antibodies 2B6 and 1B5 
(adapted from Caterson, 1999)
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using HRP conjugated antibodies. The reagent works by providing the cyclic 
diacylhydrazide, luminol, which in the presence of HRP and chemical enhancers such as 
phenols is oxidised (see fig.2.3). This reaction provides light emission which has an 
approximate half life of 60 minutes and can be detected by Hyperfilm™ ECL™, a blue 
light sensitive autoradiography film (GE Healthcare UK Ltd., UK). An equal volume of 
both ECL™ reagents 1 and 2 were added to the membranes and mixed for 1 minute. 
Excess reagent was removed from the membranes before being sealed in individual 
bags and placed in an X-ray film cassette. Two sheets of Hyperfilm™ ECL™ were 
placed on top of the sealed membranes and exposed overnight before being developed 
in standard solutions using an automatic developer (AGFA Gevaert, Germany).
2.3.5.3 The Boyden Chamber System
The Boyden chamber system uses twenty four well cell culture plate inserts with an 
8pm pore size polyethylene terephthalate (PET) membrane (Becton Dickinson, USA). 
The membrane is o f a pore size where only chondrocytes which are actively migrating 
can pass through from the upper side o f the membrane onto which they are seeded to the 
underside from which they are counted (summarised in fig.2.4).
2.3.5.3.1 Coating o f  Membranes with Extracellular Matrix Macromolecules
Both sides o f the porous membrane were coated with an ECM macromolecule for 2 
hours (individual matrix molecules, their concentrations and diluents are outlined in 
table 2.1 below). Bovine plasma fibronectin was purchased from Sigma Chemicals, UK, 
type II collagen was purified from bovine cartilage (courtesy o f Professor Vic Duance, 
School o f Biosciences, Cardiff University, UK) and A1D1 aggrecan was purified from 
bovine nasal cartilage (courtesy of Professor Bruce Caterson, School o f Biosciences, 
Cardiff University, UK). Subsequent to coating, remaining binding sites were blocked 
with filter sterilised 0.1% (w/v) bovine serum albumin (BSA) diluted in lx  phosphate 
buffered saline (PBS) (pH 7.4) for 1 hour and washed with three 5 minute washes in 
PBS (pH 7.4) before being stored at 4°C.
Secondary
Antibody-
HRP
Antibody
Peracid
2H20
Oxidised Light
Luminol
Enhancer
ECL™
Detection
Fig.2.3 Summary of Western blotting method for the detection of specific protein bands 
(adapted from Amersham Biosciences, 2002)
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Table 2.1 Working concentrations of ECM coating macromolecules for Boyden 
chambers and their respective diluents.
ECM Coating 
Macromolecule
Concentration (pg/ml) Diluent Reference for 
Concentration Used
Plasma Fibronectin 10 1 x PBS (pH 7.4) (Shimizu et al., 1997)
Type II Collagen 500 0.5M Acetic Acid (Luo et al., 1997)
Whole Aggrecan 50 1 x Tris-acetate buffer (Johnson et al., 2005)
Chondroitinase ABC 
Digested Aggrecan
50 1 x Tris-acetate buffer
2.3.5.3.2 Addition o f  Isolated Chondrocytes to the Membranes
Isolated chondrocytes were suspended at a concentration of 6.7 x 105 cells/ml in basal 
media/50pg/ml ascorbic acid, and 300pl o f the cell suspension was pipetted directly 
onto the upper side o f the membrane. Basal media (1.4 ml) was added to the bottom of 
the well through the sampling port. The chondrocytes were allowed to adhere to the 
ECM coating and migrate for periods ranging from 1 to 24 hours in the presence and 
absence o f added growth factors.
2.3.5.3.3 Quantifying the Migration o f  Chondrocytes Isolated from Young and 
Mature Cartilage
Non-motile cells were removed from the upper surface o f the membrane using a cotton 
swab (CWS Ltd., UK) and migrated chondrocytes attached to the underside of the 
membranes were stained in 0.1% (w/v) crystal violet dye in 0.1 M Borax (pH 9.0) and 
2% ethanol, for 1 hour at room temperature. Stained cells were visualised by inverting 
the plate inserts and viewing using an upright light microscope (Laborlux 12, Leitz 
DRMB, Leica, Germany) connected to a digital camera (Coolsnap RS Photometries, 
USA). Images from 3 visual fields, o f 0.25mm2, in each well were recorded using the 
Coolsnap image capture program version 1.2 (Roper Scientific Inc., USA). The average 
number of migrated cells was counted. The mean + standard error (SEM) was 
calculated for each group of samples and all data was assessed for normal distribution 
using the Anderson-Darling test (P>0.05). Statistical significance was calculated using a 
one-way analysis o f variance (ANOVA) and Bonferroni post-hoc test where P<0.05.
w
Isolated Chondrocytes Cotton Swab
Remove1-24 hrs ^
>
☆
Basal Media/ascorbic acid 
Extracellular matrix coating
Growth Factor - rhlGF-1 (10ng/ml)
- rhTGF(31 (10ng/ml)
Non-Migrated 
Cells
Stain and S*\ 
Count /  
Migrated : 
Cells I
Fig.2.4 Schematic representation of the Boyden chamber system for quantifying chondrocyte migration
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2.3.6 Measuring Cellular Proliferation Using the Cytotox 96® Assay
The Cytotox 96® non-radioactive assay (Promega, UK) allows colorimetric, 
quantitative measurement of lactate dehydrogenase (LDH) within cell culture media and 
cell extracts. LDH is a cytosolic enzyme released on cell lysis. The presence of LDH 
results in the conversion of a tetrazolium salt (INT) into a measurable red formazan 
product. The quantity of product formed is directly proportional to the number of lysed 
cells and can be read at 492nm. The reactions occurring for LDH detection are 
summarised diagrammatically in fig.2.5.
LDH
NAD+ + Lactate ---------- ► Pyruvate + NADH
Diaphorase
NADH + INT  ► NAD+ + Formazan (Red Product)
Fig. 2.5 A summary of the reactions occurring during the Cytotox 96® assay in
the detection of LDH
Before IGF-1 and TGFpi could be used as chemoattractants within the Boyden 
chamber system, it was important to ascertain whether these growth factors-at the 
concentration they were to be used at (10ng/ml)-initiated a proliferative response on 
chondrocytes isolated from young and mature articular cartilage. Any increase in 
proliferation may be misinterpreted as an increase in cell migration.
Chondrocytes isolated from young and mature articular cartilage (see section 2.3.2) 
were seeded onto 24 well plates at 1 x 106 cells/well, in basal media, and allowed to 
settle overnight. The media was aspirated from the wells and replaced with 1ml of basal 
media containing lOng/ml IGF-1 and/or lOng/ml TGFpi. Media alone served as a 
control. The chondrocytes were left in the presence of the growth factors at 37°C for 24 
hours, before the media was removed and the cells lysed in 0.9% Triton® X 100 (Fisher 
Scientific UK Ltd., UK).
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The provided assay buffer (12ml) was thawed and added to the lyophilised substrate 
mix. Cell lysates were pipetted in duplicate into a 96 well microtitre plate. The 
reconstituted substrate mix (50pl) was added to each well and the plate incubated in the 
dark for 10 minutes at room temperature. After the incubation period, 50pl of stop 
solution (1M acetic acid) was added to each well and the absorbance read at 492nm.
The mean + the SEM were calculated for each treatment group. Data was assessed for 
normality, and statistical significance calculated using the methods outlined in section 
2.3.5.3.3.
2.3.7 Assessing the Chemotactic Effects o f  IGF-1 and TGFpi on Chondrocytes 
Migrating on Extracellular Matrix Macromolecules
As previously described in section 2.3.5.3.1, Boyden chamber membranes were coated 
with ECM macromolecules for both age groups of chondrocytes to migrate on. In this 
experiment the membranes were coated with fibronectin, type II collagen, native 
aggrecan (all at the concentrations stated in table 2.1) or 0.1% (w/v) BSA, which served 
as a control. Isolated chondrocytes were seeded onto the upper side of the membrane as 
described in section 2.3.5.3.2, and allowed to adhere to the substrate for 48 hours. Basal 
media/50pg/ml ascorbic acid (1.4ml) was added through the portal to the bottom of the 
well. Growth factors were supplemented to this at a concentration of lOng/ml after the 
48 hour attachment period. BSA was added to the control wells. Treatment groups o f 
IGF-1, TGFpi and IGF-1 and TGFpi were set up in triplicate. After the addition of 
growth factors to the bottom of the well the chondrocytes were allowed to migrate over 
a period of 24 hours before non-motile cells were removed as described in section
2.3.5.3.3 and the migrated cells stained with crystal violet and counted. Statistical 
analysis was performed as stated in section 2.3.5.3.3.
2.3.8 Assessing the Chemotactic Effects o f  IGF-1 and TGFpi on Chondrocytes 
Migrating on Chondroitinase ABC Treated Aggrecan
Boyden chamber membranes were coated with chondroitinase ABC treated aggrecan as 
previously described in section 2.3.5.3.1, and isolated chondrocytes from both age 
groups o f cartilage were allowed to adhere to the substrate on the upper side of the 
membrane for 24 hours. Basal media was added to the bottom of the well as stated in
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section 2.3.5.3.2. Growth factors were supplemented to the media in the bottom of the 
well as described in section 2.3.7 after the initial attachment period, and BSA served as 
a control. Statistical analysis was performed as previously described in section 2.3.5.3.3.
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2.4 Results and Discussion
2.4.1 Comparing Articular Cartilage Isolated From Young and Mature Bovine 
Metacarpophalangeal/Metatarsophalangeal Joints Using General Histology
2.4.1.1 Morphological Differences between Young and Mature Articular Cartilage
When comparing chondrocytes isolated from different age groups of articular cartilage, 
it is important to consider the environment that they have come from and note 
differences in their morphology and distribution within the tissue. Here haematoxylin 
and eosin staining has been used to stain both the nuclei of the chondrocytes and their 
surrounding ECM to look at their zonal distribution and the changes that occur during 
maturation of the tissue. Articular cartilage isolated from skeletally mature animals is 
notably thinner than that dissected off o f a young, immature joint. This difference is 
neatly seen when comparing the gross morphology of the joints as shown in fig.2.1. 
Microscopically, the differences seen are much more detailed (see fig.2.6). The number 
o f chondrocytes found within mature cartilage was found to be greatly reduced when 
compared to the young tissue, with a higher ECM volume: cell ratio, meaning that the 
cells are more isolated from each other within the mature cartilage. More extensive 
zonal organisation was also seen with maturation. Within the superficial zone of both 
age groups the chondrocytes can be seen to be flattened and disc-like, arranged parallel 
to the articular surface. Deeper into the cartilage, the young tissue demonstrates random 
organisation of the cells compared to the more columnar organisation seen in the mature 
cartilage.
2.4.1.2 Proteoglycan Distribution
The ECM component of articular cartilage is synthesised by the resident chondrocytes, 
and the noted changes in cell morphology and cellular distribution within the tissue is 
also accompanied by a change in the composition o f the ECM. These changes 
ultimately affect the biomechanical as well as structural aspects o f the tissue.
As fig.2.7 illustrates, Safranin O staining for proteoglycans can be found extending 
throughout the full depth of the tissue, within both the young (see fig.2.7a) and 
skeletally mature (see fig.2.7b) cartilage. These findings support those previously
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Fig.2.6 Haematoxylin and eosin staining of full depth (a) young (7 day old) and (b) 
skeletally mature (18 month old) bovine articular cartilage.
SZ = superficial zone, TZ = transitional zone and DZ = deep zone.
Bar = 50pm
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documented (Buckwalter and Mankin, 1998; van Sickle and Evander, 1997). As these 
photomicrographs demonstrate, proteoglycans are evident within all three territorial 
zones i.e. the pericellular, territorial and interterritorial. These results complement the 
proposed role of proteoglycans within cartilage; to withstand compressive force exerted 
onto the tissue by entrapping water molecules and forming a hydrated gel (Guilak et al.,
1999). General histological methods can only give a gross indication as to the 
distribution of matrix molecules such as proteoglycans. Such a method does not 
demonstrate specific changes that occur during maturation o f the tissue such as the 
decrease in proteoglycan size and the increasing ratio of C-6-S:C-4-S (Hickery et al., 
2003; Plaas et al., 1988; Thonar and Sweet, 1981).
2.4,1,3 Collagen Distribution
Masson’s trichrome staining was used to localise collagens found within the articular 
cartilage ECM (Flint, 1975). As fig.2.8 demonstrates, green staining for collagen was 
found within the superficial, transitional and deep zones of both the young (see fig.2.8a) 
and mature (see 2.8b) articular cartilage. As previously discussed for proteoglycans, 
these data corroborate with that previously published (Jeffery et al., 1991; van Sickle 
and Evander, 1997). Within the superficial zone, fibrils appeared to be orientated 
parallel to the articular surface, demonstrating the function of collagen to provide tensile 
strength alongside the compressive resistance provided by the proteoglycans. The 
orientation of fibrils within the superficial zone also lends itself to provide a functional 
barrier to the transport o f molecules from the synovial fluid into the cartilage (Huber et 
al., 2000). The percentage of collagen within the tissue is seen to increase with age, 
until maturation is reached, at which time levels plateau out (Brama et al., 2000; Thonar 
and Sweet, 1981). The organisation and orientation of collagen within the ECM is also 
altered (Bland and Ashhurst, 1996; Luder, 1998). This information is well documented 
in papers but is an important consideration when comparing the activities o f cells 
isolated from both age groups o f cartilage.
2.4.2 Confirming the Generation o f  a Chondroitinase ABC Treated Aggrecan
*
One aim o f this investigation was to investigate the influence CS side chains found 
projecting from the aggrecan core protein have on the migration of chondrocytes. To 
achieve this aim it was necessary to generate a substrate that could be
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Fig.2.7 Safranin O staining, illustrating proteoglycan distribution within (a) young and 
(b) skeletally mature bovine articular cartilage.
SZ = superficial zone, TZ = transitional zone and DZ = deep zone.
Bar = 50pm
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Fig.2.8 Masson’s trichrome staining, illustrating collagen distribution within (a) young 
and (b) skeletally mature bovine articular cartilage.
SZ = superficial zone, TZ = transitional zone and DZ = deep zone.
Bar = 50pm
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coated onto the PET membranes o f the Boyden chamber system allowing the direct 
comparison of chondrocyte migration on native aggrecan (containing multiple GAG 
side-chains) and also aggrecan which had been treated with the enzyme chondroitinase 
ABC to remove the CS side-chains, leaving only CS-stubs attached to the remaining 
core protein. To confirm that the CS chains had been successfully digested using 
chondroitinase ABC, slot blotting was used to demonstrate the presence o f CS-stub neo­
epitopes generated after digestion and also the DMMB assay to illustrate a decrease in 
the sGAG concentration after treatment.
Fig.2.9a and c demonstrate that the epitopes recognised by the murine monoclonal 
antibodies 1B5 (raised against C-O-S) and 2B6 (C-4-S) are not present in native, non­
digested aggrecan. However after digestion with chondroitinase ABC for a period of 24 
hours distinct bands are visible for both C-O-S stubs (see fig.2.9e) and C-4-S stubs (see 
fig.2.9g). Primary antibody negative controls were run for both these slot blots to 
confirm the specificity o f the primary antibodies (see fig.2.9b, d, f  and h).These results 
were further confirmed by the DMMB assay. This assay uses C-6-S as a standard and 
estimates sGAG concentrations within each sample. The results demonstrated a 96% 
loss in sGAG concentration after digestion of the native aggrecan with chondroitinase 
ABC (see fig.2.10). Taken together these results confirmed that a chondroitinase ABC 
treated aggrecan had been generated for use as a substrate in further migration 
experiments.
2.4.3 Comparing the Migration o f  Chondrocytes Isolated from Young and Mature 
Articular Cartilage on Different ECM  Macromolecules
Quantitative assessment of the migration of chondrocytes was obtained using a Boyden 
chamber system. See section 2.3.5.3 for full method. Briefly PET membranes were 
coated with purified ECM molecules, plasma fibronectin, type II collagen, whole A1D1 
aggrecan or chondroitinase ABC treated aggrecan and chondrocytes were allowed to 
migrate on these substrates for periods of 1-24 hours. Chondrocytes, obtained from both 
7 day old and 18 month old bovine metacarpophalangeal or metatarsophalangeal joints 
were seen to migrate on all four matrix molecules (see fig.2.1 la  and b). This is the first 
known report demonstrating the ability of chondrocytes isolated from skeletally mature 
bovine articular cartilage to migrate. No significant difference in the number of
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Fig.2.9 Slot blot analyses using 2B6 and 1B5 to confirm the presence of chondroitinase 
ABC generated neo-epitopes against C-4-S and C-O-S stubs respectively, (a) native and 
(e) chondroitinase ABC treated aggrecan probed with 1B5, (b) native and (f) 
chondroitinase ABC treated aggrecan 1B5 primary negatives, (c) native and (g) 
chondroitinase ABC treated aggrecan probed with 2B6, (d) native and (h) 
chondroitinase ABC treated aggrecan 2B6 primary negatives.
■= 500
-  400
O 300
Native Aggrecan Chondroitinase ABC Treated Aggrecan
Treatment
Fig.2.10 Graph illustrating the results of the DMMB assay illustrating significant loss of 
sGAGs after treatment of native aggrecan with chondroitinase ABC.
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chondrocytes isolated from young cartilage migrating on any substrate between time 
points was seen. This suggests that the chondrocytes which had the ability to migrate, 
appeared to do so within the first hour of incubation, and no further increase in the 
number of migrating chondrocytes was seen by incubating them for a further 23 hours. 
Of the chondrocytes isolated from young articular cartilage, which were seeded onto the 
upper most side o f the chamber membranes, only 0.9% migrated to the lower side of the 
membrane. This result suggests there may be a subpopulation of chondrocytes within 
full depth articular cartilage which possess the ability to migrate on matrix substrates. 
Interestingly, a similar trend was seen with the chondrocytes isolated from the mature 
articular cartilage (see fig.2.lib). Comparable numbers of chondrocytes isolated from 
mature cartilage were migrating to the young, and as previously discussed, no 
differences between the number o f chondrocytes migrating between time points was 
shown either. As with the chondrocytes isolated from young cartilage, 0.9% of the 
chondrocytes isolated from mature cartilage were migrating from the upper to the lower 
side of the membrane. This suggests that the subpopulation of chondrocytes previously 
discussed is maintained throughout development and maturation o f the cartilage. Recent 
research by (Dowthwaite et al., 2004) has demonstrated that within the superficial zone 
of articular cartilage there is a progenitor cell population, with stem cell-like 
characteristics. Interestingly, an immunohistochemical study by Kim and Spector 
(2000), demonstrated the expression of the contractile protein, a  smooth muscle actin 
(SMA), in articular chondrocytes. Previous studies have demonstrated the expression of 
SMA in bone marrow stromal MSCs as well (Bonanno et al., 1994; Charbord et al., 
1985; Charbord et al., 1990; Galmiche et al., 1993). The study by Kim and Spector 
(Kim and Spector, 2000) suggests that 75% of superficial zone chondrocytes express 
this protein compared with only 10% of the deep zone cells. In addition, these 
chondrocytes were still producing the chondrocytic marker, type II collagen (Kinner and 
Spector, 2001). The role of SMA within chondrocytes is not known, although may be a 
mechanism through which these cells are able to remodel their ECM in vivo. It would be 
interesting to investigate whether the chondrocytes migrating within this model are in 
fact these chondroprogenitors and also express SMA. In a canine model of articular 
cartilage repair it was demonstrated that many o f the reparative cells did in fact express 
SMA, with a higher percentage of SMA positive cells within the cartilage/fibrocartilage 
repair tissue compared to the fibrous component (Wang et al., 2000). These results 
suggest a possible role for SMA positive chondrocytes in cartilage repair.
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No significant differences in the number of chondrocytes isolated from either age group 
of cartilage were seen migrating between fibronectin and type II collagen substrates (see 
fig.2.11a and b). A consistent trend o f increased migration, for both age groups, was 
seen on the chondroitinase ABC treated aggrecan when compared to the native 
monomeric aggrecan substrate. In the case of the young chondrocytes, this was a 
significant difference at 24 hours [P<0.05]. As previously discussed, in section 1.13.2, 
proteoglycans have been shown to be anti-adhesive in a number o f cell types including 
fibroblasts (Winnemoller et al., 1991). Specifically this is thought to be due to the 
presence of their GAG chains (Culp et al., 1979; Lewandowska et al., 1987; Merle et 
al., 1997; Winnemoller et al., 1992; Yamagata et al., 1989). The GAG chain component 
of the proteoglycan has also been shown directly to have an anti-migratory effect in 
fibroblasts (Merle et al., 1997). The data from this study supports these findings; 
however, this is the first time these interactions have been discussed with reference to 
chondrocytes. The nature of this anti-adhesive/anti-migratory interaction is unknown. 
The method by which chondrocytes interact with proteoglycans remains questionable. It 
is not thought to occur via integrin receptors found on the chondrocyte cell surface. 
Interaction studies have confirmed that the GAG, CS can bind directly to CD44, L- 
selectins, P-selectins, galectins and annexin 6, another member o f the lectin family 
(Fujimoto et al., 2001; Kawashima et al., 2000; Moiseeva et al., 2003; Takagi et al., 
2002). Previous studies have demonstrated the presence of CD44 and galectin 3 on the 
surface o f chondrocytes, however, it is not known whether annexin 6 is present 
(Guevremont et al., 2004; Hua et al., 1993). In the case of chondrocytes it has been 
previously believed that CS chains inhibit chondrocyte migration through blocking the 
binding domain of fibronectin, which is pro-adhesive, or by competing for cell 
interactions with other matrix components such as collagen fibril surfaces. This study 
indicates that this inhibitory effect is still apparent even when no other matrix 
components are present and therefore indicates a direct interaction of the cell with the 
CS chain in chondrocytes. No direct interactions between chondrocytes and CS have 
been studied to date. Aside from this, a study by Cao et al. (1998), identified the G1 
domain of aggrecan as the domain inhibiting chondrocyte attachment. Fluorescence- 
activated cell sorter (FACS) analysis by this group suggests this effect is due to high 
affinity binding of the G1 domain to the cell surface of chondrocytes. Interestingly it is 
known that in vivo the G1 domain of aggrecan accumulates with age in articular 
cartilage, as degradation of this domain decreases while synthesis o f aggrecan is 
maintained. The accumulation of this anti-adhesive domain may be a contributory factor
Chapter 2
(a) □  Fibronectin BType II Collagen □  Aggrecan □  Chondroitinase Treated Aggrecan
160 i
O 100
2  80
■9 40
Time (Hrs)
(b ) □  Fibronectin ■  Type II Collagen □  Aggrecan □  Chondroitinase Treated Aggrecan
C  120
vO 100
2  80
-O 40
Time (Hrs)
Fig. 2.11 The migration of chondrocytes using a Boyden chamber system isolated from 
(a) young and (b) mature articular cartilage on fibronectin, type II collagen, native 
aggrecan and chondroitinase ABC treated aggrecan over periods of 1 -24 hours. Results 
expressed as the average number of migrated cells with SEM bars.
*P<0.05
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in the lack of transplanted cell adhesion and integration seen with cell-based methods of 
articular cartilage repair.
2.4.4 Do the Anabolic Growth Factors, IGF-1 and TGFpi Increase Chondrocyte 
Proliferation?
Before the effects of the anabolic growth factors, IGF-1 and TGFpi, on chondrocyte 
migration could be investigated, it was important to ascertain whether the 
concentrations chosen (lOng/ml) induced cellular proliferation. The question of 
increased proliferation versus increased migration was of concern as both these growth 
factors have been shown to increase metabolic activities of the cells as well as increase 
DNA synthesis and mitotic activity (Bonassar et al., 1997; Darling and Athanasiou, 
2005; Glansbeek et al., 1998; Trippel, 1997). In order to rule out increased proliferation 
as a factor in the results obtained using the Boyden chamber system, the Cytotox 96® 
assay was used to determine the effects of these growth factors on chondrocytes from 
both age groups of cartilage, at the concentration and length of time they were exposed 
for.
The results show that IGF-1 and TGFpi, whether used singularly or combined, did not 
have a proliferative effect on either age group of chondrocytes over the 24 hour 
exposure time (see fig.2.12a and b). No significant difference in the levels of LDH, 
representative of the number of cells present in the lysates, were found confirming that 
any differences seen within the Boyden chamber system would be due to increased 
migration and not increased proliferation of the cells.
2.4.5 Investigating the Chemotactic Effects o f  IGF-1 and TGFpi on Chondrocyte 
Migration
The chemotactic effects of the anabolic growth factors, IGF-1 and TGFpi, were 
investigated using chondrocytes seeded onto type II collagen, fibronectin, A1D1 
aggrecan and BSA as a control. In contrast to the method previously described in 
section 2.3.5.3.2, the chondrocytes were allowed to adhere to the substrate for 48 hours 
before the addition of growth factors to the bottom of the chamber. IGF-1 and TGFpi 
were allowed to act as chemoattractants for 24 hours before the migrated cells were 
counted. Differences in the initial adherence time of the chondrocytes to the substrate on
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Fig.2.12 The effects of IGF-1 and TGFpi on the proliferation of chondrocytes isolated 
from (a) young and (b) mature articular cartilage as measured by the Cytotox®96 assay
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the upper side of the membrane have been taken into account in the analysis o f these 
data, but previously work discussed in section 2.4.3 demonstrated that the number of 
chondrocytes migrating does not appear to significantly alter after 1 hour o f adhesion to 
the substrate surface.
IGF-1 has been shown in a number o f studies to have a chemotactic effect, inducing the 
migration of cells towards the growth factor (Duan, 2003; Hartnell et al., 2004). This 
chemotactic effect of IGF-1 has also been previously shown to enhance the migration of 
chondrocytes from newborn calves on fibronectin using a Boyden chamber system 
(Chang et al., 2003). My data obtained using chondrocytes isolated from young articular 
cartilage support this work [P<0.05] (see fig.2.13a). These data demonstrate that the 
chemotactic effect is substrate dependent and requires the chondrocytes to be seeded 
onto fibronectin. As interactions between fibronectin and chondrocytes is pi integrin 
dependent it is interesting to link research suggesting potential synergy between the 
IGF-1R and the p i integrin subunit by activation of cell signalling proteins such as She 
(Shakibaei et al., 1999). IGF-1 has been shown to also increase levels o f the fibronectin 
specific receptor a5 p l leading to increased adhesion (Loeser, 1997). No enhanced 
migration was seen with chondrocytes isolated from young articular cartilage seeded 
onto type II collagen or aggrecan (see fig.2.13a). TGFpi is one member of a large 
TGFP superfamily, which plays a crucial role in chondrogenesis regulating growth, 
differentiation and metabolism. TGFpi has been shown to increase the motility of cell 
types such as epithelial cells (Massague, 1992), however this role has not been 
investigated in chondrocytes. These data demonstrate a substrate dependent, significant 
increase in the migration of chondrocytes isolated from young articular cartilage in 
response to TGFpi when coated onto fibronectin [P<0.005] (see fig.2.13a). As 
previously stated for IGF-1, TGFpi has also been shown to increase a 5 p i expression 
and in doing so increase adhesion to fibronectin (Loeser, 1997). Loeser’s study also 
illustrated that TGFpi can increase adhesion of chondrocytes to type II collagen. In 
addition, type II collagen has been demonstrated to modulate the effect o f TGFpi on 
chondrocytes. Type II collagen has been shown to down-regulate a2  integrin expression 
in chondrocytes (Lee et al., 2002). It is the binding o f chondrocytes to type II collagen 
that modulates TGFpi activity. Increased level of type II collagen gene expression 
parallels Smad phosphorylation and leads to TGFpi activation (Schneiderbauer et al., 
2004).
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A further experiment was carried out to look at the possible interaction of these two 
growth factors in potentiating any response that they may have on their own. Although 
there are no data in the literature to support interactions o f these growth factors in 
stimulating migration o f chondrocytes, there is evidence that these growth factors will 
interact in articular cartilage. Studies have demonstrated that combinations o f IGF-1 and 
TGFpi stimulate the proliferation and differentiation of chondrocytes (Hill et al., 1992; 
Rosselot et al., 1994; Tsukazaki et al., 1994; Yaeger et al., 1997) and that TGFpi can 
increase the expression of IGF-IRs by chondrocytes (Tsukazaki et al., 1994). A recent 
study demonstrated that this interaction occurs in situ during periosteal chondrogenesis 
(Fukumoto et al., 2003). The interaction of these growth factors was confirmed by the 
significant increase in the migration o f chondrocytes from young cartilage seeded onto 
fibronectin when IGF-1 and TGFpi were used in combination compared to IGF-1 alone 
[P<0.05] (see fig.2.13a). As discussed in section 1.15.8, it is well documented that 
chondrocytes demonstrate decreased sensitivity to growth factors with age (Dore et al., 
1994; Gueme et al., 1994; Middleton et al., 1996; Tavera et al., 1996). In support of the 
literature no significant increase in the migration of chondrocytes isolated from mature 
articular cartilage was seen in response to either growth factor (see fig.2.13b). A 
significant increase in the migration of chondrocytes from mature cartilage was seen 
when IGF-1 and TGFpi were used in combination and the cells were seeded onto 
fibronectin [P<0.05] (see fig.2.13b).
Photomicrographs taken of the migrated cells in all the experiments using the Boyden 
chamber system demonstrate that in both age groups the chondrocytic morphology has 
been maintained and that it is unlikely that migration was due to dedifferentiation of the 
cells (see fig.2.14).
2,4,6 Can the Presence o f  IGF-1 and TGFpi Increase Chondrocyte Migration on 
Chondroitinase ABC Treated Aggrecan?
IGF-1 and TGFpi were added to the bottom o f Boyden chambers, as described in 
section 2.3.7, after seeding of the chondrocytes onto a chondroitinase ABC treated 
aggrecan substrate 24 hours previous. Chondrocytes were allowed to migrate on the 
substrate, and the growth factors allowed to act as chemoattractants for 24 hours after 
seeding o f the cells.
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Fig.2.13 Comparing the migration of chondrocytes isolated from (a) young and (b) skeletally 
mature articular cartilage on ECM molecules with IGF-1 and TGFpi as chemoattractants. 
Results are expressed as the number of migrated cells within a 0.25mm2 area. N=3
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Data discussed in section 2.4.3 has demonstrated the inhibitory effect o f native aggrecan 
on chondrocyte migration and the beneficial effects seen on removal o f CS chains from 
the core protein. This study investigates whether the addition o f growth factors as 
chemoattractants can further enhance the migration o f chondrocytes on chondroitinase 
ABC treated aggrecan. Neither IGF-1 nor TGFpi had a stimulatory effect on 
chondrocyte migration o f cells extracted from young or skeletally mature articular 
cartilage (see fig.2.15a and b). This confirms the substrate dependent effects o f these 
growth factors on enhancing chondrocyte migration through a chemotactic mechanism, 
and poses the question, ‘what role does the substrate on which the chondrocyte is 
migrating play in eliciting the effect o f IGF-1 and TGFpi in potentiating chondrocyte 
migration?’
No significant effects were seen by combining these growth factors on the migration of 
young or mature chondrocytes on chondroitinase ABC treated native aggrecan (fig. 
2.15a and b), confirming those results discussed in section 2.4.5 and further 
demonstrating the importance o f fibronectin in enhancing chondrocyte migration 
through the chemotactic mechanisms o f IGF-1 and TG Fpi.
2.5 Conclusions
The aim o f the work described in this chapter was to investigate the migratory capacities 
of chondrocytes freshly isolated from young and skeletally mature articular cartilage. In 
contrast to previous studies investigating the migration o f chondrocytes, these cells were 
not previously expanded in monolayer culture prior to experimentation in order to 
preserve the chondrocytic phenotype. Using a Boyden chamber model o f cell migration, 
both chondrocytes isolated from young and mature articular cartilage were shown to be 
able to migrate when removed from their constraining ECM. In addition, the numbers of 
migrating cells were comparable between the 2 age groups.
The matrix macromolecule that the cells are attached to proved to be crucial in both 
their migratory capacity and also in their response to supplemented growth factors. No 
differential effects were seen in the number o f migrating cells between a fibronectin and 
type II collagen coated substrate; however when comparing native and chondroitinase 
ABC treated aggrecan a constant trend o f increased migration was seen on the latter
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Fig. 2.15 Measuring the chemotactic effects of IGF-1 and TGF01 on the migration of 
chondrocytes isolated from (a) young and (b) mature cartilage, seeded onto 
chondroitinase ABC treated aggrecan, using a Boyden chamber system. Results are 
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substrate. A significant difference was seen at 24 hours with the chondrocytes isolated 
from young articular cartilage. O f those chondrocytes seeded onto the upper-most side 
o f the chamber membrane, only 0.9% demonstrated the ability to migrate to the lower 
side o f the membrane. This figure was true for cells from both age groups. As 
previously discussed in section 2.4.3 this result suggests a subpopulation of 
chondrocytes exists within full depth articular cartilage which possess the ability to 
migrate on different matrix substrates. As the chondrocytes used for these experiments 
were heterogeneous and taken from all zones of the articular cartilage it would be 
interesting to see whether, like their differences in metabolic activities, the cells from 
different layers have different capacities to migrate and whether the cells that we are 
seeing migrate are a subpopulation o f those actually seeded onto the membrane surface. 
Research by Dowthwaite et al. (2004) has demonstrated that there is a subpopulation of 
cells within the superficial zone o f articular cartilage that show pluripotency and the 
ability to divide and differentiate upon stimulation.
When comparing the effects o f the anabolic growth factors on affecting chondrocyte 
migration no significant differences in the number o f cells migrating was seen by either 
age group. Published results in addition to those from my studies suggest that this is a 
substrate dependent reaction. Only migration on fibronectin has been shown to be 
enhanced by the chemotactic effects o f IGF-1 and TG Fpi.
To further support the data achieved by the Boyden chambers it would be interesting to 
directly look at the migration o f these cells in real time. Preliminary experiments were 
set up to look at the migration o f both chondrocytes isolated from young and mature 
cartilage, when coated on the four previously described matrix macromolecules. Using 
time-lapse video-microscopy I was hoping to support the previously discussed data with 
photographic evidence o f migration. Experiments set up using a multi-well system have 
been unsuccessful so far due to the fragile adhesion between cell and substrate. As a 
result, cells are being dislodged from the surface of the plate by movement o f the 
microscope stage. Whilst it is important to allow an appropriate amount o f time for the 
chondrocytes to adhere to the plate surface, it is also important to remember that these 
cells will dedifferentiate if  left coated on a surface for prolonged periods. It has, to date, 
not proved possible to establish the necessary conditions in order to obtain data for this 
experiment; however the data would be extremely beneficial to confirming the findings 
using the Boyden chamber system for measuring cell migration.
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111 sum m ary:
• Chondrocytes isolated from young and skeletally mature bovine articular 
cartilage have the ability to migrate.
• CS chains play an inhibitory role in the migration o f chondrocytes.
• Only 0.9% of chondrocytes, isolated from both age groups o f cartilage, 
demonstrated the ability to migrate, suggesting a subpopulation of 
chondrocytes which have the ability to migrate and that are maintained 
through development.
• IGF-1 and TGFpi demonstrated a substrate dependent chemotactic effect on 
chondrocyte migration, with enhanced migration only seen on cells seeded 
onto fibronectin.
• IGF-1 and TGFpi did not exert a chemotactic response on chondrocytes 
migrating on chondroitinase ABC treated aggrecan.
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3.1 Background
Many studies using animal models of cartilage injury and repair have demonstrated the 
ability to stimulate filling of the defect with repair tissue, hyaline or fibrocartilaginous. This 
repair tissue invariably degenerates with time due to poor integration with the endogenous 
cartilage (Cook et al., 2003; Han et al., 2003; Shao et al., 2006). The successful repair of 
articular cartilage is not solely dependent on the ability of chondrocytes to migrate to a site 
of injury, or in the case of cell-based surgical repair strategies, to adhere to the injured 
cartilage and fill the defect with new tissue. The answer to effective articular cartilage 
repair may not lie in the composition of the repair tissue but whether it is stably integrated 
with the pre-existing cartilage. Integration is crucial for long-term biomechanical stability 
of the cartilage during loading and the associated shearing forces within the synovial joint.
The Boyden chamber system described in chapter 2 demonstrated that both chondrocytes 
isolated from young and skeletally mature articular cartilage do have the ability to migrate, 
but that this process is dependent on the matrix molecule onto which they are seeded (see 
section 2.4.3). As discussed in section 1.13.2 the ability of native aggrecan, as well as the 
SLRPs decorin and biglycan, to inhibit cell adhesion (Merle et al., 1997; Winnemoller et 
al., 1991; Winnemoller et al., 1992) and migration (Merle et al., 1999) is well characterised 
and is hypothesised to be through their GAG chains.
Anti-adhesive properties of aggrecan have also been attributed to its G1 domain. Within 
ageing, injured or diseased cartilage there is an accumulation of G1 aggrecan as turnover of 
whole aggrecan increases, leaving just the HA-bound domain within the cartilage 
(Lohmander et al., 1993; Poole et al., 1994; Sandy et al., 1991; Saxne and Heinegard, 
1992). G1 aggrecan has the ability to accumulate around the chondrocytes, within the 
matrix and be released into the synovial fluid (Lark et al., 1997). Experiments using 
chicken chondrocytes transfected with a G1 domain construct demonstrated that not only 
did this domain inhibit cell adhesion, but also induced apoptosis as a result of this lack of 
attachment (Cao and Yang, 1999).
Taking these factors into account, and knowing that injured cartilage demonstrates an initial 
phase of increased proteoglycan synthesis close to the wound surface (Jeffrey et al., 1997;
Ohapt^i
Walker et al., 2000), in theory it would be advantageous to remove the wound surface 
proteoglycans to enhance the migration of transplanted chondrocytes into the injured tissue. 
Removal of surface proteoglycans would not only increase adhesion, and therefore 
retention of the transplanted cells within the defect, but also expose underlying pro­
adhesive matrix proteins such as collagen fibrils and fibronectin for the chondrocytes to 
adhere and migrate on. Numerous groups have investigated the effects of enzymatically 
removing wound surface proteoglycans in enhancing coverage and adhesion of transplanted 
chondrocytes (Hunziker and Kapfmger, 1998; Hunziker and Rosenberg, 1996; Lee et al.,
2000), but none have investigated whether these adhered chondrocytes are migrating into 
the digested tissue. Matrix macromolecules have been digested using different enzymes 
such as hyaluronidase as well as more aggressive methods such as guanidine hydrochloride 
and trypsinisation, which appear to be less specific (Bos et al., 2002; Quinn and Hunziker, 
2002; van de Breevaart Bravenboer et al., 2004) Interestingly some of the best results have 
been seen using the enzyme chondroitinase ABC, which directly targets the GAG chains of 
the proteoglycan molecules (Lee et al., 2000).
Chondroitinase ABC is an endolytic GAG lyase derived from the bacterium Proteus 
vulgaris. The enzyme demonstrates broad specificity, with the ability to endolytically 
degrade CS, DS and HA (although at a much slower rate) by the elimination of the 1,4 
hexosaminidic bond to unsaturated disaccharides and tetrasaccharides (Huang et al., 2003). 
The optimal temperature for enzyme activity is 37°C (Yamagata et al., 1968) and the pH 
will depend on the substrate to be digested. The optimum pH for the digestion of CS is pH 
8 whereas for HA it is 6.8. The crystal structure of chondroitinase ABC has demonstrated 3 
domains arranged in a linear fashion (see fig.3.1). The N-terminal domain has a similar 
organisation to the carbohydrate binding domains of xylanases, and therefore has been 
hypothesised to help in binding and presenting the GAG chain to the horseshoe-shaped, 
central catalytic domain. Both the middle and C-terminal domains show similarity to the 
domains of chondroitinase AC and bacterial hyaluronidases. Loops extending from the C- 
terminal into the catalytic domain are likely to be involved in substrate binding (Huang et 
al., 2003).
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Fig.3.1 Ribbon drawing illustrating the 3 structural domains of chondroitinase ABC. N- 
terminal domain (green), middle, catalytic domain (blue), C-terminal domain (yellow)
(reproduced from Huang et al., 2003)
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Enzymatic digestion using a specific enzyme such as chondroitinase ABC provides directed 
and specific GAG degradation without damage to the actual architecture of the cartilage. 
Studies to date have only allowed limited incubation of cartilage with chondroitinase ABC 
in order to digest sufficient proteoglycan for enhancing chondrocyte adherence to the 
wound surface (Hunziker and Kapfmger, 1998; Hunziker and Rosenberg, 1996; Lee et al., 
2000). In this chapter, I investigated whether prolonged digestion with this enzyme will 
allow not only adherence but also migration of the transplanted cells.
Aims:
1. To develop an in vitro model of full thickness articular cartilage injury where the 
migration and integration of transplanted chondrocytes can be monitored with time.
2. Using this developed model, optimise the time and concentration needed for 
sufficient chondroitinase ABC digestion of the injured cartilage surface in order to 
allow transplanted chondrocytes to adhere to the wounded surface and migrate into 
the damaged tissue.
3. Compare and contrast the abilities of both chondrocytes isolated from young and 
skeletally mature articular cartilage to migrate and integrate within the digested 
tissue.
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3.2 Materials
All materials were obtained from Sigma Chemical Company, UK unless otherwise stated 
within the protocol.
3.3 Methods
3.3.1 Optimisation o f Chondroitinase ABC Treatment for Proteoglycan Digestion o f  
Young Bovine Cartilage Explants
Aims:
1. Digestion of GAG chains deep enough into all zones of the cartilage to promote 
sufficient migration of transplanted chondrocytes for the integration of repair and 
endogenous tissue.
2. Optimise the degree of digestion for the enhancement of integration but maintain 
the degree of digestion at a level that the proteoglycans can be replaced by the 
endogenous and transplanted chondrocytes.
Full thickness articular cartilage explants were excised from the medial and lateral condyles 
of the metacarpophalangeal or metatarsophalangeal joints of 7 day old calves. The explants 
were injured using a sharp number 11 scalpel blade and embedded in 2% agarose 
(Flowgen, UK) dissolved in PBS (pH 7.4) and previously equilibrated with media. The 
explant was orientated such that only the wounded surface was left exposed with superficial 
through to deep zones of the cartilage present (see fig.3.2). The agarose was allowed to set 
before the addition of the chondroitinase ABC solution.
Lyophilised chondroitinase ABC was reconstituted in PBS (pH 7.4) at a concentration of 
either lU/ml or lOU/ml. The solution (250pl) was added to the exposed wound surface and 
incubated for a period of either 1, 4, 8 or 24 hours at 37°C. (Previous experiments using 
chondroitinase ABC at lU/ml for 5, 15 and 30 minutes showed very limited digestion of 
CS chains). Following incubation, the solution was removed and the explant washed 3 
times in PBS (pH 7.4) for periods of 5 minutes.
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Fig. 3.1 Schematic representation of the cartilage explant model for measuring chondrocyte 
migration and integration. 1. The explant after excision from the bovine 
metacarpalphalangeal/metatarsophalangeal joint 2. The explant was wounded using a sharp 
scalpel 3. The wounded 5mm x 4mm full thickness explant 4. The wounded cartilage was 
rotated 90° so that the all zones were left exposed to the chondroitinase ABC treatment 5. 
The wound edge (WE), demonstrating wounding through all zones of the cartilage 6. The 
explant embedded in agarose with only the wound surface exposed.
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All explants were washed three times in PBS (pH 7.4), immediately snap frozen in liquid 
nitrogen and stored at -80°C before cryosectioning.
3.3.2 Immunohistochemistry o f  Chondroitinase ABC Treated Explants
Cryosections of 10pm (Bright Instrument Co Ltd., UK), were taken of the chondroitinase 
ABC treated explants orientated at 90° to the agarose to generate full depth cartilage 
sections. The sections were and mounted onto poly-L-lysine coated microscope slides 
(BDH Laboratory Supplies, UK).
Sections were outlined using a ImmEdge™ pen (Vector Laboratories Inc., CA, USA) and 
rehydrated in PBS (pH 7.4)/0.001% Tween20™ for 10 minutes. Sections were blocked 
with normal whole goat serum (DakoCytomation, Glostrup, Denmark) at 1:20 dilution for 
30 minutes at room temperature. After the incubation period the serum was removed and 
replaced with the primary antibodies, 2B6 (1:100) and 1B5 (1:1000) and was incubated 
overnight at 4°C in a humidified chamber.
The primary antibodies were removed and the sections washed in PBS (pH 7.4)/0.001% 
Tween 20™ for 10 minutes. Sections were incubated with an anti-mouse fluorescein 
isothiocyanate-conjugated (FITC) secondary antibody raised in goat (DakoCytomation, 
Glostrup, Denmark) at 1:50 dilution for 1 hour at room temperature. Sections were then 
washed in PBS (pH 7.4) for 10 minutes before mounting under a coverslip with 
Vectashield® mountant (Vector Laboratories Inc., CA, USA) containing propidium iodide 
at 1.5pg/ml. Propidium iodide acts as an intercalating agent for double stranded nucleic 
acids and in this case is being used as a counterstain for cell nuclei (Jones and Kniss, 1987). 
The slides were sealed with clear nail varnish and stored at 4 °C in the dark.
Control slides were incubated in PBS (pH 7.4)/0.001% Tween 20™ instead of primary 
antibody were performed to confirm specific binding. Sections were viewed using an 
upright fluorescent microscope (Laborlux 12, Leitz DRMB, Leica, Germany) at x 40 
magnification.
no
( hapfcr .)
3.3.3 Visualising Cell Death at the Wound Edge as a Measure o f  the Cytotoxicity of  
Chondroitinase ABC
Ethidium homodimer was used as a measure of cell death at the wound edge of treated 
explants to investigate whether chondroitinase ABC at the chosen concentration and 
incubation time period was toxic to the chondrocytes within the cartilage explant. Ethidium 
homodimer binds to the DNA of cells whose cell membrane has been compromised and are 
therefore dead. This compound will primarily detect necrotic cell death, but will label those 
cells which are in the final stages of apoptosis. Ethidium homodimer has an excitation 
wavelength of 528nm and an emission of 617nm which can be visualised by fluorescence 
microscopy.
Cell death after incubation with chondroitinase ABC at lU/ml for 8 hrs was compared to 
controls of PBS treatment (8 hrs) and also explants which had been wounded and 
immediately snap-frozen in liquid nitrogen. Replicate samples (n=3) were used in all 
experimental groups. Explants were treated with chondroitinase ABC or PBS in the manner 
previously described in section 3.3.1 and subsequently washed in PBS (pH 7.4) three times 
over a period of 15 minutes before incubation with ethidium homodimer. Ethidium 
homodimer was reconstituted at a concentration of 2pM in PBS (pH 7.4). The treated and 
washed explants were incubated in 1ml of 2pM ethidium homodimer for a period of 1.5 hrs 
at 37°C. Explants were then washed in PBS (pH 7.4) three times over 15 minutes before 
being snap frozen in liquid nitrogen. Cryosections were cut from the explants (10pm) and 
mounted under a coverslip using Vectashield® mountant. The sections were visualised by 
fluorescence microscopy at x20 magnification.
3.3.4 Visualising Chondrocyte Migration by Fluorescence Labelling
A vial of 50pg lyophilised 5’chloromethylfluorescein diacetate (CMFDA) (Molecular 
Probes Europe BV, The Netherlands) was warmed to room temperature and dissolved in 
90pl of anhydrous dimethylsulfoxide (DMSO) and mixed well by vortexing. The stock 
concentration of dye (1.94mM) was diluted 1:1000, to a working concentration of 1.94pM
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in sterile PBS, (pH 7.4). The diluted dye (20ml) was added to tubes containing 1 x 107 
isolated chondrocytes (optimal concentration decided by personal communication with Dr. 
Tony Hayes). The chondrocytes were resuspended in the dye and incubated at 37°C for 1 
hour. Subsequent to incubation, the cells were centrifuged at 500 x g (gravitational force) 
for 10 minutes and the supernatant removed. The labelled cells were resuspended at 2 x 106 
cells/ml in basal media and 1ml was seeded directly onto the chondroitinase ABC treated 
and control (PBS treated) explants. The labelled cells were cultured with the explants for 
periods of up to 28 days in basal media /50pg/ml ascorbic acid 12% FBS. Media was 
changed every 72 hours.
3.3.5 Visualisation o f  Chondroitinase ABC Generated CS-Stubs Using 
Immunohistochemistry
Immunohistochemistry with antibodies 2B6 and 1B5 was performed using the same 
protocol as previously described in section 3.3.2; except that a Texas Red® conjugated 
secondary antibody raised in donkey (1:50 dilution) (GE Healthcare UK Ltd., UK) was 
used to counterstain the CMFDA labelled cells. Sections were also blocked with whole 
donkey serum (1:20 dilution) prior to incubating with the primary antibody. Sections were 
mounted using a Vectashield® mountant containing no propidium iodide.
3.4 Results and Discussion
3.4.1 The Effect o f Concentration and Incubation Time o f Chondroitinase ABC on the 
Digestion o f  Articular Cartilage Explants
It was important to ascertain an optimal concentration and incubation time for digestion of 
the injured cartilage explants with chondroitinase ABC in order to obtain a balance between 
sufficient digestion for the migration and integration of transplanted cells without causing 
permanent damage to the cartilage. Full thickness articular cartilage explants from young 
bovine metacarpophalangeal/metatarsophalangeal joints were embedded in agarose leaving 
only the wounded surface exposed. The injured surface was treated with either lU/ml or 
lOU/ml chondroitinase ABC for varying time periods of up to 24 hours. The explants were 
sectioned and labelled for CS-stubs generated by the chondroitinase digestion. In order to 
obtain a biomechanically stable repair tissue that will not degenerate with time, it is 
important that the endogenous and repair tissue are integrated through all the different 
zones of the cartilage. In choosing an optimal concentration for chondroitinase ABC 
digestion it was therefore important to see sufficient generation of CS-stubs through all the 
zones of the cartilage.
Initial time course experiments using published concentrations and incubation times for 
chondroitinase ABC digestion (Hunziker and Kapfinger, 1998; Hunziker and Rosenberg, 
1996; Lee et al., 2000), lU/ml chondroitinase ABC for periods between 0-1 hr, 
demonstrated no detectable digestion of the GAG content of the cartilage beyond the 
wound surface (data not shown). The described results therefore used a 1 hour incubation 
time and lU/ml concentration of enzyme as the minimum conditions. Figures 3.3-3.6 (a)- 
(f) demonstrate the labelling of C-O-S and C-4-S stubs using the monoclonal antibodies 
2B6 and 1B5 together with a FITC conjugated secondary antibody. Nuclei of the 
chondrocytes within the cartilage have been counterstained with propidium iodide.
The rate and amount of digestion between zones varied due to the differing concentrations 
of proteoglycans within these zones. The fixed charge density, (FCD) of articular cartilage
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Fig.3.3 Immunofluorescence photomicrographs illustrating chondroitinase ABC generated 
CS-stubs, after 1 hour, using the antibodies 2B6 and 1B5 together and a FITC conjugated 
secondary antibody (cells counterstained with propidium iodide), (a)-(c) superficial- 
transitional, transitional and deep zones respectively treated with lU/ml chondroitinase ABC, 
(d)-(f) superficial-transitional, transitional and deep zones respectively treated with lOU/ml
chondroitinase ABC 
Bar = 50pm
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Fig.3.4 Immunofluorescence photomicrographs illustrating chondroitinase ABC generated 
CS-stubs, after 4 hours, using the antibodies 2B6 and 1B5 together and a FITC conjugated 
secondary antibody (cells counterstained with propidium iodide), (a)-(c) superficial- 
transitional, transitional and deep zones respectively treated with lU/ml chondroitinase 
ABC, (d)-(f) surface-transitional, transitional and deep zones respectively treated with
lOU/ml chondroitinase ABC 
Bar = 50pm
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Fig.3.5 Immunofluorescence photomicrographs illustrating chondroitinase ABC generated 
CS-stubs, after 8 hours, using the antibodies 2B6 and 1B5 together and a FITC conjugated 
secondary antibody (cells counterstained with propidium iodide), (a)-(c) surface- 
transitional, transitional and deep zones respectively treated with lU/ml chondroitinase 
ABC, (d)-(f) surface-transitional, transitional and deep zones respectively treated with
lOU/ml chondroitinase ABC 
Bar = 50pm
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Fig.3.6 Immunofluorescence photomicrographs illustrating chondroitinase ABC generated 
CS-stubs, after 24 hours, using the antibodies 2B6 and 1B5 together and a FITC conjugated 
secondary antibody (cells counterstained with propidium iodide), (a)-(c) superficial- 
transitional, transitional and deep zones respectively treated with lU/ml chondroitinase 
ABC, (d)-(f) surface-transitional, transitional and deep zones respectively treated with
1 OU/ml chondroitinase ABC 
Bar = 50pm
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is low in the superficial zone and can be seen to increase with depth of the tissue from the 
articular surface (Maroudas, 1979). It would therefore be expected that the relative amount 
of digestion would be highest in the superficial zone with progressively less towards the 
deeper zones of the tissue. However, it is also important to take into account the fact that 
the SLRPs decorin and biglycan, with their GAG chains, are found in relatively high 
concentrations within the superficial and transitional zones (Poole et al., 1996; Rodrigues et 
al., 2005). As expected, digestion within the superficial zone was more extensive than 
within other zones of the cartilage. Digestion within the transitional-deep zones of the 
tissue after 1 hour of incubation with either lU/ml or lOU/ml of the enzyme did not extend 
beyond the wound surface. While this is probably enough to encourage the adherence of 
chondrocytes to the injured surface it is insufficient to enhance the migration of 
transplanted chondrocytes into the cartilage (see fig.3.3). At four hours, further digestion 
was seen within the superficial layer as expected, but within the deeper layers digestion of 
the cartilage was still seen to be minimal and insufficient for the enhancement of cell 
migration (see fig.3.4).
An incubation period of 8 hours appeared to be optimal for digestion through all zones of 
the tissue (see fig.3.5a-c). The depth of digestion from the exposed surface had increased 
within all zones, although digestion was far more limited in the transitional and deep zones 
in comparison to that of the upper region of the tissue. A similar result was visualised in the 
tissue digested with lOU/ml of chondroitinase ABC (see fig.3.5d-f). Allowing a digestion 
period of 24 hours with lU/ml chondroitinase ABC did not see a substantial difference in 
digestion within the transitional-deep zones than that already achieved at 8 hrs (see 
fig.3.6b-c). Digestion within the superficial zone extended throughout the complete explant. 
However, allowing an incubation period of 24 hours with lOU/ml of enzyme saw complete 
digestion of the CS chains with a blanket of chondroitinase ABC generated CS-stubs being 
seen throughout the tissue (see fig.3.6d-f). Complete digestion in such a manner would 
ultimately result in permanent damage to the cartilage and the ability of the cartilage to 
withstand compressive forces would be diminished. The natural FCD of the tissue would 
alter as its permeability would increase and the water trapped by the large aggregates of 
proteoglycans would be lost. An optimal concentration of lU/ml chondroitinase ABC for 
an incubation period of 8 hours was therefore chosen for subsequent experiments using this 
in vitro model for cartilage injury and repair.
3.4.2 Does Chondroitinase ABC Treatment o f Articular Cartilage Induce Cell Death?
On establishing an optimal concentration and incubation time for treatment of the wounded 
articular cartilage explants with chondroitinase ABC it was important to confirm that these 
conditions did not induce cell death of the chondrocytes within the digested explant. Cell 
death at the wound edge is an inevitable consequence of articular cartilage surgery (Bennett 
et al., 1932). Reparative methods, whether cell-based such as ACT or implant methods such 
as mosaicplasty, invariably involve debridement and cleaning of the lesion site. Cell death 
at the wound edge may in itself be a limiting factor for cartilage-cartilage interface 
integration (Tew et al., 2000). Any integration that does occur therefore is occurring within 
a zone of dead tissue which will degenerate with time and therefore limit the integration 
between pre-existing and newly generated cartilage (Wakitani et al., 1994). It is therefore 
important to consider any factors that would induce more cell death than that already seen 
as a result of initial wounding. Chondrocyte cell death was measured using ethidium 
homodimer, a DNA intercalating compound which can only travel through the 
compromised cell membranes of dead cells (Gaugain et al., 1978a; Gaugain et al., 1978b). 
Ethidium homodimer is a red, fluorescent compound which can be detected by fluorescence 
microscopy.
Explants treated with chondroitinase ABC for the optimised time and concentration (1 U/ml 
for 8 hours) were incubated with 2pm ethidium homodimer for 1.5 hours. Wounded and 
PBS treated explants served as controls for this experiment. Previous experiments have 
demonstrated that the process of wounding articular cartilage does induce cell death at the 
wound edge, however, this can be dramatically reduced by wounding with a sharp scalpel 
blade as opposed to a blunt instrument such as a trephine (Redman, et al., 2004). Cell death 
at wound edges has previously been shown to be due to necrosis, with a zone of apoptotic 
cells directly behind this (Tew et al., 2000), therefore some cell death at the wound edge 
was expected with this experiment.
Explants that were wounded with a scalpel blade and immediately incubated with ethidium 
homodimer demonstrated some cell death at the wound edge through all zones of the
cartilage (fig. 3.7a). As expected the level of cell death within the deep zone was highest 
and this can be attributed to cell death induced during removal of the explant from the bone 
for experimentation. Cell death however was limited to the wound edge and extended back 
on average 15pm into the superficial zone of the tissue (defined as 100pm from the top of 
the explant) to 89pm in the deep zone (defined as 100pm from the base of the explant). 
Explants treated with PBS as a control instead of chondroitinase ABC for 8 hours 
demonstrated a similar distribution of cell death at the wound edge within the superficial 
and transitional zones (see fig. 3.7b). Within this treatment group an average zone of cell 
death 27pm from the wound edge was seen in the surface of the explant and this remained 
unchanged in the deep zone, with cell death extending back into the tissue for an average of 
31pm. Differences in the amount of cell death seen within the deep zone can be attributed 
to the effects of explant excision from the bone as previously discussed.
The explants treated with chondroitinase ABC showed a very similar pattern of cell death 
to the controls, confirming that any cell death at the wound edge was as a direct result of 
wounding to the tissue and not due to incubation of the explant with chondroitinase ABC 
(fig. 3.7c). Although not calculated here, the zone of GAG digestion seen in the explants 
treated with chondroitinase ABC for 8 hours within section 3.3.1 (see fig. 3.5) was in 
excess of the zone of cell death demonstrated here. For example, the zone of GAG 
digestion within the superficial zone extended for the complete depth of the explant. Within 
this treatment group cell death within the defined superficial zone extended back from the 
wound edge into the treated tissue for an average of 17pm. Within the deep zone this 
increased only to an average of 31pm. These results confirm that this chondroitinase ABC 
treatment, under the conditions described above, is not toxic to the chondrocytes within the 
treated explant and therefore it can be used at this concentration and incubation time to 
investigate the migration of isolated chondrocytes at the wound edge into the digested
Fig.3.7 Fluorescent photomicrographs illustrating ethidium homodimer (dead) labelled chondrocytes within full depth articular 
cartilage explants (a) scalpel wounded explant, (b) PBS treated explant, (c) chondroitinase ABC treated explant.
SZ = superficial zone, DZ = deep zone and WE = wound edge
Bar = 50pm
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3.4.3 The Effect o f  Chondroitinase ABC Digestion on Enhancing the Migration of  
Chondrocytes Isolated from Young and Mature Articular Cartilage into Cartilage 
Explants
As previously investigated, an optimal concentration of the enzyme chondroitinase ABC of 
lU/ml and an incubation period of 8 hours was chosen. Isolated chondrocytes from the both 
the young and skeletally mature articular cartilage were labelled with the green fluorescent, 
cytoplasmic dye CMFDA and seeded onto the surface of the pre-digested explants. 
Labelled cells were seeded onto the surface of PBS treated explants to serve as controls. 
The chondrocytes were allowed to adhere to the wound surface and migrate into the 
digested tissue for a period of up to 28 days before being sectioned and viewed using 
fluorescence microscopy.
Using grids of 0.1mm it has been possible to quantify the migration of labelled cells into 
the explants over the 28 day culture period. The number of labelled cells present within the 
superficial, transitional and deep zones of the explants were counted and averaged (n=3). 
As stated in section 3.4.2, the superficial zone has been defined as the region extending 
from the articular surface to a depth of 100pm into the tissue. The deep zone has been 
defined for this purpose as the region extending 100pm above the start of the calcified 
zone. As expected variation between explants and batches of cells means that the standard 
error figures are high and for this reason graphical representation presented in fig.3.8 is 
purely to indicate the trends and differences between control and treatment groups. No 
statistics have been performed.
The data obtained support the hypothesis that GAG chains inhibit the migration of 
chondrocytes, and complement the data described in chapter 2. A negligible amount of 
migration was seen with chondrocytes from both the young and skeletally mature cartilage 
into the PBS treated control explants over the initial 7 day culture period (see fig.3.9 and 
fig.3.13). The data provided by the Boyden chambers suggesting the anti-adhesive 
properties of GAG chains and the ability of proteoglycans to mask other pro-adhesive 
matrix macromolecules present within the cartilage prevents chondrocyte migration. These 
data are also in line with that previously published demonstrating the ability of anti-
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Fig. 3.8 Graphical representation of the number of CMFDA labelled chondrocytes isolated from
(a) young and (b) mature cartilage migrating into PBS (control) and chondroitinase ABC treated 
explants over periods of 1-28 days after seeding onto the wound surface. The superficial zone is 
defined here as extending from the articular surface to 100pm into the tissue, the deep zone being 
100pm from the point of excision (excluding any calcified cartilage).
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adhesive proteoglycans present at articular cartilage wound edges to reduce the adhesion of 
transplanted chondrocytes to the wound surface (Lee et al., 2000).
At the later time points a small amount of migration was seen into the control explants, 
primarily within the superficial-transitional zones (fig. 3.10 and 3.14). However, this was 
expected as this is a static model of migration. As previously demonstrated within a number 
of models, immobilisation of a synovial joint leads to loss of proteoglycans and CS from 
the articular cartilage (Caterson and Lowther, 1978; Haapala et al., 2001; Kiviranta et al., 
1987; Palmoski et al., 1979; Palmoski et al., 1980; Saamanen et al., 1990; Tammi et al., 
1983). This would therefore allow the migration of chondrocytes still present on the wound 
surface to migrate into the tissue. This migration was limited to the upper zones of the 
cartilage where concentrations of proteoglycans are at their lowest.
Chondroitinase ABC treated explants did allow the migration of both chondrocytes isolated 
from young and mature cartilage into the digested explant (see figs.3.11-3.12 and 3.15-
3.16). Neither age group demonstrated migration beyond the region of GAG depletion; 
supporting the theory that sufficient digestion of the injured cartilage is needed prior to the 
seeding of transplanted chondrocytes in order to successfully enhance migration and 
integration. The majority of cell migration into the tissue was within the superficial zone, 
consistent with the degree of GAG digestion in this region (see figs. 3.11-3.12 and 3.15-
3.16). In comparison to the superficial and transitional zones, active migration of 
chondrocytes into the deeper zones was substantially less, even with digestion of 
proteoglycans. An additional factor to encourage migration such as a chemoattractant may 
be required to enhance migration within these deeper zones. Although these results indicate 
GAG depletion within this zone, this method is non-quantitative. It is likely that there is 
still sufficient GAG to inhibit migration.
Increasing numbers of labelled chondrocytes isolated from young cartilage were seen 
migrating into the chondroitinase ABC treated explants with time in culture (see fig.3.11 
and 3.12). This trend appeared to plateau at 14 days with no further increase in the number 
of labelled chondrocytes seen migrating into the explants (see fig.3.12). By days 21 and 28 
fluorescently labelled migrated chondrocytes were demonstrating the correct morphology
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Fig.3.9 Imm unofluorescence photom icrographs illustrating the m igration o f  CM FDA labelled 
chondrocytes (green) isolated from young articular cartilage into the (a-c) superficial- 
transitional, (d-f) transitional and (g-i) deep zones o f  PBS treated cartilage explants after (a, d, 
g) 1, (b, e, h) 5, and (c, f, i) 7 days o f  culturing. The antibodies 2B6 and 1B5 and a Texas Red® 
conjugated secondary antibody have been used to highlight the chondroitinase ABC generated
CS-stubs.
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Fig.3.10 Immunofluorescence photomicrographs illustrating the migration of CMFDA 
labelled chondrocytes (green) isolated from young articular cartilage into the (a-c) superficial- 
transitional, (d-f) transitional and (g-i) deep zones of PBS treated cartilage explants after (a, d, 
g) 14, (b, e, h) 21, and (c, f, i) 28 days of culturing. The antibodies 2B6 and 1B5 and a Texas 
Red® conjugated secondary antibody have been used to highlight the chondroitinase
generated CS-stubs.
Bar = 50pm
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Fig.3.11 Immunofluorescence photomicrographs illustrating the migration of CMFDA labelled 
chondrocytes isolated from young articular cartilage into the (a-c) superficial-transitional, (d-f) 
transitional and (g-i) deep zones of chondroitinase ABC treated cartilage explants after (a, d, g) 
1, (b, e, h) 5, and (c, f, i) 7 days of culturing. The antibodies 2B6 and 1B5 and a Texas Red® 
conjugated secondary antibody have been used to highlight the chondroitinase generated CS-
stubs.
Bar = 50pm
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Fig.3.12 Immunofluorescence photomicrographs illustrating the migration of CMFDA labelled 
chondrocytes (green) isolated from young articular cartilage into the (a-c) superficial-transitional, 
(d-f) transitional and (g-i) deep zones of chondroitinase ABC treated cartilage explants after (a, d, 
g) 14, (b, e, h) 21, and (c, f, i) 28 days of culturing. The antibodies 2B6 and 1B5 and a Texas 
Red® conjugated secondary antibody have been used to highlight the chondroitinase generated
CS-stubs.
Bar = 50pm
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Fig.3.13 Immunofluorescence photomicrographs illustrating the migration of CMFDA 
labelled chondrocytes (green) isolated from mature articular cartilage into the (a-c) 
superficial-transitional, (d-f) transitional and (g-i) deep zones of PBS treated cartilage 
explants after (a, d, g) 1, (b, e, h) 5, and (c, f, i) 7 days of culturing. The antibodies 2B6 and 
1B5 and a Texas Red® conjugated secondary antibody have been used to highlight the
chondroitinase generated CS-stubs.
Bar = 50pm
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Fig.3.14 Immunofluorescence photomicrographs illustrating the migration of CMFDA 
labelled chondrocytes (green) isolated from mature articular cartilage into the (a-c) 
superficial-transitional, (d-f) transitional and (g-i) deep zones of PBS treated cartilage 
explants after (a, d, g) 14, (b, e, h) 21, and (c, f, i) 28 days o f culturing. The antibodies 2B6 
and 1B5 and a Texas Red® conjugated secondary antibody have been used to highlight the
chondroitinase generated CS-stubs.
Bar = 50pm
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Fig.3.15 Immunofluorescence photomicrographs illustrating the migration of CMFDA 
labelled chondrocytes (green) isolated from mature articular cartilage into the (a-c) 
superficial-transitional, (d-f) transitional and (g-i) deep zones of chondroitinase ABC treated 
cartilage explants after (a, d, g) 1, (b, e, h) 5, and (c, f, i) 7 days of culturing. The antibodies 
2B6 and 1B5 and a Texas Red® conjugated secondary antibody have been used to highlight
the chondroitinase generated CS-stubs.
Bar = 50pm
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Fig.3.16 Immunofluorescence photomicrographs illustrating the migration of CMFDA labelled 
chondrocytes (green) isolated from mature articular cartilage into the (a-c) superficial- 
transitional, (d-f) transitional and (g-i) deep zones of chondroitinase ABC treated cartilage 
explants after (a, d, g) 14, (b, e, h) 21, and (c, f, i) 28 days of culturing. The antibodies 2B6 and 
1B5 and a Texas Red® conjugated secondary antibody have been used to highlight the
chondroitinase generated CS-stubs.
Bar = 50pm
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Fig. 3.17 Magnified images of migrated CMFDA labelled chondrocytes (green) 
isolated from (a-c) young and (d-f) mature articular cartilage into the (a and d) 
superficial, (b and e) transitional, (c and f) deep zones of chondroitinase ABC treated 
cartilage explants after 28 days of culturing. The photomicrographs illustrate the 
ability of the migrated chondrocytes to adapt to the cellular morphology of the zone
that they have migrated into.
Bar = 10pm
153
C hapter  3
for the zones they were situated in and occupying lacunae (see fig.3.17). Even at these later 
time points, no migration was seen beyond the zone of digestion. These data raise the 
question of whether the migrating chondrocytes are occupying existing lacunae, or 
generating new lacunae around themselves after migrating into the digested matrix. It 
would be interesting to investigate this phenomenon further with chondrocytes transfected 
with a type VI collagen expressing vector and green fluorescent protein (GFP) tag. This 
would give a clear indication as to whether the transfected, migrating chondrocytes are 
generating a pericellular matrix around themselves, once within the digested tissue.
Labelled chondrocytes were present at the wound edge replacing those lost as a result of 
injury to the articular cartilage. These results present a basis for live chondrocytes at the 
wound edge able to synthesis matrix and form a biomechanically stable region for 
integration with any neo-cartilage produced within the lesion site. A similar pattern of 
migration was seen with the chondrocytes isolated from mature cartilage. A consistent 
increase in the number of labelled chondrocytes found within the chondroitinase ABC 
treated explants was seen over the first 21 days (see fig.3.15 and 3.16). Initially fewer cells 
were seen to migrate into the explant when compared to the chondrocytes isolated from 
young cartilage. The later time points, however, demonstrated an increase in the number of 
cells migrating into the tissue, with numbers comparable to those seen with the young cells 
by day 28 (see fig.3.16). It is however possible that this increase in cells is not due to 
migration, but cell division. As discussed in chapter 2 (see section 2.4.3), only 0.9% of the 
cells seeded onto the Boyden chambers demonstrated the ability to migrate, leading to the 
hypothesis that there may be a subpopulation of cells within articular cartilage which have 
the ability to migrate. A hypothesis which supports the work by Dowthwaite et al., (2004), 
which describes the presence of a chondroprogenitor population within the superficial zone 
of articular cartilage. These chondroprogenitor cells have a phenotypic plasticity and like 
other undifferentiated cells are able to form colonies. This ability to divide may explain 
why increases in the number of labelled cells were found residing in the explant with time. 
It would be interesting to separate the chondrocytes from the different zones of articular 
cartilage, both young and skeletally mature, and investigate the migratory abilities of cells 
from the different zones to see if this is the case. These undifferentiated cells are also 
characterised by their adhesiveness to fibronectin. It is well documented that the GAG 
chains do inhibit cell adhesion to fibronectin found within the matrix by blocking the cell
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binding domain (Lewandowska et al., 1987). Removal of these inhibitory GAG chains from 
the wound surface would therefore in theory expose other matrix macromolecules, such as 
fibronectin, for these cells to bind and adhere to.
The data achieved from this work pose the questions of whether digestion of the 
proteoglycans within the cartilage matrix increases the migration of chondrocytes because 
of the reduced FCD and therefore increased the permeability of the tissue or whether it is 
due to the unmasking of pro-adhesive matrix proteins allowing chondrocytes to adhere to 
the cartilaginous matrix and migrate into the injured tissue.
3.5 Conclusions
In support of the data obtained in chapter 2, these studies have demonstrated the anti­
adhesive properties of proteoglycans and the role of the GAG chains in preventing the 
adhesion and migration of chondrocytes into injured cartilage explants. An in vitro model 
of articular cartilage injury has been developed and the optimal conditions for 
chondroitinase ABC digestion of the wound surface ascertained. The data demonstrates the 
ability of both chondrocytes isolated from young and skeletally mature cartilage to migrate 
into pre-digested tissue, but only to the depth to which digestion occurred, reinforcing this 
initial point.
Maximal migration of both age groups was seen in the superficial zones, with minimal 
migration into the deeper zones of the wounded cartilage, coinciding with the relative 
concentration of proteoglycans within these zones. Combining digestion of the tissue with 
other factors such as the use of a chemoattractant or growth factor to enhance migration 
may further encourage the motility of these cells and their integration into the articular 
cartilage matrix.
Increasing number of cells isolated from both young and skeletally mature cartilage were 
seen within the upper zones of the cartilage explants with time. Whether this was as a 
result of increased migration with time, or due to division of the migrated cells remains 
unknown. As discussed in chapter 2, a subpopulation of chondrocytes appear to have the
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ability to migrate and isolating chondrocytes from their respective zones and repeating this 
experiment may be fruitful in ascertaining whether these migratory cells are those 
previously described as chondroprogenitors.
Supplementary to this work it would be interesting to investigate the biosynthetic activities 
of the migrated cells once they are within the cartilage matrix. Using 35S04 and 3H-proline 
labelling of chondrocytes prior to transplantation within this model it would be possible to 
look at their respective proteoglycan and collagen production after migration into the 
injured tissue. In addition to this it would also be possible to look at the ability of growth 
factors such as those used in chapter 2, IGF-1 and TGFpl, in enhancing the migratory 
process and the biosynthetic activity of the cells once they are within the cartilage.
In summary:
• The inhibitory role of CS in chondrocyte migration and integration using an in vitro 
model of cartilage injury corroborated with the data described in chapter 2 .
• Chondrocytes isolated from young and skeletally mature cartilage migrated into 
chondroitinase ABC treated cartilage explants.
• Migrated chondrocytes at day 21 and 28 were seen to have adopted the morphology 
of the endogenous cells within the zone into which they have migrated.
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Investigating the Ability of 
IGF-1 and TGFpl to 
Enhance Matrix 
Biosynthesis in Articular 
Chondrocytes
4.1 Background
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The previous experimental chapters have discussed the importance of combining both 
cellular migration and integration in the formation of a biomechanically stable tissue for 
cartilage repair. The composition and attributes of the newly formed cartilage are crucial 
for conveying its stability. As discussed in section 1.4.4, it is the balance of the tensile 
strength providing collagens and compressive force resisting proteoglycans that gives 
articular cartilage its ability to function. This chapter describes work aimed at enhancing 
matrix biosynthesis for the production of a functionally integrated repair tissue. The effects 
of the anabolic growth factors, IGF-1 and TGFpi have been investigated with reference to 
their ability to alter the synthesis of proteoglycans and collagens whilst maintaining the 
chondrocytic phenotype. We have previously demonstrated the ability of IGF-1 and TGFpl 
to enhance the migration of chondrocytes and also their co-operation and synergising 
effects when used in combination (see chapter 2 ).
The nature and attributes of these growth factors have been discussed in sections 1.15.1 and 
1.15.2. The positive role of IGF-1 in aiding cartilage homeostasis and the maintenance of 
the mechanical properties of the tissue, including the equilibration modulus and 
electrokinetic coefficient is well documented (Sah et al., 1996). IGF-1 was chosen as a 
target growth factor in this study due to its well characterised anabolic effects within 
chondrocytes as well as other cell types. Specifically within cartilage, IGF-1 has been 
implicated in matrix homeostasis and in maintenance of the chondrocytic phenotype 
(Gueme et al., 1994; Tyler, 1989). IGF-1 is known to increase both proteoglycan and 
collagen biosynthesis (Bonassar et al., 1997) and can also enhance cellular proliferation and 
differentiation with an increase in DNA synthesis (Trippel, 1997). These effects are 
accompanied by decreased expression of degradative factors such as MMPs and up- 
regulation of TIMP expression (Hui et al., 2001a; Hui et al., 2001b). In addition to this, 
IGF-1 is able to counteract the catabolic effects of inflammatory cytokines such as IL-1 and 
TNFa (Tyler, 1989).
The metabolic effects of TGFpl on cartilage are less well characterised and conflicting 
results have been published. These conflicting reports appear to be dependent on the target 
cell’s cell cycle stage. TGFpl will enhance proliferation of those cells within S phase,
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whereas those dividing slowly within Gi will be inhibited (Trippel, 1995; Vivien et al., 
1992; Vivien et al., 1990). Some studies have demonstrated TGF01 to be stimulatory on 
proteoglycan synthesis (Glansbeek et al., 1998) and cell proliferation (Darling and 
Athanasiou, 2005a). Other publications indicate no such effects on chondrocytes or even 
the reverse with inhibition of proteoglycan synthesis seen (van der Kraan et al., 1992). As 
with IGF-1, TGFpl has the ability to reduce pro-inflammatory cytokine-induced 
proteoglycan degradation. Studies with IL-1 have shown that TGFpl is able to counteract 
the degradative effects this cytokine can induce (van Beuningen et al., 1993; van 
Beuningen et al., 1994). Despite conflicting reports this growth factor was chosen for 
investigation as, unlike other growth factors older cells maintain the ability to respond to 
TGFpl. In a study by Gueme et al. (1994), all three isoforms of TGFP proved to be the 
most effective growth factor in old chondrocytes in comparison to IGF-1, FGF2 and PDGF. 
However, a recent study by Hickery et al. (2003) suggests that TGFpl may not enhance 
proteoglycan synthesis in mature cells. This report suggests that differences in sensitivity to 
growth factors such as TGFpl might be due to differences in ECM composition. Since we 
know that substantial differences in the ECM structure develop with age this theory may be 
plausible.
It is well accepted that cellular ageing is accompanied by a decreased ability to divide and 
respond to growth factors. The reasons and mechanisms for this are still to be determined. 
Most hypotheses centre on an alteration in the expression of the specific growth factor 
receptors and/or the affinity of the ligand for the receptor. Ribault et al. (1998) 
demonstrated in the case of EGF that the number of these receptors decreased on the 
surface of rat articular chondrocytes with increasing age. Martin et al. (1997) also showed 
that there are fewer binding sites for IGF-1 in ageing chondrocytes but the affinity of the 
ligand for its receptor is not altered. In the case of IGF-1 this decrease in responsiveness by 
the ageing chondrocytes may be due to the increasing numbers of IGFBPs, especially 3 and 
4 (Martin et al., 1997). These binding proteins would, in theory, compete at the cell surface 
for IGF-1 binding to its receptor, resulting in reduced IGF-1 activity. This work is 
supported by in vivo studies where a diminished sensitivity to growth factors is seen in 
osteoarthritic chondrocytes directly due to increased expression of IGFBPs (Dore et al., 
1994; Tardif et al., 1996). Osteoarthritic chondrocytes are less responsive to the anabolic 
effects of IGF-1 even if there is increased availability of the growth factor within the matrix
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and synovial fluid (Chevalier and Tyler, 1996; Dore et al., 1994; Tavera et al., 1996). 
Messai et al. (2000) demonstrated that old rat chondrocytes maintain the ability to bind 
IGF-1 the ligand to its specific receptors and suggested that despite this binding a decreased 
responsiveness is due to an altered intracellular signalling pathway. The activation of 
adenylcyclase and subsequently the production of cAMP result in the activation of PKC. 
However, levels of cAMP and therefore downstream effectors were much lower in the 
older cells suggesting less efficient signalling machinery in the older chondrocytes than the 
young cells.
Aims:
1. Determine the effects of IGF-1 and TGFpl on the biosynthesis of proteoglycans and 
collagen.
2. Confirm that the biosynthetic effects of IGF-1 and TGFpl are accompanied by 
maintenance of the chondrocytic phenotype.
3. Investigate changes in target gene expression, including those encoding for IGF-1, 
TGFpl and their respective receptors induced by these growth factors at the mRNA 
level.
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All materials were obtained from Sigma Chemical Company, UK unless otherwise stated 
within the protocol.
4.3 Methods
4.3.1 Isolation and Culturing o f  Chondrocytes from Bovine Cartilage
Chondrocytes from young and mature cartilage were isolated and resuspended in basal 
media as previously described in section 2.3.2. Cells were seeded into 48 well culture plates 
at a concentration of 5 x 105 cells/well and left overnight to stabilise.
4.3.2 Labelling o f  Chondrocytes with Sulphate and H-proline
Subsequent to the stabilisation period, media was aspirated off the chondrocytes and 
replaced with 500pl of basal media containing 1 of the following:
1. lOng/ml IGF-1
2. lOng/ml TGFpl
3. lOng/ml IGF-1 and lOng/ml TGFpl
Media alone served as a control. All treatment groups were further supplemented with 
lOpCi/ml (microcuries) 35S04 and 20pCi/ml 3H-proline (GE Healthcare Ltd., UK) and 
incubated for periods of 1, 3 or 7 days.
4.3.3 Calculating Proteoglycan and Collagen Biosynthesis Using 35Sulphate and 3H- 
Proline
A measure of the biosynthesis of sGAG (representative of proteoglycan biosynthesis) and 
collagen was calculated within the media (radiolabel secreted by the chondrocytes) and also 
within the cell lysate (radiolabelled intracellular and extracellular associated material).
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4.33.1 Equilibriation o f  Ultrafree®-MC Centrifugal Filter Units
Unincorporated radiolabel was removed from media and lysate samples using Ultrafree®- 
MC centrifugal filter units (Millipore (UK) Ltd., UK). These filter units contain a 
regenerated cellulose membrane with a cut-off value of lOKDa. Prior to addition of the 
sample, the units required equilibriation using a buffer consisting of 1% BSA and 1% 
sucrose. Units were centrifuged with 400pl of the buffer for 20 minutes at 2000 x g at room 
temperature. The buffer was aspirated from both the upper and lower chambers before 
addition of the sample.
43.3.2 Removal o f  Unincorporated Radiolabel using Ultrafree®~MC Centrifugal Filter 
Units
4.3.3.2.1 Processing o f  Media Samples
Protease inhibitor cocktail (500pM AEBSF hydrochloride, 150nM aprotinin, lpM  E-64 
protease inhibitor, 0.5mM EDTA disodium, lpM  leupeptin hemisulphate), 4pl of a 1 x 
stock (Calbiochem®, UK), was added to the culture media before aspiration from the 48 
well plate. This prevented any breakdown of newly synthesised matrix molecules within 
the sample. The aspirated media was transferred to a pre-equilibriated Ultrafree®-MC 
centrifugal filter unit and centrifuged for 20 minutes at 2000 x g at room temperature. A 
further 5 x 20 minute spins were performed with the addition of lOOpl of PBS (pH 7.4) to 
the upper chamber between each centrifugation step (work by Dr E. Blain and Dr S. Gilbert 
within our laboratory had previously demonstrated that 5 wash spins was sufficient to 
remove all unincorporated label from media samples). After the removal of unincorporated 
radiolabel, a lp l aliquot of sample remaining in the upper chamber was removed for 
scintillation counting.
4.33.2.2 Processing o f Cell Lysates and Associated Material
Cultured chondrocytes were lysed in 0.9% Triton® X 100 containing protease inhibitors at 
the above concentrations. The cells and their associated matrix were removed from the 48 
well plate and transferred to pre-equilibrated Ultrafree®-MC centrifugal filter units. The
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culture plates were scraped with a pipette tip to ensure any matrix remaining bound to the 
plastic was removed and included within the subsequent experiments. The aspirated lysates 
were spun for 20 minutes at 2000 x g at room temperature. A further 4 x 20 minute spins 
were performed with the addition o f lOOpl of PBS (pH 7.4) between centrifugation steps. 
After complete removal of the unincorporated radiolabel, a lp l aliquot was removed from 
the upper cup for scintillation counting.
4.3.3.2.3 Calculating Collagen Biosynthesis
Tritiated proline served as a measure of total protein biosynthesis within the media and cell 
lysate samples. As discussed within section 1.4.4.3, all collagens are characterised by the 
presence of continuous or interrupted triple helices containing the amino acid repeat 
sequence Gly-X-Y, where X and Y are typically proline or hydroxyproline. The use of 
tritiated proline in calculating protein biosynthesis within chondrocytes therefore biases the 
results towards collagen biosynthesis. To accurately calculate what percentage of the total 
protein biosynthesis was in fact collagen, samples previously processed through the filter 
units to remove unincorporated radiolabel were collagenase digested and run through the 
filter units again to remove the digested collagen. A measurement of non-collagenous 
protein could then be calculated and subtracted from the total protein value in order to 
ascertain the amount of collagen synthesised. Data are expressed in counts per minute 
(CPM).
A 50pl aliquot of the filtered media or cell lysate sample was removed and digested with 
8 U of type III bacterial collagenase, isolated from Clostridium histolyticum , (Worthington 
Biochemical Corporation, NJ, USA) overnight at 37°C with agitation. Post-digestion, lOpl 
was removed and counted using the scintillation counter. The remaining 40pl was added to 
the top of a pre-equilibrated filter unit and processed using the methods outlined in section
4.3.3.2.1 for media and section 4.3.3.2.2 for cell lysates. A lOpl aliquot of the processed 
sample was then removed for scintillation counting.
The mean + the SEM were calculated for both the sGAG and collagen biosynthesis 
samples. All data were assessed for normal distribution using the Anderson-Darling test
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(P>0.05). Statistical significance was calculated using a one-way ANOVA and Bonferroni 
post-test where P<0.05.
4.3.4 Calculating Cytotoxicity and Total Cell Number Using the Cytotox 9 6 0  Assay
As previously described in section 2.3.6, the Cytotox 96® assay can be used to calculate 
both total cell number and cytotoxicity by measuring LDH levels within cell lysates and 
culture media respectively.
Samples generated from a ‘cold’ experiment were run alongside the radiolabelled samples. 
As in the original setup described in section 4.3.1 and 4.3.2, chondrocytes were cultured for 
1, 3 or 7 days in the presence of lOng/ml of IGF-1, TGFpi or both growth factors. Media 
alone served as a control. No radiolabel was added to this experiment. The media was 
aspirated off the plates and the cells lysed in 0.9% Triton® X 100. LDH levels were 
measured within both the culture media and cell lysates to determine whether IGF-1 and/or 
TGFpl treatment was cytotoxic or effected total cell number at these time points. The mean 
+ SEM was calculated for each treatment group. The data were assessed for normality and 
statistical analysis performed using the methods outlined in section 4.3.3.2.3.
4.3.5 Confirming the Chondrocytic Phenotype by Western Blotting fo r  Type II  Collagen
4.3.5.1 Separation o f  Proteins Using SDS-PAGE
SDS-PAGE allows the separation of proteins within a sample according to relative 
molecular weight. Prior denaturation using sample buffer containing the anionic detergent 
SDS allows dissociation of proteins into their individual polypeptide subunits and 
minimises aggregation (Laemmli, 1970).
For the separation of collagen within the samples a 7.5% resolving gel was used with a 4% 
stacking gel (see table 4.1). Gel mixtures were polymerised with the final addition of 
tetramethylethylenediamine (TEMED).
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Table 4.1 SDS-PAGE gel mixes for 7.5% resolving and 4% stacking gels
Gel Component Resolving Gel (7.5%) Stack Gel (4%)
Distilled Water 8.16ml 4.075ml
10% SDS lOOpl 50pl
10% APS T 75pl 37pl
Tris-HCl pH 8 .8 3.63ml -
Tris-HCl pH 6 .8 - 1.3ml
40% Bisacrylamide 2.72ml 575pl
TEMED 15pl 7.5pl
T Abbreviation of ammonium persulphate
Samples were generated from a ‘cold* experiment similar to that described in section 4.3.4. 
Chondrocytes were cultured for 1, 3 or 7 days in the presence of lOng/ml of IGF-1, TGFpi 
or both growth factors. Media alone served as a control. No radiolabel was added to this 
experiment. At the end o f the culture period, the treatment containing media was replaced 
and the chondrocytes cultured for a further 3 days. The media was aspirated off the plates 
and the cells lysed in 0.9% Triton® X 100. Previous work within the laboratory 
demonstrated that matrix macromolecule biosynthesis is increased by this treatment and 
therefore generating enough protein for successful detection using Western blotting.
The cell lysates and their associated ECM material were denatured and reduced in 2 x 
sample buffer (0.06M Tris-HCl, pH 6 .8 , 2% (w/v) SDS, 10% (w/v) glycerol, 2mg/ml 
Bromophenol Blue) containing 2.5% p-mercaptoethanol for 30 minutes at 60°C. This 
ensured that any pro-collagen present would be reduced to its constitutive a  chains. 
Samples (15pl) and a bovine type II collagen standard (5pl) were run on a 7.5% resolving 
SDS-PAGE gel at 150V in 1 x Laemmli buffer [see appendix 5.1.3] until the dye 
approached the bottom of the gel. A molecular weight marker (Biorad Laboratories Ltd., 
UK) was loaded for the identification of proteins and their relative molecular sizes. Each 
gel was run in duplicate, acting as a positive and negative control for binding of the 
secondary antibody.
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4,3,5,2 Western Blotting fo r  Type I I  Collagen
Samples were transferred from the SDS gel onto Immobilon-P PVDF transfer membrane in 
transfer buffer at a constant 20V overnight. As detailed in section 2.3.5.2, on completion of 
transfer, membranes were washed 3 times over 30 minutes in blocking buffer with 3% 
skimmed milk powder to block any remaining binding sites before incubation with the 
primary antibody.
4,3,5,2,1 Primary Antibody — A VT-6E3
The primary monoclonal antibody, AVT-6E3 (courtesy of Dr. A Vaughan-Thomas, The 
Faculty of Veterinary Science, University of Liverpool, UK) was raised in mouse and 
specifically recognises an epitope within the triple helical domain of type II collagen as 
well as the % fragment produced by collagenase degradation. Positive control membranes 
were exposed to AVT-6E3 at a 1:5 dilution in blocking buffer overnight on a roller at 4°C. 
Corresponding primary antibody negative controls were exposed to blocking buffer in the 
same conditions. On removal of the primary antibody, all membranes were soaked in 
blocking buffer for 1 hour with 3 changes and subsequently exposed to the secondary 
antibody (sheep anti-mouse) conjugated to HRP (1:10,000 diluted in blocking buffer) for 
detection, for 2 hours at room temperature on a roller. The membranes were again washed 
in blocking buffer for 2 hours with 6  changes before detection using the ECL™ method 
previously described in section 2.3.5.2.2. Membranes were exposed to Hyperfilm™ ECL™ 
overnight in an X-ray cassette before developing in standard solutions using an automatic 
developer.
4,3,6 Investigating Changes in mRNA Levels o f Target Genes by Exogenous IGF-1 and 
TGFpl
As described in section 4.3.2 isolated chondrocytes were incubated with lOng/ml of IGF-1, 
TGFpl or both growth factors for periods of up to 7 days. As with those samples generated 
for the purpose of Western blotting, the samples required for RNA analysis had no 
radiolabel added to the culture media. Samples were otherwise treated the same and after 
the required incubation period the media was aspirated and the cells lysed in Trizol®
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(Invitrogen Life Technologies Ltd., UK) for the extraction of RNA. The purpose of these 
experiments was to investigate the effects of these growth factors on a number of target 
genes within both chondrocytes isolated from young and mature cartilage.
4.3.6.1 Extraction o f  Total RNA
Isolated chondrocytes were resuspended at a concentration of 1 x 106 cells/ml. One ml of 
suspension was aliquoted into a 1.5ml microcentrifuge tube and centrifuged at 100 x g for 5 
minutes to pellet the cells. The supernatant was replaced by 1ml of Trizol® and the 
suspension was left at room temperature for 5 minutes to lyse the cells. One hundred and 
seventy five pi of chloroform was added. The chloroform was mixed by inverting the tube 
and allowed to stand at room temperature for a further 3 minutes. The chloroform/Trizol® 
mixture was transferred to a phase-lock gel™ (PLG) tube (Eppendorf AG, Hamburg, 
Germany) and the RNA containing aqueous phase was separated by centrifugation at 
13,000 x g for 2 minutes. The aqueous phase was then transferred to a fresh 1.5ml tube. All 
plastic-ware used was RNase free.
4.3.6.2 Precipitation o f  RNA
RNA was precipitated from the aqueous phase by the addition of an equal volume of 
isopropanol. The tubes were mixed by inversion and left at -20°C overnight to precipitate. 
The RNA pellet was isolated by centrifugation at 12,000 x g for 10 minutes at 4°C. The 
supernatant was removed and the pellet washed in 75% ethanol. The pellet was spun again 
at 7500 x g for 5 minutes at 4°C and the ethanol supernatant removed. The RNA pellet was 
air-dried for 5 minutes before resuspending in 43 pi of RNase (ribonuclease) free water.
4.3.6.3 DNase Treatment o f  Extracted RNA
Isolated RNA (43pi) was treated with 1U DNase [deoxyribonuclease] (Promega, UK), 40U 
RNasin® recombinant ribonuclease inhibitor (Promega, UK) and buffered with 1 x DNase 
buffer (Promega, UK) to remove any genomic DNA contamination. The final volume of
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50(xl was heated to 65°C for 5 minutes to aid resuspension and then transferred to 37°C for 
15 minutes before then cooling on ice and storing at -80°C.
43.6.4 Purification o f  DNase Treated RNA
The RNA was purified from any contaminating reagents such as DNases using the 
RNeasy® MinElute™ protocol for RNA cleanup (Qiagen, UK) (see fig.4.1). Briefly, an 
equal volume of RNase free water was added to the RNA suspension. Three hundred and 
fifty pi of buffer RLT (1% (3-mercaptoethanol) was added and mixed thoroughly by 
vortexing. Two hundred and fifty pi of ice-cold 100% ethanol was added and mixed well 
by pipetting. The sample was transferred to an RNeasy® spin column and centrifuged for 1 
minute at 8000 x g.
The eluate was disposed of and 500pl of buffer RPE was added to the column and spun 
again at 8000 x g for 1 minute. This step was repeated but the column was spun at 14,000 x 
g for 2 minutes to dry the membrane. The purified RNA was eluted by addition of 50pl of 
RNase free water to the spin column and centrifuging at 8000 x g for 1 minute. Purified 
RNA was stored at -80°C.
43.6.5 Confirming the Presence o f  RNA by Agarose Gel Electrophoresis (Sambrook et 
aL, 1989)
The presence of ribosomal RNA was confirmed by running purified RNA samples, 
combined with a loading dye (lOmM Tris-Cl, pH 7.5, 50mM EDTA, 10% Ficoll® 400, 
0.255% Bromophenol blue, 0.25% Xylene Cyanol FF, 0.4% Orange G) (Promega, UK) at a 
1:5 ratio, on a 1% agarose gel containing 0.5% (v/v) ethidium bromide. The gel was 
buffered in 1 x Tris-Borate ethylenediaminetetraacetic acid (TBE) (89mM Tris-Borate, 
2mM EDTA, pH 8.3) and run at 50V for 2 hours. Molecular weights were estimated by 
running a lOObp DNA ladder (Promega, UK) on the same gel. The products were visualised 
using a transilluminator.
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RNeasy MinElute 
Cleanup Procedure
O  Add Buffer RLT and ethanol 
to adjust binding conditions.
©  Apply sample to RNeasy  
MinElute Spin Column for 
adsorption of RN A  to 
membrane.
©  Remove contaminants with 
simple wash steps.
O  Elute ready-to-use RNA in 
RNase-free water or Buffer BR5
©
©
Add Buffer RLT 
and ethanol
i
Bind RNA 
RNA
Wash
Elute
Concentrated RNA solution
Fig.4.1 Summary of the RNeasy® MinElute™ cleanup procedure 
(reproduced from Qiagen, 2003)
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4.3.6.6 Generation o f  cDNA by Reverse Transcription
Ten pi of RNA was primed with 0.5pg/pl oligo (dT) 15 (Promega, UK) at 65°C for 5 
minutes. The reaction mix was immediately chilled on ice and a master mix of 4pl of 5 x 
first strand buffer, 2pl 0.1M DTT (dithiothreitol), and lp l of RNAsin® was added 
(Promega, UK). The contents were mixed and incubated at 42°C for 2 minutes. The 
reaction tubes were transferred back to ice and 200U of Superscript II™ reverse 
transcriptase (Invitrogen Life Technologies Ltd., UK) was added. Samples were incubated 
at 42°C for 50 minutes. The reaction was inactivated by heating to 70°C for 15 minutes. 
cDNA (complementary DNA) samples were stored at -20°C.
4.3.6.7 Amplification o f  cDNA by Polymerase Chain Reaction (PCR)
Genes of interest were amplified using a standard PCR reaction. A master mix was 
prepared of 1 x buffer (lOmM Tris-HCl, pH 9.0, 50mM KC1, 0.1% Triton® X 100), MgCh 
(see table 4.3 for details), 200pM dNTPs (deoxynucleotide triphosphates), 1U Taq 
Polymerase (all reagents are from Promega, UK) and both forward and reverse primers (see 
table 4.3 for concentrations). One pi of DNA was added per reaction and the final volume 
made up to 20pl by the addition of DNase free water. DNA was amplified for 30 (day 0, 1 
and 3 samples) or 45 cycles (day 7 samples) using a denaturation temperature of 94°C for 1 
minute, annealing temperature (Tanneal) (see table 4.3) for 30 seconds and an elongation 
step at 74°C for 1 minute. The final elongation step was extended to 10 minutes (Express™ 
thermocycler, Hybaid, UK). PCR products (5pi) were run out on agarose gels and 
visualised as described in section 4.3.6.5.
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Table 4.2 Forward and reverse primer sequences for the target genes, Sox 9, Col 2a/2b, 
IGF-1, TGFpl, IGF-1 receptor and TGFpi receptor and the housekeeping gene 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
1 Primer sequence courtesy o f Drs E.Blain and S. Gilbert (School of Biosciences, Cardiff
University, UK)
2 Primer sequence courtesy of Dr. I Khan (School of Biosciences, Cardiff University, UK) 
3 Primer sequence taken from Valcourt et al., 1999. Primers designed against the murine 
sequence for type II collagen and cross-react with the bovine sequence
Gene Accession
Number
Primer Sequence Position
(bp)
GAPDH1 U85042 F 5’ TGG TCA CCA GGG CTG CTT TTA 3’ 
R 5* CTC CTG CTT CAC CAC CTT CT 3’
14-34
759-739
Sox 9* AF27803 F 5’ CTC AAG GGC TAC GAC TGG AC 3’ 
R 5’ CGT TCT TCA CCG ACT TCC TC 3’
241-260
553-534
Col2a/2b'* - F 5’ GCC TCG CGG TGA GCC ATG ATC 3’ 
R 5’ CTC CAT CTC TGC CAC GGG GT 3’
-
IGF-1 X I5726 F 5’ GGA CCC GAG ACC CTC TGC GGG 3’ 
R 5’ GGC CGA CTT GGC GGG CTT GA 3’
145-165
354-335
TGFpi M36271 F 5’ GCC CTG GAC ACC AAC TAC TGC TTC 
AGC TCC 3’
R 5’ GCT GCA CTT GCA GGA GCG CAC 
GAT CAT GTT 3’
612-641
947-918
IGF-1R X54980 F 5’ TCA AGG ACG GAG TCT TCA CC V  
R 5’ GCT CAA ACA GCA TGT CAG GA 3’
1370-1389
1549-1530
TGFP1-R NM_174621 F 5’ GGA CTT GCC CAT CTT CAC AT 3’ 
R 5’ CAC TCT GTG GTT TGG AGC AA 3’
967-986
1152-1133
Table 4 3  PCR reaction conditions and expected product sizes for the amplification of Sox 
9, Col2a/2b, IGF-1, TGFpl, IGF-1R, TGFplR and the housekeeping gene, GAPDH.
Gene MgCl2
Concentration
(mM)
Primer
Concentration
(PM)
Tanneal (°C) Product Size 
(bp)
GAPDH 2.5 0.25 60 746
Sox 9 1.5 1 53 313
Col2a/2b 2 0 .2 60 2A-472
2B-268
IGF-1 2 0.25 65 2 1 0
TGFpl 2 1.1 55 336
IGF-1R 2 1.7 52 180
TGFP1R 2 1.7 52 186
4.4 Results and Discussion
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4.4.1 The Effects o f  IGF-1 and TGFpl Treatment on Sulphated GAG Biosynthesis in 
Articular Chondrocytes
Radiolabelled sulphate (35S(>4) was used to measure the effects of the anabolic growth 
factors, IGF-1 and TGFpl on sGAG biosynthesis. In this experiment it was possible to 
quantify levels of biosynthesis as well as the incorporation of sGAGs into a cell associated 
matrix by measuring levels of the radiolabelled compound in both the conditioned media 
and cell lysates with their associated material. Experiments using chondrocytes isolated 
from young articular cartilage demonstrated a significant increase in sGAG biosynthesis 
with TGFpl treatment at 24 hours when comparing levels of radiolabel within the control 
media [P<0.01] (see fig.4.2a). This trend was similar to the combined treatments of IGF-1 
and TGFpl [P<0.05] (see fig.4.2a). No differences were seen at later time points between 
any of the treatment groups and their respective time point controls. Data obtained from the 
cell lysates and their cell associated material indicate a significant increase in radiolabel in 
the TGFpl treatment group compared to controls at the 3 day time point [P<0.05] (see 
fig.4.2b). Such a result would indicate that at this later time point no significant difference 
in sGAG is being seen with the conditioned media as this macromolecule is being laid 
down as ECM. Further results at the day 7 time point indicate no differences of sGAG 
concentrations between controls and treatment groups (see fig.4.2b). This may suggest that 
matrix being synthesised and laid down by the cells is being degraded at later time points.
Interestingly, the effects of these growth factors on articular chondrocytes isolated from 
skeletally mature cartilage did not reflect those demonstrated by the younger cells. In 
contrast to the diminished response expected by these more mature cells, a strong response 
was seen to both growth factors. Within the conditioned media samples a significant 
increase in sGAG biosynthesis was seen at 24 hours in response to all three treatments 
when compared to controls [P<0.001 in all treatment groups] (see fig.4.3a). This response 
was also maintained at the 3 day time point, although the statistical significance was lower 
[P<0.05 with IGF-1 treatment and P<0.01 in the TGFpi and combined treatment groups].
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T re a tm e n t
Dav 1 Day 3 Day 7
M edia IGF-1 T G F b l IG F/TG F M edia IGF-1 T G F b l IG F/T G F  M edia IGF-1 T G F b l IG F/TG F
T r e a tm e n t
Day 1 Day 3 Day 7
°  Media control ®  IGF-1 D  TGFB-1 ®  IGF-1/TGFB1 
Fig-4.2 sGAG biosynthesis as assessed by incorporated 35S04 within (a) conditioned media 
and (b) cell lysates and associated material of treated chondrocytes isolated from young 
articular cartilage. Cells have been treated with IGF-1 and/or TGFpl and cultured for periods 
of up to 7 days. Media alone serves as a control. Values are expressed + SEM. N=4
* P<0.05 ** P<0.01
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M edia IGF-1 T G F b l IG F/T G F  M edia IGF-1 T G F b l IG F/TG F M edia IGF-1 T G F b l IG F/TG F
T re a tm en t
Day 1 Day 3 Day 7
M edia IGF-1 T G F b l IG F/TG F M edia IGF-1 T G F b l IG F/TG F M edia IGF-1 T G F b l IG F/TG F
T r e a tm e n t
Day 1 Day 3 Day 7
°  Media control B  IGF-1 D  TGFB-1 D  IGF-1/TG FB1
Fig.4.3 sGAG biosynthesis as assessed by incorporated 35S04 within (a) conditioned media 
and (b) cell lysates and associated material o f  treated chondrocytes isolated from mature 
articular cartilage. Cells have been treated with IGF-1 and/or TG Fpl and cultured for 
periods o f up to 7 days. M edia alone serves as a control. Values are expressed + SEM. N=4
* P< 0.05 ** P<0.01 ***P<0.001
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As seen with chondrocytes isolated from young articular cartilage, by day 7 biosynthesis 
levels had returned to normal. A similar trend of matrix deposition was also seen at day 3, 
with significant increases of radiolabel found in the cell lysates and associated material 
samples. This deposition was in response to IGF-1 [P<0.01] and the combined growth 
factor treatments [P<0.05], in contrast to TGFpl as previously described (see fig.4.3b). 
Levels of sGAG at day 7 had also returned to normal within these samples. Together these 
results indicate that the level of sGAG biosynthesis is being up-regulated by the growth 
factor treatment and this is leading to the deposition of ECM. However, this is a short-lived 
response and as levels of matrix degradation are up-regulated these levels of biosynthesis 
and deposited matrix will return to those of control cells.
Both of these growth factors have a short half life once in their active form. For significant 
differences to be observed within the cell lysate samples at 3 days, there is the suggestion 
that these growth factors are exerting a positive feedback on the cells up-regulating their 
own biosynthetic rate of IGF-1 and/or TGFpi. It has been previously shown by Kim et al., 
(1990) and deMoura at el., (2000) that both these growth factors can auto-induce through a 
positive feedback mechanism. A study in dermal fibroblasts also demonstrated that IGF-1 
can up-regulate both mRNA and protein expression of TGFpl (Ghahary et al., 1998). This 
mechanism was shown to be through increased levels of c-fos and c-jun. Within the 
combined growth factor treatment group it is possible that such a mechanism is occurring 
within chondrocytes.
4,4,2 The Effects o f  IGF-1 and TGFfll Treatment on Collagen Biosynthesis in Articular 
Chondrocytes
The biosynthesis and possible deposition of collagen was analysed using radiolabelled 
proline (3H-proline). As outlined in section 1.4.4.3, collagen is composed of Gly-X-Y 
repeats, with proline and hydroxyproline frequently occurring in the X and Y positions. For 
this reason as well as giving an indication of total protein biosynthesis, the use of 
radiolabelled proline will provide a good analysis of collagen biosynthesis.
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Fig.4.4 Collagen biosynthesis as assessed by incorporated 3H-proline within (a) conditioned 
media and (b) cell lysates and associated material o f treated chondrocytes isolated from young 
articular cartilage. Cells have been treated with IGF-1 and/or TG Fpi and cultured for periods o f 
up to 7 days. Media alone serves as a control. Values are expressed + SEM. N=4
* P<0.05 ** P<0.01 ***P<0.001
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Fig.4.5 Collagen biosynthesis as assessed by incorporated 3H-proline within (a) conditioned media 
and (b) cell lysates and associated material o f  treated chondrocytes isolated from mature articular 
cartilage. Cells have been treated with IGF-1 and/or TGFpl and cultured for periods o f  up to 7 days. 
Media alone serves as a control. Values are expressed + SEM. N=4 * P<0.05 ** P<0.01 ***P<0.001
176
C h a pt e r  4
Coinciding with the data illustrated in fig.4.2a, the biosynthesis of collagen demonstrated 
the exact same trend as seen for sGAG biosynthesis using chondrocytes isolated from 
young articular cartilage (see fig.4.4a). Within the conditioned media samples, both TGF(J1 
[P<0.01] and combined growth factor treatment [P<0.05] saw a significant increase in 
collagen biosynthesis when compared to controls. This effect was lost by day 3. As before, 
TGFpl treatment saw a significant level of collagen deposition at day 3, as ascertained 
from the cell lysate and associated material samples (see fig.4.4b). This was a short-lived 
response as levels returned to those of the controls by day 7.
Analysis of the data obtained from the chondrocytes isolated from mature articular cartilage 
show a more prolonged response to TGFpl in terms of collagen biosynthesis than seen with 
the sGAG biosynthesis previously discussed. Significant increases in collagen biosynthesis 
were seen in the conditioned media samples in response to all three growth factor 
treatments at 24 hours when compared to controls [P<0.001 in all treatment groups] (see 
fig.4.5a). This significant response was maintained at day 3 with all three treatment groups 
[P<0.001 for all three treatment groups] and furthermore at day 7 within the TGFpi treated 
cells [P<0.05]. In addition, significant levels of collagen were demonstrated in the cell 
lysates and cell associated material at 24 hours in both the IGF-1 [P<0.05] and TGFpl 
[P<0.01] treated cells when compared to controls (see fig.4.5b). Significance further 
increased within these samples at day 3 where all three treatments initiated an increase in 
collagen levels [P<0.05 for TGFpl treatment and P<0.001 for IGF-1 and combined growth 
factor treatments]. As previously seen within the other experiments these effects were not 
evident at the day 7 time point. Analysis of total protein biosynthesis (data not shown) from 
both the chondrocytes isolated from young and mature cartilage demonstrated the same 
trends as those shown for collagen biosynthesis.
The data from these experiments suggest that within this experimental setup chondrocytes 
isolated from mature bovine cartilage do not have a diminished capacity to respond to 
either IGF-1 or TGFpl. It is important to consider however, the fact that although the 
chondrocytes were isolated from skeletally mature articular cartilage, these animals are not 
in fact considered to be old. This project addresses the issues of growth factor uses in the 
repair of articular cartilage defects within skeletally mature, but relatively young 
individuals that have obtained the injury through trauma or sport.
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4.4.3 The Effects o f  IGF-1 and TGFpl Treatment on Chondrocyte Cell Number
In order to ascertain whether the effects seen by IGF-1 and TGFpl treatment (lOng/ml for 
both growth factors) were a true indication of the up-regulation of matrix biosynthesis, 
changes in cell number were calculated over the 7 day culture period. As previously 
discussed in section 4.1, these growth factors have been previously shown to up-regulate 
DNA synthesis and cellular proliferation levels (Darling and Athanasiou, 2005a; Trippel, 
1995; Trippel, 1997; Vivien et al., 1992; Vivien et al., 1990). Chondrocytes cultured over 
periods of up to 7 days and treated with IGF-1 and/or TGFpl were lysed and their LDH 
levels measured using the Cytotox 96® assay.
No significant change in cell number was seen on treatment of either chondrocytes isolated 
from young (see fig.4.6a) or mature articular cartilage (see fig.4.6b) when compared to 
media controls. LDH levels in samples from chondrocytes isolated from young articular 
cartilage initially increased between 1 and 3 days in culture, although a statistical increase 
was only demonstrated in the TGFpi and combined growth factor treatment groups 
[P<0.05 for both treatments]. Significant decreases in LDH in all treatment groups were 
seen however between the 3 day and 7 day time periods [P<0.001 for all treatments]. In 
contrast to this, no increase in LDH was seen in the chondrocytes isolated from mature 
articular cartilage, with decreases in LDH being seen at each time point. All the treatment 
groups saw significant decreases in LDH between 1 and 3 days [P<0.001 for all 
treatments], and both the IGF-1 and TGFpl treatment groups saw further significant 
decreases in LDH between 3 and 7 days [P<0.001 for IGF-1 and P<0.05 for TGFpi]. 
Decreasing levels of LDH within the cell lysates with time in culture may be indicative of a 
decrease in cell number. Data obtained from this experiment must be interpreted with 
caution though. Recent research suggests that within monolayer culture chondrocytes 
increase their oxygen consumption, decreasing their levels of glycolysis (Heywood and 
Lee, 2006). This may in turn affect levels of LDH found within the cells, with a down- 
regulation of the enzyme with time in culture. Such an effect may suggest that the data 
obtained from this experiment is due to the down-regulation of LDH expression, and not a 
decrease in cell number. In order to confirm that none of the growth factor treatments were 
exerting a toxic effect on the chondrocytes, the LDH levels within the conditioned media 
from these cells was also measured.
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Fig. 4.6 The proliferation of chondrocytes isolated from (a) young and (b) mature 
articular cartilage in response to IGF-1 and/or TGFpl treatment. Average 
absorbencies are shown with standard error bars. N=4 
* P<0.05 
*** P<0.001
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This response was sustained for periods of up to 7 days in the case of collagen biosynthesis 
with TGFpl treatment. This period of time is substantially longer than the half life of the 
exogenous active form of TGFpl with what the chondrocytes were previously treated with. 
To establish whether this sustained response is due to a positive feedback response on the 
treated cells resulting in an up-regulation in expression of the specific growth factor, 
experiments were performed to investigate mRNA levels of both IGF-1 and TGFpi in 
treated chondrocytes isolated from mature articular cartilage over the 7 day culture period. 
The quality of RNA extracted from the treated chondrocytes was checked by running on an 
agarose gel before the generation of cDNA. As shown in fig.4.8, clear bands are visible for 
the 28S and 18S ribosomal subunits, with no degradation of the RNA apparent.
No obvious differences in the mRNA levels of IGF-1 were seen over the 7 day culture 
period in any of the treatment groups when compared to their respective controls (see 
fig.4.9a-d). In addition to this, no differences in expression were observed between 
treatment groups and controls in the mRNA levels of TGFpl (see fig.4.9e-h). However, at 
the day 7 time point, there does appear to be an increase in TGFpi expression in cells 
treated with both growth factors (see fig.4.9h, lane 4). It is not possible to accurately 
determine whether this is a genuine difference using standard PCR and therefore it would 
be speculative to comment on this result. During time in culture the expression of both 
these growth factors decreased, irrespective of their treatment group, with increasing cycle 
numbers required for the detection of their message levels using PCR. To accurately 
determine whether this is a representational result and there is in fact a positive feedback 
response on the mRNA expression of these growth factors when cells are exposed to the 
active form exogenously, quantitative PCR would need to be performed. It is possible 
however that a feedback response is occurring but in fact this is happening at a post- 
transcriptional level, in which case no significant changes would be demonstrated at the 
mRNA level.
4.4.6 Does Treatment o f  Articular Chondrocytes with Exogenous IGF-1 and TGFpl 
Lead to an Increase in the mRNA Expression o f  Their Respective Receptors?
It has been previously demonstrated that the presence of TGFpi can, in chondrocytes, 
increase the level of expression of the IGF-1R (Tsukazaki et al., 1994). These experiments
i s :
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1500bp
Fig.4.8 RNA extracted from chondrocyte monolayer cultures, separated on a 1% 
agarose gel. Bands representing the 28S and 18S ribosomal subunits have been 
marked. Molecular sizes were determined using a lOObp DNA ladder
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Fig.4.9 Comparing the relative mRNA expression of IGF-1 (a)-(d) and TGFpl (e)-(h) in 
chondrocytes isolated from mature articular cartilage over a 7 day culture period. Lane 1 
indicates media controls, lane 2 IGF-1 treatment, lane 3 TGFpl treatment and lane 4 IGF-1 and 
TGFpl treatment. Relative levels of the house-keeping gene, GAPDH are shown below each
panel.
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address whether exposure of articular chondrocytes to IGF-1 and TGFpi regulates the 
mRNA expression of either the IGF-1 or TGFpi receptors. Coinciding with the data 
obtained for matrix biosynthesis discussed in sections 4.4.1 and 4.4.2, increased levels of 
IGF-1R mRNA was detected in the IGF-1 treated cells at day 3 when compared to both 
media controls and also the other treatment groups (see fig.4.10c). This effect was not 
apparent at day 7 however, corroborating the data from the radiolabelling experiments 
where any increases in biosynthesis were returned to basal levels by this time point (see 
fig.4.10d).
TGFplR expression was immediately affected by the treatment of chondrocytes with 
TGFpl, either on its own or in combination. As figure 4.9e illustrates, TGFplR mRNA 
expression levels were lower within these treatment groups at day 0  (a 1 0  minute exposure 
to the growth factor). Repetition of this experiment has confirmed that these results were 
not due to experimental error. Expression levels of this receptor were also lower within 
these treatment groups compared to controls at day 3 (see fig.4.10g). These results suggest 
that exposure to TGFpi down-regulates the mRNA expression of its receptor on the cell 
surface of chondrocytes. At the day 7 time point mRNA levels of TGFplR were not 
detectable using PCR in any of the treatment groups (see fig.4.10h). These results would 
need to be further confirmed by quantitative PCR.
It is apparent that the levels of this receptor, irrespective of treatment group do diminish 
with time, and as figure 4.9h illustrates, no mRNA expression of this receptor could be 
detected at day 7. It is possible that this may occur due to the culturing of the chondrocytes 
in an artificial monolayer system, an unnatural 2 -dimensional environment for this cell 
type. It is known that the cell surface expression of receptors does alter with monolayer 
culturing although no specific study has investigated this response in chondrocytes with the 
TGFP1R.
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Fig. 4.10 Comparing the relative mRNA expression of IGF-1R (a)-(d) and TGFplR (e)-(h) in 
chondrocytes isolated from mature articular cartilage over a 7 day culture period. Lane 1 
indicates media controls, lane 2 IGF-1 treatment, lane 3 TGFpi treatment and lane 4 IGF-1 and 
TGFpl treatment. Relative levels of the house-keeping gene, GAPDH are shown below each
panel.
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4.4.7 Confirming the mRNA Expression o f  Chondrocytic Genes in Monolayer Cultured 
Chondrocytes
It is widely accepted that chondrocytes are prone to dedifferentiation upon removal of their 
native ECM and culturing in monolayer (Darling and Athanasiou, 2005b). To confirm 
preservation of the chondrocytic phenotype in the chondrocytes which have been cultured 
for 7 days in monolayer, PCRs were performed using primers targeting both the 
transcription factor, Sox 9 and type II collagen. Both these genes are markers for the 
chondrocytic phenotype. In addition, the primer pair used for amplifying type II collagen 
will amplify both alternatively spliced forms of the gene, the embryonic type IIA as well as 
the mature form; type IIB. Expression of the former indicates dedifferentiation of the cell 
population.
RNA extracted from both chondrocytes isolated from young and mature articular cartilage 
and cultured for 7 days in monolayer indicated positive expression of both type II collagen 
B (see fig.4.1 la-d) and Sox 9 (see fig.4.1 le-h) mRNA. Only the results from chondrocytes 
isolated from mature articular cartilage have been shown, although an identical result was 
seen using chondrocytes isolated from young cartilage. This confirms that the chondrocytic 
phenotype was maintained throughout the culture period in both age groups of cells. No 
expression of the type IIA  form was detected at any time point.
4.4.8 Confirming the Protein Expression o f  Type II Collagen in Monolayer Cultured 
Chondrocytes
In addition to visualising the mRNA expression of chondrocytic genes within monolayer 
cultured chondrocytes, it was also important to confirm that the collagen synthesised, as 
measured previously by radiolabelling (see section 4.4.2) was the characteristic type II 
collagen.
Western blotting using a monoclonal antibody to type II collagen was performed using the 
cell lysates extracted from treated chondrocytes as described in section 4.3.5.2. As shown 
in figure 4.12a and b, type II collagen was being produced by both age groups of 
chondrocytes. When comparing to the type II bovine collagen standard, it is
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Fig.4.11 Confirming mRNA expression of type II collagen B [268bp] (a)-(d) and Sox 9 
[313bp] (e)-(h) in chondrocytes isolated from mature articular cartilage over a 7 day culture 
period. Lane 1 indicates media controls, lane 2 IGF-1 treatment, lane 3 TGFpl treatment
and lane 4 IGF-1 and TGFpl treatment.
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apparent that the collagen being synthesised by both groups of cells is most likely to be 
pro-collagen. Here the pro-peptide of the collagen molecule has yet to be cleaved and 
therefore runs above the characteristic o l chain on an SDS-PAGE gel. As the samples 
assessed for collagen content were cell lysates, the majority of the collagen was expected to 
be intracellular pro-collagen. It was interesting to note the low levels of type II collagen in 
control and IGF-1 treated chondrocytes from the young articular cartilage compared to the 
levels seen within both TGFpl treated groups. TGFpl obviously had a significant effect on 
type II collagen biosynthesis within these cells. In addition to this, extracellularly processed 
mature collagen was seen in these TGFpi treated young samples, which would have been 
from the ECM laid down by the cells and collected after lysis of the cells. No processing of 
pro-collagen into mature type II collagen was apparent with the chondrocytes isolated from 
mature articular cartilage, irrespective of their treatment. These results confirm that these 
monolayer cultured cells have maintained their chondrocytic phenotype, further supporting 
the data illustrated in section 4.4.7.
4.5 Conclusions
This chapter aimed to address the effects of the anabolic growth factors, IGF-1 and TGFpl 
as well as their combined treatment on the biosynthesis of sGAGs and collagen in 
chondrocyte monolayer culture systems. This work has demonstrated the ability of both 
factors to up-regulate the biosynthesis of these matrix molecules within chondrocytes 
isolated from young and mature articular cartilage, when used alone or in combination. It 
has also convincingly demonstrated that chondrocytes isolated from mature bovine articular 
cartilage do not have a diminished capacity to respond to these growth factors.
Data obtained from the radiolabelling experiments demonstrated an up-regulation of matrix 
biosynthesis in both age groups of cells with growth factor treatment (using conditioned 
media), and that significant levels were seen at the day 3 time point incorporated into the 
cell associated material extracted on lysis of the cells. With both age groups of cells 
however, matrix synthesis levels had returned to normal by the day 7 time point suggesting 
possible up-regulation of matrix degradation. The capacity of the chondrocytes isolated 
from mature articular cartilage to demonstrate increased biosynthetic levels of collagen and 
sGAG after the exogenous growth factor would have been depleted by natural half-life
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turnover, suggested a possible positive feedback resulting in the cell up-regulating its own 
synthesis of the specific growth factor. PCR experiments using primers against both IGF-1 
and TGFpi suggested that this may not be the case. However, this technique is non- 
quantitative and therefore experimentation using quantitative PCR would be required to 
confirm such an effect. It is also possible that a positive feedback effect is occurring but 
that this is post-transcriptional and therefore not detectable using the methods employed 
here.
The proliferative and toxic effects of these growth factors at the concentration used 
(lOng/ml for both growth factors) were investigated using the Cytotox 96® plate assay. No 
proliferative effects were seen with treatment confirming that the increased biosynthesis 
seen in the radiolabelling experiments was not as a result of increased cell numbers. 
Toxicity experiments suggested a significant increase in LDH levels in IGF-1 treated 
chondrocytes isolated from young articular cartilage at the 3 day time point and a similar 
effect with TGFpl at 1 day with the chondrocytes isolated from mature chondrocytes. 
Discrepancies between the data obtained at different time points may suggest that these 
results are anomalies.
Experiments looking at the relative mRNA expression of the growth factor receptors with 
treatment did suggest an up-regulation of the IGF-1R with IGF-1 treatment at the day 3 
time point. Expression of the TGFplR was immediately affected by exogenous TGFpl. A 
decrease in expression of the receptor was apparent 10 minutes after exposure to TGFpi. 
Expression levels of the TGFplR were also lower at the 3 day time point within TGFpl 
treatment groups. These results suggest a down-regulation of the receptor in response to 
exposure to TGFpi. Both PCR and Western blotting were used to confirm the phenotype of 
the treated chondrocytes after 10 days in culture. Sox 9 and type II collagen B mRNA 
expression was demonstrated at the 10 day time point in all treatment groups. Western 
blotting using a type II collagen antibody further confirmed production of type II pro­
collagen in all of the samples.
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In summary:
• The anabolic effects of IGF-1 and TGFpl on the biosynthesis of collagen and 
proteoglycans in both chondrocytes isolated from young and skeletally mature 
bovine articular cartilage was demonstrated.
• Synthesised matrix molecules were laid down into ECM by both age groups of 
chondrocytes.
• Western blotting and PCR for chondrocytic phenotype markers demonstrated 
maintenance of the chondrocyte characteristics within the cultured cells.
• Chondrocytes from skeletally mature articular cartilage were not seen to exhibit a 
diminished response to IGF-1 or TGFpl.
• No proliferative effect was seen in either age group of cells by exposure to IGF-1 or 
TGFpi.
• IGF-1R was suggested to be up-regulated on exposure to IGF-1, whereas TGFpi 
appeared to have a negative effect on the expression of its cell surface receptor 
(TGFpl R).
• No changes in the expression of IGF-1 and TGFpi mRNA were seen in response to 
exposure to the growth factor exogenously.
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5.1 Background
This chapter addresses the possibility of over-expressing IGF-1 and TGFpi in chondrocytes 
isolated from young and mature articular cartilage. The data in chapter 2 demonstrated the 
chemotactic effect of both these growth factors on chondrocyte migration when the cells 
are seeded onto a fibronectin substrate. This chemotactic response appeared to be abolished 
in the presence of other ECM substrates such as type II collagen and aggrecan, suggesting a 
substrate dependent, chemotactic response. The effects seen in terms of both a chemotactic 
and biosynthetic response by the chondrocytes on exposure to IGF-1 and TGFpi would 
have been limited by the short half lives of these molecules. A limiting factor of this kind 
may well be overcome by over-expressing the molecule within chondrocytes.
As discussed in section 1.13.2 the key to biomechanically stable integration between pre­
existing cartilage and any ‘neo-cartilage’ formed lies not only in the enhancement of cell 
migration but also in the stimulation and regulation of matrix biosynthesis to provide the 
appropriate composition and ratio of matrix molecules. In chapter 4, the data discussed 
demonstrated the ability of IGF-1 and TGFpl to enhance both proteoglycan and collagen 
biosynthesis while maintaining the chondrocytic phenotype. As seen with the effect on the 
chondrocytes isolated from mature articular cartilage, these growth factors have a short half 
life once in their active form, but may be able to initiate a positive feedback effect on the 
cells maintaining their stimulatory response for longer periods of time. In addition, it is 
well documented that maturation of chondrocytes leads to diminished sensitivity to growth 
factors with age (as discussed in section 1.15.8). Published data supporting this theory 
comes from the use of old chondrocytes, possibly explaining why a response to IGF-1 and 
TGFpl was still seen when using chondrocytes isolated from skeletally mature, but not old, 
articular cartilage. Combining the data achieved from the migration and biosynthesis 
experiments, the over-expression of IGF-1 and TGFpi may provide a solution to problems 
such as short half life and diminished sensitivity.
The successful transfection of chondrocytes has been demonstrated using both viral 
(Cucchiarini et al., 2005) and non-viral methods (Kaul et al., 2005; Madry et al., 2005). 
Non-viral methods, such as lipid-mediated gene transfer offer great advantages over viral 
methods in the context of in vivo gene delivery. The use of retroviruses, for example, carry
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the risk of insertional mutagenesis, and adenoviruses the complication of immunogenicity 
(Madry and Trippel, 2000). Lipofectin® (Invitrogen Ltd., UK), a cationic liposome used 
within these experiments for transfection has the advantage of being easy and safe to use 
and removes the restriction of the size of DNA that can be delivered to the target cell (Gao 
and Huang, 1995). In the context of transfection for cell-mediated cartilage repair 
techniques, liposomal methods allow transient over-expression of the inserted gene for the 
relatively short time period during which integration will occur. The principle of this 
method is to use a liposome formulation that interacts with DNA, resulting in the formation 
of a lipid-DNA complex where the DNA is completely entrapped. These liposomes are able 
to fuse with the cell membrane and mediate uptake and subsequent expression of the DNA. 
The limiting factor of these lipid-mediated transfer methods is the low transfection 
efficiency associated with them. A study by Madry and Trippel (2000) compared the 
different lipid transfection systems on the market using both bovine and human articular 
chondrocytes. In this report they published that low transfection efficiencies within adult 
chondrocytes may be due to the low mitotic activity which they exhibit. They also 
emphasised the importance of optimising the ratio of lipid to DNA for transfection 
efficiency. A factor already raised by Caplen et al. (1995).
Within the context of application for clinical cases, the use of genes such as IGF-1 within 
localised areas of articular cartilage defects may offer the potential to enhance tissue 
healing and integration. The clinical application of soluble growth factors is limited though 
due to delivery problems. To deliver such a treatment in the concentrations and sustained 
time period required for any response would be to risk a reaction within non-target organs 
and therefore undesirable side effects (Evans et al., 2000). In such a context, the potential 
for delivery via genetic manipulation is huge. However, in order to provide sufficient 
concentrations of the gene for prolonged periods of time, a stable method of transfection 
would be required. The potential of IGF-1 and TGFpl has been demonstrated within 
numerous studies (Madry et al., 2005; Madry et al., 2001; Shuler et al., 2000; Smith et al., 
2000) as well as the work presented within this thesis (chapters 2 and 4). TGFpi has been 
used in transfection studies with reference to both articular defects due to trauma and also 
OA. A recent study by Ulrich-Vinther et al. (2005) demonstrated the ability of adeno- 
associated viral transfer of TGFpl to normal chondrocytes to induce up-regulation of 
mRNA levels of type II collagen and aggrecan. In addition, MMP3 was seen to be down-
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regulated, a response that they also demonstrated in human osteoarthritic chondrocytes. 
This study demonstrates the ability of TGFpi not only to increase anabolism within 
articular chondrocytes, but also to decrease the effect of degradative enzymes responsible 
for matrix degradation within degenerative diseases such as OA. These findings are not 
alone; studies by Lee et al. (2005) and Shuler et al. (2000) also demonstrated the up- 
regulation of matrix biosynthesis by transfection with TGFpl and the maintenance of the 
chondrocytic phenotype, as confirmed by the production of the characteristic cartilage 
matrix macromolecules, type II collagen and aggrecan.
The anabolic inducing characteristics of IGF-1 have also been widely demonstrated in 
articular chondrocytes. Recent reports have focussed on the ability of over-expressing IGF- 
1 and the ability of these transfected cells to enhance articular cartilage defects (Fortier et 
al., 2002; Madry et al., 2005; Madry et al., 2001). Madry et al. (2001) demonstrated that 
over-expression of human IGF-1 in chondrocytes induced both cell proliferation and matrix 
synthesis, culminating in new tissue formation when the transfected cells were transplanted 
onto the surface of articular cartilage explants. This study also suggested the possibility that 
the over-expression of IGF-1 within transplanted chondrocytes was able to induce activity 
within chondrocytes resident within the cartilage explants. Interestingly, the authors noted 
good integration between the newly formed tissue and the explant, which they have 
attributed to the IGF-1 over-expression and pre-treatment of the explant with 
chondroitinase ABC. A later study demonstrated IGF-1 to enhance the structural and 
functional integrity of tissue engineered cartilage as well (Madry et al., 2002). All these 
studies demonstrated the increased production of a type II collagen and aggrecan rich 
matrix confirming the maintenance of the chondrocytic phenotype. The chondroprotective 
effect of IGF-1 has already been noted as a response co-ordinated through the Sox 9 
transcription factor (Kolettas et al., 2001).
This chapter focuses on the development of constructs for the over-expression of both IGF- 
1 and TGFpl in bovine articular chondrocytes. Whereas research already published has 
placed emphasis on the ability of over-expression of these growth factors to increase matrix 
biosynthesis and decrease matrix degradation, here the emphasis has been placed on 
whether over-expression of IGF-1 and TGFpi can induce an enhanced migratory response.
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Aims:
1. To develop constructs for the over-expression of IGF-1 and TGFpl in chondrocytes 
isolated from young and mature articular cartilage.
2. Confirm protein and mRNA levels of over-expression and efficiency of transfection 
using a liposomal method of gene delivery.
3. Determine whether the over-expression of these growth factors enhances the 
migration of chondrocytes when seeded on chondroitinase ABC treated aggrecan.
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All reagents were purchased from Promega, UK unless otherwise stated within the 
protocol.
5.3 Methods
5.3.1 Preparation o f Plasmids Containing IGF-1 and TGFpl
Clones encoding the mature peptides of bovine IGF-1 and TGFpi for over-expression in 
bovine chondrocytes were constructed from cDNA generated from bovine liver and 
cartilage respectively (cDNA was a generous gift from Dr. P Callender, School of 
Biosciences, Cardiff University, UK).
5.3.7./ Polymerase Chain Reaction
Standard PCR reactions, as described in section 4.3.6.7, were employed to amplify the 
sequences encoding the mature peptides of bovine IGF-1 and TGFpi using the previously 
described primers (see table 4.3). Bovine liver and cartilage cDNAs were used as templates 
in reactions of 40 cycles.
5.3.1.2 Agarose Gel Electrophoresis
Amplification of the gene of interest was confirmed by running 5jnl of the PCR reaction on 
a 2% agarose gel as previously described in section 4.3.6.5. Product sizes of 210bp and 
336bp were expected for IGF-1 and TGFpi respectively.
5.3.1.3 PCR Product Purification
Amplified genes were purified using the QIAquick PCR purification kit (Qiagen, UK). This 
removes any primer dimers, buffer, unused nucleotides and polymerases from the reaction. 
This process has been summarised in fig. 5.1. As per the Qiagen handbook (Qiagen, 2002),
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Fig.5.1 Summary of the QIAquick PCR purification procedure used for the removal of 
contaminants from PCR products (reproduced from Qiagen, 2002)
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5 volumes of buffer PN was added to 1 volume of PCR product and pipetted directly onto 
the membrane of a QIAquick spin column connected to a 2ml collection tube. The column 
was spun for 1 minute at 13,000 RPM to bind the DNA to the membrane. Subsequently, 
750pl of buffer PE was added to the top of the spin column and spun again at 13,000 RPM 
for 1 minute. The eluate was disposed of and the column spun again to remove any residual 
buffer PE. The spin column was connected to a new microcentrifuge tube and the DNA 
eluted in 200pl of DNase-free water (Sigma Chemicals, UK) by spinning for a further 
minute at 13,000 RPM. The purified DNA was stored at -20°C.
5.3.1.4 TA-Cioning: Ligation o f Purified PCR Products into pGEM®-T Vector
A lpl aliquot of the purified PCR product was incubated in a master mix of 1 x rapid 
ligation buffer (30mM Tris-HCl, pH 7.8, lOmM MgCh, lOmM DTT, ImM ATP and 5% 
polyethylene glycol), 25ng of pGEM®-T vector and 1.5U T4 DNA ligase with a final 
reaction volume of 5pi. The reaction contents were mixed by pipetting and left overnight at 
4°C.
5.3.1.5 Transformation o f Ligated Product into JM109 High Efficiency Competent Cells 
for Plasmid Purification
The ligated product (2pl) was combined with 25pl of competent JM109 E.coli (1 x 108 
cfu/pg DNA). The DNA and cells were gently mixed and left on ice for 20 minutes. The 
cells were heat shocked at 42°C for 45 seconds in a water bath and returned back to ice for 
a further 2 minutes. This process ensures the cells are permeable to the vector and insert. 
SOC medium (475pl) [see appendix 3.1.1] (Invitrogen Life Technologies, UK) was added 
and incubated at 37°C for 90 minutes with agitation at 150 RPM.
The transformed culture (lOOpl) was plated onto Luria broth (LB) agar [see appendix 3.1.2] 
containing lOOpg/ml ampicillin, lOOpg/ml 5-bromo-4-chloro-3-indolyl p-o- 
galactopyranoside (X-Gal) and 500pg/ml isopropyl-p-o-thiogalactopyranoside (IPTG) and 
incubated overnight at 37°C. Recombinants were selected for using blue/white colony 
screening. Colonies containing the correct insert, white due to disruption of the lac Z gene
199
C h a p t e r  5
within the multiple cloning site (MCS) of pGEM®-T, were picked and grown up in 5ml of 
LB broth containing lOOpg/ml ampicillin at 37°C overnight with agitation (225 RPM).
5.3.1.6 Plasmid DNA Purification
Amplified plasmid DNA was purified using the SV Wizard™ DNA purification mini-prep 
kit according to the manufacturers protocol. A 500pl aliquot of the bacterial culture was 
taken and combined with an equal volume of glycerol for storage at -80°C before the 
remaining DNA was purified. Bacterial cultures were pelleted by centrifugation at 3000 
RPM for 10 minutes at room temperature. The pellet was resuspended in 250pl of cell 
resuspension solution (50mM Tris-HCl, pH 7.5, lOmM EDTA, lOOpg/ml RNase A) and 
the mixture transferred to a sterile microcentrifuge tube. An equal volume of cell lysis 
solution (0.1M NaOH, 0.5% SDS) was added and the contents of the tube mixed by 
inversion. The solution becomes clear as the bacterial cell wall is destroyed and the plasmid 
is released. Alkaline phosphatase (lOpl) was added, mixed by inversion and the mixture 
incubated for 5 minutes at room temperature. Alkaline phosphatase removes endonucleases 
and other proteins released during cell lysis which may interfere with the quality of the 
purified DNA. The reaction was terminated by the addition of 350pl of neutralisation 
solution (1.66M guanidine hydrochloride, 0.309M potassium acetate, 0.862M glacial acetic 
acid, final pH 4.2) and after thorough mixing the bacterial lysate was centrifuged at 14,000 
RPM for 10 minutes at room temperature. The resulting supernatant was decanted into a 
mini-prep spin column and centrifuged at 14,000 RPM for 1 minute at room temperature to 
bind the DNA. The spin column membrane was washed twice with column wash solution 
(60mM potassium acetate, 8.3mM Tris-HCl, pH 7.5, 0.04mM EDTA, pH 8.0, 60% ethanol) 
by centrifugation at 14,000 RPM and the plasmid DNA eluted in 50pl of nuclease free 
water by centrifugation again at 14,000 RPM for 1 minute. Purified DNA was stored at - 
20°C.
5.3.1.7 Ncol and Sail Restriction Digestion o f Cloned Inserts
The restriction sites Ncol and Sail within the MCS of the pGEM®-T vector were used to 
confirm insertion and cloning of the correct product. Purified plasmid DNA (0.5 pg) was 
digested using 0.5U Ncol and 0.5U Sail with 0.5pg/ml BSA, in 1 x digest buffer D (50mM
200
C h a p t e r  5
Tris-HCl, pH 7.9, 1.5mM NaCl, 60mM MgCb, lOmM DTT). The final reaction volume 
was made up to 20pl using DNase-free water. Restriction occurred at 37°C for 2 hours. 
Single digests using these restriction enzymes were also performed to confirm site specific 
cleavage. Restricted samples were run on 2% agarose gels alongside the undigested vector 
to confirm the presence of inserts. A 1 OObp DNA ladder was used to estimate the size of the 
insert.
5.3.1.8 Assessing the Concentration and Purity o f  Plasmid DNA
Spectrophotometry was used to determine the concentration and purity of the plasmid DNA 
obtained. Samples were diluted appropriately to keep absorbencies within the linear range, 
and transferred to a quartz cuvette. Absorbance was measured at 260nm (A260) and 280nm 
(A280). DNA concentration was determined using the extinction coefficients for DNA i.e. 
an absorbance of 1 is equal to 50pg/ml of DNA. Purity of the sample can be measured by 
calculating the ratio of A260 to A280- A ratio of approximately 1.8 is expected for DNA, 
anything higher is indicative of ethanol contamination, and lower, protein contaminants.
5.3.1.9 DNA Sequencing
All sequencing was performed by an in house support facility (School of Biosciences, 
Cardiff University, UK) using the ABI Prism® Genetic Analyser (Applied Biosystems, 
UK). Sequencing reactions were prepared according to the ABI Prism® Big Dye 
Terminator Reaction Cycle Sequencing kit protocol. This involves the use of a ready 
reaction mix containing; dNTPs, AmpliTaq DNA Polymerase, MgCU (at a concentration 
previously determined but not disclosed) and dye terminators. DNA samples were provided 
at a concentration of approximately lOOpg/ml. The reaction mix consisted of 8pl of 
terminator ready reaction mix, 290ng of plasmid DNA, 2.4pmol of forward or reverse 
primer [for sequencing primers see appendix 4.1] and DNase-free water to make the 
reaction up to 20pl. Samples were briefly vortexed and spun before being subjected to 25 
sequence cycles of 96°C for 20 seconds, 50°C for 10 seconds and 60°C for 4 minutes 
(Express thermocycler, Hybaid).
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DNA extension products from the PCR were precipitated using an ethanol/sodium acetate 
solution (3pl 3M sodium acetate, pH 4.6, 62.5pl non-denatured 95% ethanol and made up 
to 80pl with deionised water) to remove any unincorporated Big Dye Terminators. The 
20pl sample was added to 80pl of the ethanol/sodium acetate solution and briefly vortexed. 
The samples were incubated for 15 minutes at room temperature to allow precipitation to 
occur before spinning at 12,000 x g for 20 minutes. The pellet was washed in 250pl of 70% 
ethanol to remove any remaining residual salts before spinning again at 12,000 x g for 5 
minutes. The pellet was air-dried for 10-15 minutes and resuspended in 20pl of HiDi® 
formamide (Applied Biosystems, UK) to denature the sample before running on the ABI 
Prism® 3100 Genetic Analyser (Applied Biosystems, UK). Resulting sequence 
chromatograms were viewed using the computer software program, Chromas, version 1.43 
(Conor McCarthy, Griffith University, Brisbane, Australia). Text data were copied into 
Microsoft Word (and examined for homology on the NCBI database using the search 
engine, BLAST (www.ncbi.nlm.gov/BLAST).
5.3.2 Over-expression o f IGF-1 and TGFpl in Primary Chondrocytes
In order to over-express the above growth factors in primary articular chondrocytes, the 
pGEM®-T cDNA clones needed to be subcloned into the mammalian expression vector, 
pSecTag2. Construction of this vector for transfection required multiple steps which have 
been summarised in fig. 5.2.
5.3.2.1 Amplification o f Target DNA and Addition o f Restriction Sites for Insertion into 
pSecTag2
To aid the insertion of the IGF-1 or TGFpl cDNA sequences into the expression vector, the 
DNA was amplified using primers designed to add restriction enzyme sites to both the 5’ 
and 3’ ends of the cDNA sequences. The use of different restriction sites at each end of the 
cDNA allowed directional cloning of the insert. The resulting PCR products were TA 
cloned into pGEM®-T to confirm sequence homology and in frame expression of the 
insert. DNA sequences of the inserts were also run through the Webcutter 2.0 
(www.firstmarket.com/cutter/cut2.html) database to confirm that these restriction enzymes 
would not cut anywhere within the target sequence. The original primer sequences for both
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IGF-1 and TGFpi were altered to include a BamH I site on the forward primer and a Not I 
site on the reverse (MWG Biotech, UK). Extra nucleotides were incorporated at the 5’ end 
of both primers as restriction enzymes will not cleave DNA if the recognition site is less 
than 3 nucleotides from the start the DNA fragment (see table 5.1).
Table 5.1 Forward and reverse primer sequences encoding the mature peptides of IGF-1 
and TGFpl with BamH I and Not I restriction sequences at the 5’ end respectively.
Primer Name Primer Sequence
IGF-1 BamH I forward 5’GCG GGA TCC AGG ACC CGA GAC 3’
IGF-1 Not I reverse 5’CGC GCG GCC GCG GCC GAC TT 3’
TGFpi BamH I forward 5’GCG GGA TCC GCC CTG GAC ACC AAC TAC TGC 
TTC AGC TCC 3’
TGFpi Not I reverse 5’CGC GCG GCC GCG CTG CAC TTG CAG G 3’
DNA containing both the restriction site and insert were amplified using a standard PCR 
reaction with the proof-reading DNA polymerase, BIO-X-ACT (Bioline, UK). Proof­
reading DNA polymerase was used to ensure that no base pair errors were incorporated into 
the sequence. The amplified products were run on a 2% agarose gel to confirm the correct 
product size and purified as previously described in section 5.3.1.3 using the QIAquick 
PCR purification kit. Purified products were ligated into pGEM®-T vector and transformed 
into JM109 E.coli cells as described in sections 5.3.1.4 and 5.3.1.5. Glycerol stocks were 
taken of the colonies grown up and the DNA purified using the SV Wizard™ DNA 
purification mini-prep kit according to the manufacturers protocol (see section 5.3.1.6). 
Purified DNA was sequenced to confirm 100% homology of both the restriction sites and 
the insert cDNAs (see section 5.3.1.9) using M l3 forward and reverse sequencing primers 
[see appendix 4.1].
53.2.2 Maintenance o f  pSecTag2
In order to maintain long-term stocks of the pSecTag2 expression vector, the lyophilised 
vector was resuspended in DNase-free water to a concentration of lpg/ml. The
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reconstituted vector (2jj.1) was transformed into JM109 cells as previously described in 
section 5.3.1.5, and plated onto LB agar containing lOOpg/ml ampicillin. Colonies were 
picked and transferred to 5ml of LB broth for growing up overnight at 37°C. Glycerol 
stocks were taken from the bacterial culture for storage at -80°C. DNA from the remaining 
culture was purified using the SV Wizard™ DNA purification mini-prep kit according the 
manufacturers protocol (see section 5.3.1.6).
53.2.3 Purification o f Plasmid DNA
To achieve a higher yield of plasmid DNA the Qiagen HiSpeed® Midi Plasmid Purification 
Kit was used (see fig. 5.3). As per the manufacturer’s instructions (Qiagen, 2005b), a swab 
from the glycerol stock of the bacterial culture, confirmed by sequencing to contain the 
correct insert with 100% homology, was taken and placed in a 5ml culture of LB broth 
containing lOOpg/ml ampicillin. The culture was incubated at 37°C overnight with 
agitation at 225 RPM. From the resulting broth culture, lOOpl was transferred into 50ml of 
LB broth and incubated for a further 16 hours at 37°C and at 150 RPM. The resulting 50ml 
culture was centrifuged at 3000 RPM for 15 minutes. The supernatant was disposed of and 
the pellet resuspended in 6ml of buffer PI (containing the supplied RNase A solution) by 
pipetting up and down. An equal volume of buffer P2, a cell lysis buffer, was added to the 
suspension and mixed gently by inversion of the tube. The suspension was incubated for 5 
minutes at room temperature to lyse the cells. A further 6ml of chilled buffer P3 was added 
to the lysate and mixed by inversion of the tube and subsequently decanted into the barrel 
of the QIAfilter cartridge. The cell lysate was incubated in the cartridge for 10 minutes at 
room temperature. This allows a precipitate containing proteins, genomic DNA and 
detergent to form a layer on the surface of the solution and allows efficient filtration 
through the QIAfilter cartridge. The cell lysate was filtered through the cartridge into a pre­
equilibrated HiSpeed® tip (equilibrated with buffer QBT) allowing the DNA to bind to the 
resin. The tip was subsequently washed with 20 ml of buffer QC and the DNA eluted in 
5ml of buffer QF.
The eluted DNA was precipitated by adding 3.5ml of isopropanol, mixing by inversion and 
incubating at room temperature for 5 minutes. The eluate/isopropanol mixture was 
transferred to a syringe barrel attached to a QIAprecipitator midi module and passed
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through the QIAprecipitator. The DNA was then washed by pushing 2ml of 70% ethanol 
through the QIAprecipitator. The membrane was then dried by pushing air repeatedly 
through the syringe attached to the QIAprecipitator. The nozzle of the QIAprecipitator was 
dried to prevent ethanol carryover and attached to a new 5ml syringe containing 1ml of 
DNase-free water. The water was pushed through the syringe eluting the DNA. The eluate 
was then transferred back to the barrel of the syringe and pushed through the 
QIAprecipitator again to maximise the yield. Eluted DNA was stored at -20°C.
In order to further concentrate the purified plasmid DNA, an equal volume of isopropanol 
was added and the solution mixed by inversion. The DNA was then allowed to precipitate 
overnight at -20°C. The precipitated DNA was pelleted by centrifugation at 12,000 RPM 
for 10 minutes at 4°C and the supernatant removed. The pellet was resuspended in lOOpl of 
DNase-free water.
5.3.2.4 Cloning o f IGF-1 and TGFpl into the Expression Vector, pSecTag2
Purified pSecTag2 (A and B) vector and pGEM®-T containing IGF-1 or TGFpl cDNA 
inserts were double-digested using the restriction enzymes, BamH I and Not I. Each digest 
was carried out separately using the optimal buffer and incubation conditions in order to 
achieve an effective cut. The BamH I restriction enzyme requires a lower NaCl 
concentration (lOOmM) to Not I (150mM) and therefore was carried out first in the 
provided buffer E (6mM Tris-HCl, pH 7.5, 6mM MgCh, lOOmM NaCl, ImM DTT). Each 
digest was incubated at 37°C for 2 hours. DNA was cleaned up between digests using the 
QIAquick PCR purification kit as per the manufacturer’s instructions (see section 5.2.1.3). 
This removes enzymes and salts from the reaction. Double-digested products were run on a 
2% agarose gel alongside undigested vectors to confirm presence of the insert.
5.3.2.4.1 Gel Extraction and Purification o f the Restricted Insert
The digested pSecTag2 (A and B) vector and correctly sized insert from the IGF-1 and 
TGFpl containing plasmids were extracted from the agarose gel using the QIAEX II 
purification kit (Qiagen, UK) according to the manufacturer’s instructions (see fig.5.4).
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Briefly, the band was excised from the gel using a clean scalpel and transferred to a sterile 
1.5ml microcentrifuge tube. The gel was weighed and 3 volumes of buffer QX1 were added 
to 1 volume of gel. The QIAEX II solution containing silica particles was resuspended by 
vortexing, and 30pl added to the sample. The agarose was solubilised by incubation at 
50°C for 10 minutes. The sample was vortexed every 2 minutes to prevent settling of the 
QIAEX II particles. Subsequently, the sample was spun for 30 seconds at 10,000 x g and 
the supernatant removed. The pellet was resuspended and washed in 500pl of buffer QX1 
and spun again. The supernatant was removed and disposed of and the pellet resuspended 
in 500pl of buffer PE. The sample was spun once again and this step repeated. The pellet 
was then air-dried for 30 minutes at room temperature before resuspending in 20pi of 
DNase-free water. The sample was spun at 10,000 x g for 30 seconds and the supernatant 
transferred to a new, sterile microcentrifuge tube. A further 20pl of water was added to the 
pellet and the step repeated to increase the yield of DNA.
5.3.2.4.2 Ligation o f IGF-1 and TGFpl Inserts into Expression Vector
The gel excised DNA was ligated together with the linearised pSecTag2 vector 
(pSecTag2A for IGF-1 and pSecTag2B for TGFpl) using T4 DNA ligase according to the 
manufacturer’s instructions (see section 5.3.1.4). The constructs were then transformed into 
JM109 E.coli and plated onto LB agar as previously described (see section 5.3.1.5). 
Glycerol stocks were taken from the colonies grown up in LB broth, and the plasmid DNA 
purified using the Endo-free® Mega kit (Qiagen, UK).
5.3.2.4.3 Endo-free® Purification o f Plasmid DNA
Endotoxins are found within the lipid portion of the outer layer of the cell membrane of 
gram-negative bacteria such as E.coli (see fig.5.5). Each endotoxin, or lipopolysaccharide 
(LPS), contains both hydrophobic and hydrophilic moieties as well as charged regions with 
the potential to interact with numerous other molecules. These endotoxins are shed during 
growth of the bacterium and during lysis. Large quantities of these toxins are released 
during plasmid preparations into the cell lysates. The presence of endotoxins drastically 
affects transfection efficiencies of plasmid DNA into both primary cells and sensitive
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cultured cells. Large levels of endotoxins dramatically decrease the level of transfection 
achieved by competing with the plasmid DNA for transfection reagent. In order to achieve 
the highest level of transfection efficiency possible, plasmid DNA containing the inserts 
IGF-1 or TGFpi and the pSecTag2 (A or B) vector alone were purified using the Endo- 
free® Mega kit (Qiagen, UK) as per the manufacturer’s instructions (see fig.5.6). This 
method incorporates the use of a QIAfilter cartridge as used in the HiSpeed® Midi Plasmid 
Purification Kit, but also includes an incubation step on ice, in the presence of an endotoxin 
removal buffer. This prevents the binding of the endotoxins to the resin within the filter 
cartridge and therefore allows purification of the plasmid DNA without contamination by 
the endotoxins.
Colonies of the JM109 cells grown up on LB agar containing either the pSecTag2 (A or B) 
vector alone or vector and insert were picked and transferred to 5ml LB broth containing 
lOOpg/ml ampicillin. The broth cultures were incubated overnight at 37°C and at 225 RPM. 
These starter cultures were subsequently diluted by using 1ml in 500ml of LB broth and 
incubated for a further 16 hours at 37°C at 150 RPM. The resulting bacterial cells were 
spun at 3000 RPM for 10 minutes and the supernatant removed. The pellet was 
resuspended in 50ml of buffer PI (50mM Tris-Cl, pH 8.0, lOmM EDTA, lOOpg/ml RNase 
A). An equal volume of buffer P2 (200mM NaOH, 1% SDS (w/v) was added to the 
suspension, mixed by inversion and incubated at room temperature for 5 minutes to lyse the 
cells. A further 50ml of chilled buffer P3 (3M potassium acetate, pH 5.5) was added to the 
lysate and mixed thoroughly by inversion before pouring into the QIAfilter mega cartridge 
and incubating at room temperature for 10 minutes. This allows the formation of a 
precipitate layer on the surface of the solution, containing proteins, detergent and genomic 
DNA, and prevents interference of the filtration process. The cartridge was connected to a 
vacuum source and the solution filtered through. The precipitate left in the cartridge was 
washed in 50ml of buffer FWB2 (1M potassium acetate, pH 5.0) before allowing the 
vacuum to pull through the buffer. The endotoxin removal buffer (buffer ER), 12.5ml, was 
added to the filtered lysate, mixed by inversion and incubated on ice for 30 minutes. During 
this incubation step a QIAGEN-TIP 2500 was equilibriated by adding 35ml of buffer QBT 
(750mM NaCl, 50mM MOPS [4-Morpholinepropanesulfonic acid], pH 7.0, 15% 
isopropanol (v/v), 0.15% Triton® X 100), allowing the solution to flow through by gravity.
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The filtered lysate was transferred to the pre-equilibriated QIAGEN-TIP and allowed to 
flow through by gravity. The DNA bound to the resin within the tip was washed in 200ml 
of buffer QC (1M NaCl, 50mM MOPS, pH 7.0, 15% isopropanol (v/v)). The DNA was 
then eluted in 35ml of buffer QN (1.6M NaCl, 50mM MOPS, pH 7.0, 15% isopropanol 
(v/v)). The eluted DNA was precipitated by the addition of 24.5ml of isopropanol, mixed 
and centrifuged at 4,000 RPM for 30 minutes at 4°C. The supernatant was removed and the 
DNA pellet was washed in 7ml of 70% endotoxin-free ethanol and centrifuged for a further 
10 minutes at 4,000 RPM at 4°C. The supernatant was removed and the pellet air-dried for 
10-20 minutes at room temperature, before re-suspending in 1ml of DNase-free water. The 
purified DNA was quantified using spectrophotometry (as described in section 5.3.1.8) and 
sequence homology to the gene sequence encoding the mature peptides of IGF-1 and 
TGF|31 confirmed by DNA sequencing (see section 5.3.1.9).
5.3.2.5 Transfection o f  Expression Vector Constructs into Articular Chondrocytes
Cationic liposomes form an effective method for the delivery of DNA constructs to 
eukaryotic cells, protecting them from nuclease degradation and enhancing both their 
uptake and potency (Chiang et al., 1991; Lappalainen et al., 1994; Zelphati and Szoka, 
1996b). It is now thought that the lipid-DNA construct is internalised by endocytosis, 
ultimately resulting in the diffusion of the DNA out of its lipid carrier (Zelphati and Szoka, 
1996a). In this experiment, the cationic liposome formula, Lipofectin® (Invitrogen Ltd., 
UK) was used for the transfection of both IGF-1 and TGFpl DNA constructs into primary 
chondrocytes. Lipofectin® is a 1:1 (w/v) formulation of the cationic lipid, N-[l-(2,3- 
dioleyloxy)propyl]-n,n,n-trimethylammonium chloride (DOTMA) and dioleoyl 
phophotidylethanolamine (DOPE). The transfection process was carried out as per the 
manufacturer’s instructions. Optimal concentrations of the reagent and DNA for 
transfection of primary chondrocytes had been previously determined by Drs. S. Gilbert 
and E. Blain (Cardiff University, UK).
Bovine chondrocytes were isolated from articular cartilage of both 7 day old and 18 month 
old animals as previously described in section 2.3.2. Cells were seeded onto 8 well Lab 
Tek® II glass chamber slides (Nalge (Europe) Ltd., UK) at a concentration of 1 x 106 
cells/ml in basal media and left to settle overnight. The transfection reagent, Lipofectin®,
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was prepared in basal media (with no antibiotics present) at a 5.6% (v/v) ratio and 
incubated at 37°C for 40 minutes. DNA to be transfected was also diluted in basal media 
(with no antibiotics) to a concentration of lpg/lOOpl and incubated for the same time 
period. Lipofectin® reagent and DNA were combined in a 1:1 ratio and mixed well by 
pipetting up and down. The mixture was subsequently incubated for a further 10 minutes at 
37°C. The media from the cells was removed and disposed of and replaced with 200pl of 
either Lipofectin® alone, or Lipofectin® combined with the pSecTag2 vector or 
Lipofectin® combined with pSecTag2 containing insert. The media was made up to 500pl 
with the addition of basal media (containing no antibiotics). Cells were incubated for 18 
hours in the presence of the transfection reagent before its removal and replaced with 500pi 
of basal media. The cells were incubated for a further 24 hours before the addition of 
0.1 pM monensin (Sigma Chemicals, UK). Monensin blocks the secretion of proteins from 
the Golgi apparatus by preventing the production of secretory vesicles (Moore et al., 1987). 
This allows the accumulation and concentration of proteins within the ER and Golgi 
apparatus for detection by immunohistochemistry. The chondrocytes were treated with 
monensin for 18 hours. In a similar setup, chondrocytes were seeded at 1 x 106 cells/ml 
onto 24 well plates and transfected as described above. After 18 hours the transfected cells 
were lysed in 1ml of Trizol® for extraction of RNA.
5.3.2.6 Confirmation o f  Protein Over-Expression o f  IGF-1 and TGFpl
To confirm successful transfection and protein over-expression of the inserted DNA, 
immunohistochemistry was performed using the monensin treated chondrocytes seeded 
onto glass chamber slides. Within the C-terminal fusion peptide of the pSecTag2 vector 
there is a c-myc epitope. Immunohistochemistry using a monoclonal antibody raised 
against this epitope (Clontech, UK) was used to localize the expression of transcribed c- 
myc tagged protein within the transfected cells. Media from the monensin treated 
chondrocytes was removed and the cells were fixed in chilled 95% ethanol for 10 minutes. 
Ethanol preserves the structure of the cells as well as the secondary structure of intracellular 
proteins. Alcohol also acts to permeabilise the cell membrane, exposing epitopes for the 
antibody to act on. The fixed cells were washed twice in PBS (pH 7.4) for 10 minutes and 
then blocked in whole sheep serum (1:20) diluted in PBS/0.001% Tween20® for 30 
minutes. The serum was removed and replaced with the c-myc primary antibody (1:500)
2 14
C h a p te r  5
diluted in PBS/0.001% Tween20®. The primary antibody was incubated overnight at 4°C 
in a humidified chamber. Incubation with PBS/0.001% Tween20® instead of the primary 
antibody served as a negative control. All slides were washed with PBS/0.001% Tween20® 
for 10 minutes after overnight incubation with either the primary antibody or PBS/0.001% 
Tween20®, and subsequently incubated in a FITC-conjugated sheep anti-mouse secondary 
antibody (1:10,000) for 1 hour at room temperature. The slides were washed in 
PBS/0.001% Tween20® for 10 minutes before mounting under a coverslip using 
Vectashield® mountant.
Labelled chondrocytes were viewed and analysed by confocal laser scanning microscopy, 
using a Leica TCS SP2 AOBS spectral confocal microscope (Leica, Heidelberg, Germany). 
Chondrocytes were scanned with 63x/40x oil immersion objective lenses using appropriate 
settings for either single channel fluorescence recordings of FITC alone, or dual channel 
fluorescence of FITC and propidium iodide in combination (see table 5.1). Selected images 
are presented as single confocal optical sections and maximum intensity type 
reconstructions that were made using Leica Confocal Software (Leica, Heidelberg, 
Germany).
Table 5.2 Excitation and emission wavelengths for the fluorochromes, FITC and propidium 
iodide, as detected by scanning laser confocal microscopy.
Fluorochrome Laser Excitation Line (nm) Emissions Detected (nm)
FITC 488 500-540
Propidium iodide 546 590-680
5.3.2.7 Confirmation o f mRNA Over-expression o f  IGF-1 and TGFpl
Transfected cells were lysed in 1ml of Trizol® and RNA was extracted as detailed in 
sections 4.3.6.1-4.3.6.5. cDNA was generated using oligo dT primers (see section 4.3.6.6) 
and GAPDH (see table 4.3) was used as a house keeping gene for PCR. IGF-1, TGFpi and 
GAPDH primers (see table 4.3) were used in a 30 cycle PCR reaction (see section 4.3.6.7).
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PCR products from both control (Lipofectin® only and pSecTag2 vector only treated cells) 
and treatment groups (either IGF-1 or TGFpl transfected cells) were run on a 2% agarose 
gel to confirm over-expression of mRNA within the treatment groups.
5.3.2.8 Comparing the Migration o f Transfected Chondrocytes with Untreated Controls
Transfected chondrocytes (Lipofectin® and vector only controls and IGF-1 and TGFpl 
treatment groups) from both age groups of cartilage were detached from their 24 well plates 
using 0.05% trypsin EDTA (Invitrogen Ltd., UK) for 5 minutes with agitation at 37°C. 
Resuspended cells were diluted into basal media and counted using a haemocytometer (see 
section 2.3.2 for constituents of basal media). Resuspended cells were seeded onto Boyden 
chamber membranes previously coated with chondroitinase ABC treated A1D1 aggrecan at 
a concentration of 1 x 105 cells/well. The cells were allowed to migrate to the underside of 
the membrane over 24 hours before the remaining cells on the uppermost side of the 
membrane were removed. Migrated cells were stained with crystal violet dye and counted 
(see section 2.3.5.3.3). The mean + SEM was calculated for each treatment group and all 
data was assessed for normality using the Anderson-Darling test (P>0.05). Statistical 
analysis was performed using a 2 sample T-test.
2 1 6
5.4 Results and Discussion
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5.4.1 Design and Preparation o f  Vector Constructs Encoding IGF-1 and TGFpl for the 
Transfection into Articular Chondrocytes
5.4.1.1 Isolation o f mRNA encoding the Mature Peptides o f IGF-1 and TGFpl from  
bovine cDNA.
A clear band observed at 210bp on a 2% agarose gel (see fig.5.7a) demonstrated the 
presence of the sequence encoding the mature peptide of IGF-1 mRNA on amplification of 
bovine cDNA generated from young (7 day old) calf liver RNA Liver cDNA was chosen 
for this initial amplification as IGF-1 is highly expressed within this organ (Lindberg et al., 
2005). The sequence encoding the mature peptide of bovine TGFpl was also successfully 
amplified from young bovine chondrocyte cDNA. This was viewed as a 336bp band on a 
2% agarose gel (see fig.5.7b). Both PCR products were purified and ligated into pGEM®-T 
vector for confirmation of 100% sequence homology by sequencing.
5.4.1.2 Confirmation o f Sequence Identity and 100% Homology
The purified PCR products for IGF-1 and TGFpl cDNA were ligated into pGEM®-T 
vector and transformed into the competent bacterial cell line, JM109. The resulting 
bacterial plasmid DNA encoding IGF-1 or TGFpi was purified for sequencing. Sequence 
identity and homology was confirmed by sequencing using M l3 forward and reverse 
primers. These primers sit outside of the MCS and can be used to amplify sequences within 
it. Sequencing data were analysed and the identity of the IGF-1 and TGFpi cDNA was 
confirmed with 100% homology to the known bovine sequences (see figs 5.8 and 5.9).
5.4.1.3 Restriction Digestion o f Plasmid DNA to Confirm Expression o f  Correctly Sized 
Inserts
Purified plasmid DNA containing inserts coding for the IGF-1 and TGFpi mature peptides 
were digested using the restriction enzymes Ncol and Sail, both found within the MCS of
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IGF-1
(210bp)
TGFpl
(336bp)
Fig.5.7 Amplification of bovine (a) IGF-1 and (b) TGFpi mRNA. Lane 1: lOObp ladder, 
lane 2: (a) IGF-1 amplified from bovine liver cDNA (b) TGFpi amplified from bovine 
chondrocyte cDNA, lane 3: water negative control.
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the pGEM®-T vector. To ensure complete digestion by Ncol and Sal 1, and to confirm a 
product of the correct size after digestion with both enzymes, a series of reactions were set 
up and run together on a 2% agarose gel. As seen in figs 5.10a and b, undigested and single 
digested samples were run alongside the double digested samples. Double digestion of the 
plasmid DNA confirmed bands of the correct size for the full length cDNA of IGF-1 (see 
fig.5.10a) and TGFpl (see fig. 5.10b).
5.4.1.4 Cloning o f Sequences Encoding the Mature Peptides o f IGF-1 and TGFpl into 
Expression Vector
Primers previously designed to encode IGF-1 and TGFpi were redesigned to encode a 
restriction site at the 5’ end. In order to control the orientation which the insert would sit 
within the expression vector, the primers were designed to encode a BamH I site on the 
forward primer and a Not I site on the reverse. Plasmid DNA, previously confirmed to 
contain the correct insert with 100% homology was used as a template in the ensuing PCR 
reaction in order to generate PCR products with the restriction sites added to them. A proof­
reading DNA polymerase was used to ensure no mutations within the sequence (see 
fig.5.11a and b). As previously described, the resulting cDNA could then be purified and 
ligated into pGEM®-T to confirm sequence homology and the correct restriction sequences 
using a T7 forward primer (see fig.5.12 and 5.13).
Restriction digests using the enzymes whose recognition sequences had been cloned into 
the insert were also performed confirming an insert of the correct size and also that the 
recognition sequences were of the correct homology for the enzymes to cut efficiently (see 
fig.5.14a and b). The insert bands were then gel extracted and the DNA purified for ligation 
into the expression vector chosen -  pSecTag2A for IGF-1 and pSecTag2B for TGFpi. Both 
these expression vectors have an Immuoglobulin (Ig)-leader sequence for secretion of the 
generated product and a c-myc tag at the 3’ end for detection. Once within the expression 
vector the construct was transformed into JM109 cells once again to produce the required 
plasmid DNA. Purified plasmid DNA with the expression vector could then be sequenced 
once again to confirm sequence homology and in frame expression before large scale 
plasmid DNA preparation. The resulting vector insert construct sequence is shown in 
figs.5.15 and 5.16.
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Q u e r y  1 :  GGACCCGAGACCCTCTGCGGGGCTGAGTTGGTGGATGCTCTCCAGTTCGTGTGCGGAGAC 60
I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I  I  I  I  I  I  I
S b j c  t  4 0 3 :  GGACCCGAGACCCTCTGCGGGGCTGAGTTGGTGGATGCTCTCCAGTTCGTGTGCGGAGAC 4 6 2
1 :  G P E T L C G A E L V D A L Q F R C G D
Q u e r y  6 1 :  AGGGGCTTTTATTTCAACAAGCCCACGGGGTATGGCTCGAGCAGTCGGAGGGCGCCCCAG 1 2 0
l l l l l l l l l l l l l l l l l l l l l l l
S b j c t  4 6 3 :  AGGGGCTTTTATTTCAACAAGCCCACGGGGTATGGCTCGAGCAGTCGGAGGGCGCCCCAG 5 2 2
2 1 :  R G F Y F N K P T G Y G S S S R R A P Q
Q u e r y  1 2 1 :  ACAGGAATCGTGGATGAGTGCTGCTTCCGGAGCTGTGATCTGAGGAGGCTGGAGATGTAC 1 8 0
l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
S b j c t  5 2 3 :  ACAGGAATCGTGGATGAGTGCTGCTTCCGGAGCTGTGATCTGAGGAGGCTGGAGATGTAC 5 8 2
4 1 :  T G I V D E C C F R S C D L R R L E M Y
Q u e r y  1 8 1 :  TGCGCGCCTCTCAAGCCCGCCAAGTCGGCC 2 1 0
l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
S b j c t  5 8 3 :  TGCGCGCCTCTCAAGCCCGCCAAGTCGGCC 6 1 2
6 1 :  C A P L K P A K S A
Fig.5.8 Comparing the mRNA sequence of the pGEM®-T vector containing the bovine 
IGF-1 insert (query) for 100% homology with the known mRNA sequence for the bovine 
IGF-1 mature peptide (subject). The amino acids encoded have been included below the
nucleotide sequences.
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Q u e r y  1 :  GCCCTGGACACCAACTACTGCTTCAGCTCCACAGAAAAGAACTGCTGTGTTCGTCAGCTC 60
I  I  I I  I  I I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I I  I I  I I  I  I  I  I  I  I
S b j c t  6 1 2 :  GCCCTGGACACCAACTACTGCTTCAGCTCCACAGAAAAGAACTGCTGTGTTCGTCAGCTC 6 7 1  
1 :  A L D T N Y C F S S T E K N C C V R Q L
Q u e r y  6 1 :  TACATTGACTTC CGGAAGGAC CTGGGCTGGAAGTGGATT CATGAAC C CAAGGGGTAC CAC 1 2 0
I  I I  I  I  I  I I  I  I I I I  I  I  I  I I I I  I I I I I I  I I I I I I I I I  I I I I I I I I I I I  I  I I I I  I II I I  I I  I  I
S b j c t  6 7 2 :  TACATTGACTTCCGGAAGGACCTGGGCTGGAAGTGGATTCATGAACCCAAGGGGTACCAC 7 3 1  
2 1 :  Y I D F R K D L G W K W I H E P K G Y H
Q u e r y  1 2 1 :  GCCAATTTCTGCCTGGGGCCCTGCCCTTACATCTGGAGCCTGGATACACAGTACAGCAAG 1 8 0
l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
S b j c t  7 3 2 :  GCCAATTTCTGCCTGGGGCCCTGCCCTTACATCTGGAGCCTGGATACACAGTACAGCAAG 7 9 1  
4 1 :  A N F C L G P C P Y I W S L D F Q Y S K
Q u e r y  1 8 1 :  GTCCTGGCCCTGTACAACCAGCACAACCCGGGCGCTTCGGCGGCGCCGTGCTGCGTGCCT 2 4  0
l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
S b j c t  7 9 2 :  GTCCTGGCCCTGTACAACCAGCACAACCCGGGCGCTTCGGCGGCGCCGTGCTGCGTGCCT 8 5 1  
6 1 :  V L A L Y N Q H N P G A S A A P C C V P
Q u e r y  2 4 1 :  CAGGCGCTGGAGCCCCTGCCCATCGTGTACTACGTGGGCCGCAAGCCCAAGGTGGAGCAG 
3 0 0
l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
S b j c t  8 5 2 :  CAGGCGCTGGAGCCCCTGCCCATCGTGTACTACGTGGGCCGCAAGCCCAAGGTGGAGCAG 9 1 1  
8 1 :  Q A L E P L P I V Y Y V G R K P K V E Q
Q u e r y  3 0 1 :  TTGTCCAACATGATCGTGCGCTCCTGCAAGTGCAGC 3 3 6
l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
S b j c t  9 1 2 :  TTGTCCAACATGATCGTGCGCTCCTGCAAGTGCAGC 9 4 7  
1 0 1 :  L S N M I V R S C K C S
Fig. 5.9 Comparing the mRNA sequence of the pGEM®-T vector containing the bovine 
TGFpl insert (query) for 100% homology with the known mRNA sequence for the bovine 
TGFpl mature peptide (subject). The amino acids encoded have been included below the
nucleotide sequences.
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lOOObp
200bp
Supercoiled 
pGEM®-T Vector
pGEM®-T Vector
IGF-1 Insert 
(231 bp)
(b)
lOOObp'
500bp
300bp
Supercoiled 
pGEM®-T Vector
pGEM®-T Vector
TGFpl Insert 
(356bp)
Fig. 5.10 Restriction digest of (a) pGEM®-T-IGF-l and (b) pGEM®-T-TGFpi plasmid DNA 
using the restriction enzymes Nco I and Sal I. Lane 1: lOObp ladder, lane 2: undigested 
plasmid DNA, lane 3: Nco I digested plasmid DNA, lane 4: Sal I digested plasmid DNA and 
lane 5: Nco I and Sal I digested plasmid DNA. Lane 5 demonstrates a correctly sized band for
(a) IGF-1 and (b) TGFpi DNA.
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IGF-1 with restriction sites 
(231bp)
TGFpl with restriction sites 
(356bp)
Fig. 5.11 Amplification of plasmid DNA encoding (a) IGF-1/(b) TGFpl and the BamH I 
and Not I restriction sites. Lane 1: lOObp ladder, lane 2: (a) IGF-1 and the restriction sites 
for BamH I and Not I, (b) TGFpi and the restriction sites for BamH I and Not I, lane 3:
water negative control.
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(a)
TCG GAT CCA GGA CCC GAG ACC CTC TGC GGG GCT GAG TTG GTG GAT
GCT CTC CAG TTC GTG TGC GGA GAC AGG GGC TTT TAT TTC AAC AAG 
CCC ACG GGG TAT GGC TCG AGC AGT CGG AGG GCG CCC CAG ACA 
GGA ATC GTG GAT GAG TGC TGC TTC CGG AGC TGT GAT CTG AGG AGG 
CTG GAG ATG TAC TGC GCG CCT CTC AAG CCC GCC AAG TCG GCC GCG 
GCC CGC
(b)
Q u e r y  1 1  GGACCCGAGACCCTCTGCGGGGCTGAGTTGGTGGATGCTCTCCAGTTCGTGTGCGGAGAC 
7 0
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I
S b j  c t  1 4 5  GGACCCGAGACCCTCTGCGGGGCTGAGTTGGTGGATGCTCTCCAGTTCGTGTGCGGAGAC 
2 0 4
Q u e r y  7 1  AGGGGCTTTTATTTCAACAAGCCCACGGGGTATGGCTCGAGCAGTCGGAGGGCGCCCCAG
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I
S b j  C t 2 0 5  AGGGGCTTTTATTTCAACAAGCCCACGGGGTATGGCTCGAGCAGTCGGAGGGCGCCCCAG 
2 6 4
Q u e r y  1 3 1  ACAGGAATCGTGGATGAGTGCTGCTTCCGGAGCTGTGATCTGAGGAGGCTGGAGATGTAC 
1 9 0
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I
S b j  C t  2 6 5  ACAGGAATCGTGGATGAGTGCTGCTTCCGGAGCTGTGATCTGAGGAGGCTGGAGATGTAC 
3 2 4
Q u e r y  1 9 1  TGCGCGCCTCTCAAGCCCGCCAAGTCGGCC 2 2 0
l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
S b j c t  3 2 5  TGCGCGCCTCTCAAGCCCGCCAAGTCGGCC 3 5 4
Fig.5.12 Sequencing data confirming (a) in frame expression (red) and (b) homology with 
IGF-1 within pSecTag2A vector. Figure (a) also confirms the correct recognition sequences 
for the restriction enzymes BamH I (blue) and Not I (green).
224
Chapter 5
CG GGA TCC GCC CTG GAC ACC AAC TAC TGC TTC AGC TCC ACA GAA 
AAG AAC TGC TGT GTT CGT CAG CTC TAC ATT GAC TTC CGG AAG GAC 
CTG GGC TGG AAG TGG ATT CAT GAA CCC AAG GGG TAC CAC GCC AAT 
TTC TGC CTG GGG CCC TGC CCT TAC ATC TGG AGC CTG GAT ACA CAG 
TAC AGC AAG GTC CTG GCC CTG TAC AAC CAG CAC AAC CCG GGC GCT 
TCG GCG GCG CCG TGC TGC GTG CCT CAG GCG CTG GAG CCC CTG CCC 
ATC GTG TAC TAC GTG GGC CGC AAG CCC AAG GTG GAG CAG TTG TCC 
AAC ATG ATC GTG CGC TCC TGC AAG TGC AGC GCG GCC GCG CG
Q u e r y  9 GCCCTGGACACCAACTACTGCTTCAGCTCCACAGAAAAGAACTGCTGTGTTCGTCAGCTC 6 8
1 1 1 1 1 1 1 I I I I 1 1 1 1 1 1 1 1 H  f i l l  I i l l  I I I I  i I i 1 1 1 I t  I M I I I I I I 1 1 !  11 I I I  11
S b j c t  6 1 2  GCCCTGGACACCAACTACTGCTTCAGCTCCACAGAAAAGAACTGCTGTGTTCGTCAGCTC 6 7 1  
Q u e r y  6 9  TACATTGACTTCCGGAAGGACCTGGGCTGGAAGTGGATTCATGAACCCAAGGGGTACCAC 1 2 8
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  i 1 1 1 1  M i l  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
S b j c t  6 7 2  TACATTGACTTCCGGAAGGACCTGGGCTGGAAGTGGATTCATGAACCCAAGGGGTACCAC 7 3 1  
Q u e r y  1 2 9  GCCAATTTCTGCCTGGGGCCCTGCCCTTACATCTGGAGCCTGGATACACAGTACAGCAAG 1 8 8
l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
S b j c t  7 3 2  GCCAATTTCTGCCTGGGGCCCTGCCCTTACATCTGGAGCCTGGATACACAGTACAGCAAG 7 9 1  
Q u e r y  1 8 9  GTCCTGGCCCTGTACAACCAGCACAACCCGGGCGCTTCGGCGGCGCCGTGCTGCGTGCCT 2 4  8
l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
S b j c t  7 9 2  GTCCTGGCCCTGTACAACCAGCACAACCCGGGCGCTTCGGCGGCGCCGTGCTGCGTGCCT 8 5 1  
Q u e r y  2 4  9 CAGGCGCTGGAGCCCCTGCCCATCGTGTACTACGTGGGCCGCAAGCCCAAGGTGGAGCAG 3 08
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Sb  j  c t  8 5 2  CAGGCGCTGGAGCCCCTGCCCATCGTGTACTACGTGGGCCGCAAGCCCAAGGTGGAGCAG 9 1 1  
Q u e r y  3 0  9 TTGTCCAACATGATCGTGCGCTCCTGCAAGTGCAGC 3 4 4
l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
S b j c t  9 1 2  TTGTCCAACATGATCGTGCGCTCCTGCAAGTGCAGC 94  7
Fig.5.13 Sequencing data confirming (a) in frame expression (red) and (b) homology with 
TGFpi within pSecTag2B vector. Figure (a) also confirms the correct recognition 
sequences for the restriction enzymes BamW I (blue) and Not I (green).
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5.4.2 Transfection o f  IGF-1 and TGFpl into Bovine Articular Chondrocytes
Subsequent to confirmation of in frame expression of the inserts and their homology with 
the gene of interest, the DNA was amplified using a large scale preparation and endotoxins 
from the bacterial cells removed before transfection of the DNA into mammalian cells.
5.4.2.1 Confirmation o f  Over-expression o f  IGF-1 and TGFpi mRNA
Bovine chondrocytes isolated from both young and skeletally mature cartilage were 
transfected with either IGF-1, TGFpi or a vector control. Lipofectin® alone was also used 
as a control group. Transfected cells were lysed in Trizol® and their RNA was extracted. 
cDNA generated from these transfected cells was amplified using standard PCR reaction 
using the primers originally designed encoding the mature peptides of both of these growth 
factors. Over-expression of IGF-1 and TGFpi was confirmed within the sense transfected 
treatment groups with intense bands demonstrating expression of growth factor when 
compared to the controls used (see fig.5.17a-h). This confirmed successful transfection of 
the constructs within the treatment groups. As both IGF-1 and TGFpl would be found 
within both the control and treatment groups, protein levels of the c-myc tag were 
investigated as this will only be present within transfected cells and not the lipofectin 
controls. Western blotting methods using a monoclonal antibody against c-myc did not 
demonstrate the presence of bands within the treatment groups (data not shown). This is 
probably due to the low levels of protein for detection within the cells and culture media. In 
the light of this information, transfected chondrocytes were treated with monensin. 
Monensin prevents the secretion of protein from the ER and Golgi apparatus but does not 
affect protein synthesis. Treatment with this ionophore allows concentration of the protein 
produced within the cell and therefore detection by immunohistochemistry using 
monoclonal antibodies to the c-myc tag.
Treatment of the cells with monensin increased the size of the cell. Immunohistochemistry 
for c-myc using a FITC conjugated secondary antibody demonstrated definite patterns of 
staining within transfected chondrocytes. Staining was exclusively cytoplasmic and 
punctate foci were seen around the edge of the cell close to the cell membrane as well as
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lOOObp
IGF-1 Insert 
(231bp)
(b)
lOOObp-
500bp
300bp
TGFpl Insert 
(356bp)
Fig. 5.14 Restriction digest of pSecTag2 vector encoding the mature peptide of (a) IGF-1 
and (b) TGFpl using the restriction enzymes BamH I and Not I. Lane 1: lOObp ladder, 
lane 2: undigested plasmid DNA, lane 3: BamH I digested plasmid DNA, lane 4: Not I 
digested plasmid DNA and lane 5: BamH I and Not I digested plasmid DNA. Lane 5 
demonstrates a correctly sized band for the plasmid insert.
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intense ‘hot spots’ close to the Golgi and ER (see fig.5.18 and 5.19 a, b and c). By taking 
sections through transfected cells using confocal microscopy it was possible to develop a 
3D image of the cell and define exactly where the transfected protein was residing. Figure 
5.20c and f  demonstrated specific staining in TGFpl transfected cells with no staining seen 
in Lipofectin® controls (see fig.5.20a and d). Similar results were seen with the IGF-1 
transfected chondrocytes.
S.4.2.2 Evaluating the Transfection Efficiency o f  Chondrocytes Using Lipofectin®
Using images at x 40 magnification, generated by confocal laser scanning microscopy, it 
was possible to calculate an efficiency rate of transfection for both the chondrocytes 
isolated from young and mature cartilage. No difference in transfection efficiency between 
the age groups was seen, with an average of 22% of chondrocytes isolated from the young 
tissue successfully expressing the c-myc epitope and 24% from the mature cartilage.
Cells transfected with the pSecTag2 expression vector can be selected for using the 
Zeocin™ antibiotic resistance gene encoding the Sh ble protein (Dumas et al., 1994; 
Gatignol et al., 1988). Unfortunately the effectiveness of this antibiotic is dependent on the 
high division rate of the treated cells. As chondrocytes have a low rate of division Zeocin™ 
does not exert a toxic effect and is therefore not effective as a selective agent in this cell 
type. As a result of this successfully transfected chondrocytes were not able to be selected 
for and isolated from the non-transfected cells. This must be taken into account when 
interpreting the results obtained in section 5.4.3 where the ability of chondrocytes 
transfected with IGF-1 and TGFpl to migrate is discussed.
5.4.3 Does the Transfection o f  Chondrocytes with IGF-1 or TGFpl Alter Their Ability to 
Migrate?
Chondrocytes transfected with IGF-1 or TGFpl were seeded onto Boyden chamber 
membranes coated with 50pg/ml of chondroitinase ABC treated aggrecan. As previously 
described for the experiments within chapter 2, the cells were allowed to migrate from the 
upper side of the membrane to the lower side over a period of 24 hours. After this 
incubation period the number of migrated cells was counted. As previously mentioned, the
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IGF-1
(21Obp)
GAPDH
(746bp)
TGFpi
(336bp)
GAPDH
(746bp)
IGF-1 
(21Obp)
GAPDH
(746bp)
TGFpl
(336bp)
GAPDH
(746bp)
Fig. 5.17 Comparing the expression of (a and e) IGF-1 and (c and g) TGFpl mRNA 
between: lane 1 Lipofectin® only, lane 2 vector only controls and lane 3 IGF-1/TGFpl 
over-expressing chondrocytes. Lane 4 water negative control. Rows (a-d) mRNA from 
chondrocytes isolated from young articular cartilage and (e-h) mRNA from chondrocytes 
isolated from mature articular cartilage. GAPDH was used as a housekeeping gene.
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Fig. 5.18 Confocal microscopy demonstrating the expression of c-myc (labelled green) in mature bovine chondrocytes over­
expressing the pSecTag2A vector (a-d) and IGF-1 (e-h). (a-c) and (e-g) illustrate the expression of c-myc protein through different 
optical sections within the cell and its localisation in punctate foci. Fig.5.18 (d) and (h) are 3 dimensional reconstructions constructed
from all the optical sections taken throughout the cell.
Fig. 5.19 Confocal microscopy demonstrating the expression of c-myc (labelled green) in young bovine chondrocytes over-expressing 
the pSecTag2A vector (a-d) and IGF-1 (e-h). (a-c) and (e-g) illustrate the expression of c-myc protein through different optical 
sections within the cell and its localisation in punctate foci. Fig.5.19 (d) and (h) are 3 dimensional reconstructions constructed from all
the optical sections taken throughout the cell.
Fig. 5.20 Confocal microscopy demonstrating the expression of c-myc protein (labelled green) in young (a-c) and mature (d-f) 
transfected chondrocytes. Cell nuclei are stained red with propidium iodide. Figures (a) and (d) are Lipofectin® only controls, (b) 
and (e) illustrate the cytoplasmic expression of c-myc in pSecTag2B vector only controls, (c) and (f) illustrate transfection with
TGFpl.
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transfection efficiency of chondrocytes isolated from both young and mature articular 
cartilage is approximately 22-24% and due to the low division rate of these primary cells 
transfected cells were unable to be selected from non-transfected chondrocytes using the 
Zeocin™ resistance gene.
Both vector control and IGF-1 transfected chondrocytes isolated from both age groups of 
articular cartilage were seen to migrate over 24 hours on chondroitinase ABC treated 
aggrecan (see fig.5.21a and b). Although no significant differences between vector control 
and IGF-1 treatment groups were seen with either age group of cells, definite trends were 
apparent. Chondrocytes from both age groups demonstrated increased trends of migration 
in the IGF-1 transfected group when compared to vector controls. Two sample T-tests 
performed between vector control groups and IGF-1 treatment groups demonstrated a P 
value of 0.083 for the chondrocytes isolated from young tissue (see fig.5.21a). The lack of 
statistical significance can in part be attributed to the fact that not all of the chondrocytes 
seeded onto the Boyden chamber membranes were in fact transfected with either the vector 
or IGF-1 construct. This would also explain variability between the wells, although the 
standard error bars are not high between samples.
Treatment with TGFpl also demonstrated an increasing trend of migration in both age 
groups when compared to the vector controls (see fig.5.22a and b). Again these differences 
were not significant when compared using a 2 sample T-test however. In contrast to the 
IGF-1 treatment where trends were more apparent with the chondrocytes isolated from 
young tissue, the effects of TGFpi were the reverse. A P value of 0.051 was achieved for 
the increased levels of migrating TGFpl transfected chondrocytes isolated from mature 
tissue when compared to vector controls (see fig.5.22b). Higher error bars in the younger 
age group resulting in a P value of only 0.530 (see fig.5.22a).
Both sets of data clearly demonstrate the ability of these growth factors to exert pro- 
migratory effects through a non-chemotactic mechanism. No studies to date have 
investigated the effects of over-expressing growth factors in chondrocytes on their 
migratory capabilities. In addition, the photomicrographs shown in fig.5.23 and 5.24
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Fig. 5.21 The migration of chondrocytes transfected with pSecTag2A vector or IGF-1 isolated 
from (a) young [P=0.083] and (b) mature articular cartilage [P=0.150] over 24 hours. Results 
illustrate the mean number of migrating cells per 0.25mm2 visual field with SEM bars and an n
value of 3.
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Fig. 5.22 The migration of chondrocytes transfected with pSecTag2B vector or TGFpl isolated 
from (a) young [P=0.530] and (b) mature [P=0.051] articular cartilage over 24 hours. Results 
illustrate the mean number of migrating cells per 0.25mm2 visual field with SEM bars and an n
value of 3.
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Fig. 5.23 Photomicrographs illustrating migratory chondrocytes isolated from young (a-b) 
and mature (c-d) articular cartilage transfected with (a and c) the vector pSecTag2A or (b 
and d) pSecTag2A encoding the mature peptide of IGF-1. Photomicrographs were taken 
from the lower side of the Boyden chamber membrane after the 24 hour incubation period.
Bar = 50pm
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demonstrate a definite chondrocytic cell morphology suggesting that these migrating cells 
are still expressing the chondrocyte phenotype. Over-expression of IGF-1 and TGFpi 
demonstrated definite trends in the up-regulation of chondrocyte migration in both age 
groups. Adaptation of the employed method to incorporate a selection step for the isolation 
of transfected cells from the non-transfected cells may provide a means to prove a 
statistically significant effect of over-expression of IGF-1 and TGFpi on the migration of 
chondrocytes isolated from both young and skeletally mature articular cartilage.
5.5 Conclusions
The aim of the work described within this chapter was to develop constructs for the over­
expression of IGF-1 and TGFpi in articular chondrocytes. Work detailed in chapters 2 and 
4 have demonstrated the positive effects that these 2 growth factors have on chondrocyte 
migration and matrix biosynthesis; however these effects are limited by the short half lives 
of IGF-1 and TGFpl once in their active form.
I have successfully developed constructs for the over-expression of IGF-1 and TGFpi in 
articular chondrocytes. Within this chapter, chondrocytes isolated from young and mature 
articular cartilage were transfected with the growth factors, and confirmation of their over­
expression was achieved by PCR and immunohistochemistry using a c-myc tag antibody. 
The transfected chondrocytes were used in a Boyden chamber system to determine whether 
their ability to migrate was enhanced by over-expression of the growth factor. This 
experiment was limited by the inability to select for the successfully transfected cells. 
Results obtained from the migration assay did demonstrate a consistent trend of increased 
migration with the transfected chondrocytes from both age groups when compared to 
controls. The development of an appropriate method to select for the transfected cells may 
prove this difference in migratory capacity to be statistically significant. Due to time 
restrictions, only preliminary experiments were carried out using these growth factor 
constructs. It would be interesting to look at the longevity of the expression of these 
constructs within chondrocytes and also their effects on chondrocyte matrix biosynthesis in 
addition to migration. Further work could also be undertaken to look at the effects of over­
expressing both these growth factors within the same cell.
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In summary:
• Constructs were successfully developed for the over-expression of IGF-1 and 
TGFpi in chondrocytes.
• Confirmation of over-expression was achieved at the protein level by 
immunohistochemistry using a c-myc antibody, and at the mRNA level using 
primers designed against the region encoding the mature peptides of IGF-1 and 
TGFpi.
• Transfected chondrocytes encoding IGF-1 or TGFpi demonstrated increased trends 
of migration on chondroitinase ABC aggrecan.
• These results suggest that IGF-1 and TGFpl may be able to increase chondrocyte 
migration through a non-chemotactic mechanism.
Chapter 6 
Final Discussion
6.1 Background
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Articular cartilage is an aneural and avascular tissue which consequently demonstrates a 
low capacity to initiate a repair response once injured. The low density and entrapment of 
the endogenous chondrocytes within an extensive ECM further hinders the ability of 
articular cartilage to self-renew. Left untreated, articular cartilage defects lead to 
degeneration of the surrounding cartilage and the development of diseases such as OA. 
Injuries which have extended into the subchondral bone frequently lead to filling of the 
defect area with a fibrocartilaginous tissue generated by the stem cells transported into the 
defect site from the vasculature. This repair tissue frequently degenerates with time as it is 
unable to withstand the biomechanical forces exerted on the joint.
Significant advances in the area of cartilage repair have been made in the last twelve years. 
Development of autologous chondrocyte transplantation by Brittberg et al. (1994) 
demonstrated the ability of isolated chondrocytes to form new cartilage and fill defects 
caused by injury. Long term clinical studies into the durability of this repair tissue suggest 
that it is stable for up to 10 years (Peterson et al., 2003). Histological analysis has shown 
that this repair tissue is rarely integrated with the endogenous cartilage however, and the 
compressive and shearing forces associated with use of the joint frequently lead to 
fibrillation of this repair tissue with subsequent degeneration in later years. Recent research 
into cell-based cartilage repair strategies has focussed on the generation of a hyaline-like 
repair tissue that is able to withstand biomechanical loading, and the enhancement of 
integration with the endogenous, surrounding cartilage.
Findings from both in vitro and in vivo studies have demonstrated 2 main areas needing to 
be addressed in order to improve the quality of cartilage repair techniques for the future. 
These areas are: the need for integration between newly synthesised cartilage and the 
endogenous tissue, and the generation of a biomechanically stable repair tissue, with the 
correct composition of collagen and proteoglycan molecules for both tensile and 
compressive force resistance. This led to the hypothesis that integration between injured 
articular cartilage surfaces can be enhanced by the addition and stimulation of isolated 
chondrocytes to the interface regions.
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The aim of this project was primarily to devise novel strategies for the enhancement of 
integration of transplanted chondrocytes and newly synthesised tissue with pre-existing 
cartilage. Work in the study has focussed on investigating the innate migratory capacities of 
both chondrocytes isolated from young and skeletally mature articular cartilage and ways 
that this can be enhanced by the use of the growth factors, IGF-1 and TGFpl. The ability of 
these cells to migrate on different matrix components has also been investigated. Few 
studies have been published looking at the migratory capacity of articular chondrocytes. It 
is generally accepted that these cells do not migrate. A recent publication by Chang et al., 
(2003) demonstrated the migration of chondrocytes isolated from newborn calves on 
fibronectin. No studies to date have investigated the migration of chondrocytes isolated 
from skeletally mature bovine articular cartilage. Studies within this project have used an in 
vitro model of cartilage injury to establish the role of the GAG, CS in limiting the 
migration of transplanted chondrocytes into intact articular cartilage. It has been previously 
demonstrated that the presence of proteoglycans at the wound edge can inhibit the adhesion 
of transplanted chondrocytes onto the endogenous cartilage (Lee et al., 2000). The effects 
of IGF-1 and TGFpl on chondrocyte biosynthesis of collagen and proteoglycans have also 
been investigated. Both these growth factors have been demonstrated within my studies to 
have anabolic effects on articular chondrocytes. Previous studies using TGFpi have 
conflicting results, with both anabolic and catabolic responses being reported. This is 
thought to be dependent on the cell cycle stage of the treated cells (Trippel, 1995; Vivien et 
al., 1992; Vivien et al., 1990). The data from my studies demonstrated the potential value of 
IGF-1 and TGFpi in enhancing cartilage repair and led to the development of constructs 
for the transfection of IGF-1 or TGFpl into articular chondrocytes. Transfected 
chondrocytes were used to look at the over-expression of IGF-1 and TGFpl on the 
migration of articular chondrocytes. No previous studies have looked at the effects of 
transfecting IGF-1 and TGFpi on chondrocyte migration. The overall objective of this 
project was therefore to combine stimulation of migration of chondrocytes into pre-existing 
cartilage with enhanced biosynthesis of matrix to produce an integrated and 
biomechanically stable repair tissue.
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6.2 The Migratory Capacities of Chondrocytes Isolated from Young and Mature 
Bovine Articular Cartilage
Initially the differences in gross morphology of young and skeletally mature articular 
cartilage was characterised by general histological methods. The number of chondrocytes 
decreased within the mature cartilage when compared to the younger tissue and 
consequently the cells were more isolated from each other in this older cartilage. The 
localisation of the major ECM components, proteoglycans and collagen, were comparable 
between age groups.
The ability of both chondrocytes isolated from young and skeletally mature articular 
cartilage to migrate was investigated on a number of ECM macromolecules. This study 
demonstrated that chondrocytes isolated from mature articular cartilage can migrate when 
released from their ECM. The choice of matrix protein was shown to affect both the degree 
of migration and the cellular response to any supplemented growth factors. The migration 
of chondrocytes isolated from young articular cartilage was inhibited by the anti-cell 
adhesive proteoglycan aggrecan, but enhanced on the pro-adhesive glycoprotein fibronectin 
when compared to BSA controls. Treatment of the native monomeric aggrecan substrate 
with chondroitinase ABC allowed increased migration of chondrocytes isolated from young 
articular cartilage compared to native aggrecan. Matrix protein did not appear to effect 
chondrocytes isolated from mature cartilage, but as seen with the younger cells a trend of 
decreased migration on native aggrecan when compared to chondroitinase ABC treated 
aggrecan was demonstrated. Chemotactic effects by the growth factors IGF-1 and TGFpl 
to enhance the migration of both age groups of chondrocytes only occurred when the cells 
were seeded onto a fibronectin substrate. Further to this, a significant increase in the 
migration of chondrocytes isolated from mature articular cartilage was only seen when both 
growth factors were used in combination.
In summary these experiments demonstrated the ability of isolated chondrocytes from both 
young and skeletally mature articular cartilage to migrate and the role of CS in inhibiting 
this migratory process. Data from these experiments also demonstrated that IGF-1 and 
TGFpl only have chemotactic effects on chondrocytes when the cells are seeded onto a 
fibronectin substrate.
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6.3 Removal of Wound Surface Chondroitin Sulphate to Enhance Migration of 
Chondrocytes into Articular Cartilage Explants
In light of the findings summarised in section 6.2, the role of CS in inhibiting cell adhesion, 
migration and integration into wounded articular cartilage was investigated. Many studies 
have demonstrated the up-regulation of proteoglycan synthesis after articular cartilage 
injury (Jeffrey et al., 1997; Walker et al., 2000). These proteoglycans have been targeted as 
one of the reasons for poor integration in cartilage repair. An in vitro model of cartilage 
injury was designed and wound surface CS chains were digested using the eliminase, 
chondroitinase ABC prior to transplantation with isolated chondrocytes. The region of 
digestion was detected using monoclonal antibodies, 2B6 and 1B5, which recognise the 
chondroitinase ABC generated CS-stubs C-4-S and C-O-S respectively. The migration of 
fluorescently labelled transplanted chondrocytes was tracked into the digested tissue over 
periods of up to 28 days. Cells from both age groups migrated into the digested tissue, with 
increasing numbers of labelled chondrocytes found within all zones of the cartilage with 
time in culture. Depth of chondroitinase ABC digestion of the tissue was a limiting factor 
for the migration of both age groups of chondrocytes. Controls with undigested explants 
saw no migration of either age group of cells within the first 7 days. These results 
correlated well with those discussed in section 6.2. Later time points demonstrated a small 
number of cells migrating into the undigested explants. This is probably due to the leaching 
of proteoglycans from the explants with time in culture. Work published by Caterson and 
Lowther (1976) demonstrated that if cartilage is not under compressive force, 
proteoglycans will leach out of the tissue with time.
These experiments have demonstrated the ability of chondrocytes from both age groups of 
cartilage to migrate through the native cartilage ECM if the CS chains from the 
proteoglycans found within the tissue have been removed. Sufficient digestion of the 
injured tissue is fundamental to the adequate migration of transplanted cells into the matrix.
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6.4 The Effects of IGF-1 and TGFpl on the Biosynthesis of Matrix Macromolecules
Work detailed in chapters 2 and 3 has emphasised the importance of chondrocyte migration 
and the role of matrix macromolecules, as well as chemoattractants, in enhancing this 
process. In addition to their chemotactic effects, IGF-1 and TGFpl have both been 
demonstrated to have anabolic effects on chondrocytes (Bonassar et al., 1997; Glansbeek et 
al., 1998). The effects, therefore, of IGF-1 and TGFpl on the biosynthesis of the matrix 
macromolecules, proteoglycans and collagens, and cellular proliferation were investigated, 
as well as the ability of these growth factors to maintain the chondrocytic phenotype.
IGF-1 and TGFpl demonstrated the ability to significantly increase the biosynthesis of 
sGAGs and collagen in chondrocytes isolated from both age groups of cartilage. The 
increase in these matrix macromolecules was firstly seen within the culture media removed 
from the cells after a 1 day incubation period. Significant levels were later seen at day 3 
within the cell lysates and their cell associated material. These results strongly suggest 
deposition of the newly synthesised molecules into matrix. No significant differences in 
sGAG or collagen levels were seen between treatment groups and the controls by day 7 
however, suggesting an up-regulation of matrix degradation returning levels back to 
normal. Experiments set up to investigate the levels of degradation with IGF-1 and TGFpl 
treatment unfortunately did not result in any meaningful data which could be analysed.
The work within this chapter also addresses the effects of IGF-1 and TGFpi on the 
chondrocytic phenotype. IGF-1 has previously been reported to maintain the chondrocytic 
phenotype (Gueme et al., 1994; Tyler, 1989) and TGFpl has recently been documented to 
aid in the re-differentiation of chondrocytic cells grown in monolayer culture for ACT 
techniques (Goldberg et al., 2005). As the chondrocytes used in this study were being 
grown in a monolayer system, their ability to maintain the chondrocytic phenotype on 
exposure to both IGF-1 and TGFpl was investigated by Western blotting using a type II 
collagen antibody as well as looking at the mRNA levels of the transcription factor Sox 9 
and type II collagen gene. Western blotting conclusively demonstrated the presence of type 
II pro-collagen in cell lysates and associated material from both age groups of 
chondrocytes. PCR analysis also demonstrated the consistent expression of both Sox 9 and
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type IIB collagen (mature form) throughout time in culture. These data confirm the 
maintenance of the chondrocytic phenotype throughout the culture period.
The effects of IGF-1 and TGFpi on the gene expression of these growth factors, as well as 
their corresponding receptors were determined. With time in culture message levels of both 
the growth factors and their receptors decreased. Exposure of chondrocytes to these growth 
factors exogenously did not affect the message levels of IGF-1 or TGFpl. Exposure to IGF-
I did up-regulate its own cell surface receptor however, with visible differences in 
expression between IGF-1 treatment groups and controls at the initial sampling point of 10 
minutes and again at days 1 and 3. Conversely exposure to TGFpl down-regulated its cell 
surface receptor with a decrease in expression seen at the 10 minutes, 1 and 3 day time 
points. The results from these PCR based experiments must be treated with caution and 
would need to be confirmed by quantitative PCR.
In addition to the previously documented effects of IGF-1 and TGFpi on chondrocyte 
migration, these results confirm the anabolic stimulation they have on this cell type at the 
concentration they were used at (lOng/ml). PCR data demonstrate that a consequence of 
exposure to these growth factors is a differential regulation of the specific growth factor’s 
cell surface receptor. These effects were seen whilst still maintaining the characteristic type
II collagen and Sox 9 expressing chondrocyte phenotype.
6.5 The Over-expression of IGF-1 and TGFpi in Articular Chondrocytes
This chapter brought together the findings and ideas generated from the previous studies 
and sought to address the limitations and obstacles uncovered; chapter 2 demonstrated the 
chemotactic effects of both IGF-1 and TGFpl on chondrocyte migration but also confirmed 
the fact that this only occurred if the cells were seeded onto a fibronectin substrate. The 
effects of these growth factors on chondrocyte migration and matrix biosynthesis, as 
discussed in chapters 2 and 4 were limited by the short half lives of these growth factors. 
Once within their active state both IGF-1 and TGFpl have a half life of minutes. In order to 
have a sustained effect on chondrocytes, these growth factors need to be over-expressed 
within the cell. This chapter documents the development of constructs encoding for the 
mature peptides of bovine IGF-1 and TGFpl.
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Constructs were developed and initially expressed using the pGEM®-T vector within 
competent E-coli (JM109). Bacterial plasmid was produced and the correct sequence 
homology was confirmed as well as in frame expression. Sequences encoding BamH I and 
Not I restriction sites were added to the 5’ ends of the forward and reverse primers 
respectively of IGF-1 and TGFpi ensuring the correct orientation of the inserted sequences 
into the mammalian expression vector, pSecTag2.
Chondrocytes were transfected with the plasmids using a liposomal method. This allows 
transient over-expression of the growth factors within the chondrocytes. Due to the low 
replication rate of this cell type, transfected cells could not be selected for using the 
selective antibiotic Zeocin®. Over-expression of the constructs and a good transfection 
efficiency (22% and 24% of chondrocytes isolated from young and mature cartilage 
respectively) was confirmed by immunohistochemistry using an antibody raised against the 
c-myc epitope. PCRs also demonstrated an increased level of mRNA for IGF-1 and TGFpl 
in the transfected cells with the respective growth factor when compared to vector only 
controls.
The beneficial effects of removing CS chains in enhancing migration were demonstrated in 
chapters 2 and 3. Transfected chondrocytes were seeded onto a chondroitinase ABC treated 
aggrecan substrate to investigate whether these growth factors could further increase cell 
migration. Data from this experiment suggests that this may be the case with a consistent 
trend of increased migration with cells transfected with either IGF-1 or TGFpl when 
compared to vector only controls. Due to the inability to select over-expressing cells from 
those non-transfected, these effects were not significant. Development of a method to select 
transfected chondrocytes from the mixed population may confirm this increased migratory 
effect.
The data from this chapter uses the information gathered from previous work to 
demonstrate the use of over-expression of these anabolic growth factors with a cartilage 
repair system. By transiently over-expressing IGF-1 or TGFpl there is the possibility of 
increasing both cell migration and matrix biosynthesis within the initial repair period and 
then returning the cells back to their normal status. My data confirm that chondrocytes 
isolated from young and mature articular cartilage can be successfully transfected and that
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increased expression of these growth factors exerts a positive effect on chondrocyte cell 
migration.
6.6 Implications for Cartilage Repair
These experiments bring together the ideas of enhanced integration for the development of 
stable repair tissue for cartilage repair. Data from the migration and biosynthesis 
experiments, and the generation of transfected chondrocytes over-expressing an anabolic 
growth factor such as IGF-1 or TGFpi, suggests that the phenotype of chondrocytes can be 
manipulated such that they may enhance cartilage repair.
As discussed in section 1.13.2, enhanced migration will not improve cartilage repair on its 
own. Enhanced migration will provide a scaffold for integrated repair but the strength and 
stability of the repair tissue also needs to be considered. Fibrocartilaginous repair tissue; 
containing a large proportion of type I collagen does not possess the same biomechanical 
characteristics as native articular cartilage. Stabilisation of the chondrocytic phenotype is 
essential for the development of a stable hyaline cartilage repair tissue. A culmination of 
enhanced migration and the formation of integrated hyaline cartilage repair tissue may 
provide an advance in cell-based cartilage repair strategies currently available. 
Fibrocartilaginous repair tissue seen with monolayer expanded chondrocytes is most likely 
due to the fragility of the chondrocyte phenotype and the dedifferentiation of the cells into 
fibroblasts. Over-expression of a growth factor such as IGF-1 or TGFpl, which potentially 
stabilises and protects the chondrocytic phenotype, and the ability to produce characteristic 
type II collagen, may be important during the necessary monolayer expansion of isolated 
chondrocytes required for the ACT procedure. As discussed in section 5.1 exogenous 
provision of growth factors is not effective due to their short half-lives. Transient over­
expression of the gene within the target cell may help overcome these problems.
6.7 Future Avenues for Investigation
Experiments from this project have confirmed that chondrocytes isolated from both young 
and mature articular cartilage have the ability to migrate. This has not previously been 
reported in cells from skeletally mature, bovine articular cartilage. The Boyden chambers
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used for these experiments are a simple and effective way of quantifying cell migration, 
however it would be interesting and highly informative to visualise the migratory process 
of these cells using time-lapse video-microscopy. This method would not only allow the 
migration of chondrocytes to be measured using a different system but also provide a 
means to look at the morphology of the cell and rearrangement of the cytoskeleton during 
motility. As discussed in section 2.5, attempts were made to investigate chondrocyte 
migration using time-lapse video-microscopy. Ideally, using an automated microscope 
stage, comparative analysis of chondrocyte migration on different ECM substrates, using 
the same batch of cells, could have been achieved. The lack of adhesion of the cells to the 
substrates resulted in the detachment of the cells from the plate surface as the microscope 
stage moved. Further optimisation regarding the attachment period is required to resolve 
this issue. It is possible to overcome this problem by the use of a static microscope stage; 
however this would mean that it would not be possible to use the same batch of primary 
cells for each substrate to be investigated.
Data in chapter 2 documented the enhanced migration of chondrocytes in the presence of 
IGF-1 and TGF|31. This effect was substrate dependent and was only seen when the cells 
were seeded onto fibronectin. Chemotactic effects can also be calculated using a Dunn 
chamber. This system uses time-lapse video-microscopy to visualise the movement of cells 
towards a source of chemoattractants. It is possible using this method to calculate whether 
directional movement and therefore a true chemotactic response is being seen.
Work in chapter 3 developed the ideas from the previous migration work and used an in 
vitro model of cartilage injury to visualise the migration and integration of transplanted 
chondrocytes into an articular cartilage explant. The tissue had been previously digested 
with chondroitinase ABC, and it was reported that CS inhibited the migration of these 
isolated cells into the cartilage matrix. Removal of this GAG resulted in increased 
migration of both age groups of cells into the explant. As discussed in chapter 3, migrating 
chondrocytes appeared to demonstrate the correct morphology for the zone of the cartilage 
explant that they had migrated into, and were also situated within lacunae. It would be 
interesting to investigate this finding further, possibly through the transfection of 
chondrocytes with a type VI collagen expressing vector and GFP tag. This would
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demonstrate whether the migrating chondrocytes are moving in and occupying pre-existing 
lacunae, or rather are generating their own.
Furthering this work, it would be possible to adapt this model to look at the migration of 
isolated chondrocytes into opposing cartilage explants digested with chondroitinase ABC, 
and visualise over time, the possible integration of the explants by the transplanted 
chondrocytes. Their increased migration and continued matrix biosynthesis may provide a 
well integrated repair tissue. The mechanical integrity of the integrated tissue needs also to 
be investigated. Techniques, such as the single-lap shear test, for the quantification of 
mechanical integration between opposing cartilage explants have been previously described 
(DiMicco and Sah, 2001; Giurea et al., 2002; McGowan and Sah, 2005).
In addition, it would be beneficial to investigate whether other GAG chains such as KS 
within the cartilage ECM have such an inhibitory effect on chondrocyte migration. Using 
the previously established model, it would be possible to use specific keratanase enzymes 
to digest the matrix of this GAG chain and look at chondrocyte migration into the digested 
matrix. Valuable information could also be gathered from further understanding of the 
interaction between CS with the chondrocyte in exerting its inhibitory effects. Knowing the 
structure of CS it would be feasible to generate fragments of the GAG which could be used 
as substrates for further migration studies, possibly elucidating the inhibitory component.
Further work investigated the effects of the growth factors, IGF-1 and TGFpi, on 
chondrocytes from young and mature cartilage. The data illustrated the anabolic effects of 
these growth factors on matrix biosynthesis, but it would have been greatly beneficial to 
have been able to compare these biosynthesis data to the amount of degradation occurring 
within the cells, and to have looked at whether this had also been affected by the growth 
factors. IGF-1 has been previously shown to decrease MMP expression and increase the 
levels of TIMPs (Hui et al., 2001a; Hui et al., 2001b). In addition, as seen with TGFpl, this 
growth factor can also counteract the degradative effects of pro-inflammatory cytokines 
such as IL-1 (Tyler, 1989; van Beuningen et al., 1993; van Beuningen et al., 1994). A cold 
chase experiment running alongside the biosynthesis experiment would have given an 
indication as to the amount of degradation of the newly synthesised material over the
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culture period. Such an experiment was set up for inclusion in this thesis; however the data 
obtained was insufficient for analysis. Optimisation of the procedure would be required.
These biosynthesis experiments used exogenous growth factors. Using the constructs 
developed for the transient over-expression of IGF-1 and TGFpl it would now be possible 
to investigate the effects of long-term exposure to these growth factors on both matrix 
biosynthesis and degradation. Time limitations only allowed preliminary experiments to be 
performed using the transfected cells. It would be interesting to further characterise the 
longevity of the transfected construct and also its effects on protein expression of the 
encoded growth factor. These transfected cells were used in a preliminary experiment to 
investigate whether over-expression of IGF-1 or TGFpl enhanced the migration of isolated 
chondrocytes. Development of an appropriate selection technique would have proved these 
results to be significant, although without such conditions in place it was encouraging to 
see a consistent trend of increased migration in the growth factor over-expressing cells 
when compared to controls. It would also be interesting to investigate the effects of over­
expressing both growth factors within articular chondrocytes, in terms of their migratory 
capacity and biosynthetic activities. Further experiments, using both the time-lapse method 
previously discussed with different substrates as before, and the model developed for 
cartilage injury would investigate any differences in migratory capacities further.
All the experiments within this project have compared chondrocytes isolated from young 
and skeletally mature bovine cartilage. This work gives proof of principle to methods for 
enhancing cartilage repair. Further research is required to demonstrate that similar effects 
are seen within human chondrocytes. Clinical studies investigating ways to enhance 
cartilage repair using methods such as ACT have started to encompass older patients and 
those suffering from degenerative diseases such as OA. The results described in this thesis 
have focussed on young and skeletally mature cartilage, but not old. Further work is 
therefore needed to investigate whether chondrocytes isolated from old cartilage behave in 
the same manner to those isolated from the skeletally mature cartilage.
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In conclusion, this study demonstrates the ability of both chondrocytes isolated from young 
and skeletally mature articular cartilage to migrate when released from their ECM. The 
importance of the matrix protein in contact with the migrating cell has been demonstrated, 
with aggrecan seen to have an inhibitory effect. This inhibitory effect was partially 
attributed to the anti-cell adhesive sGAG, CS as demonstrated in both the Boyden chamber 
system and using an in vitro model of cartilage injury. Removal of this sGAG enhanced the 
migration of cells from both age groups into the ECM of articular cartilage. The substrate 
dependent chemotactic effects of IGF-1 and TGFpl on chondrocyte migration were also 
elucidated, with their enhancing effects only demonstrated when the cells were seeded onto 
a fibronectin substrate. Further work confirmed the anabolic effects of both these growth 
factors on chondrocyte matrix biosynthesis in addition to their chemotactic effects. The 
short half life of exogenous IGF-1 and TGFpl led to the development of constructs 
encoding these growth factors, used to transfect articular chondrocytes. Preliminary work 
suggests that over-expression of IGF-1 and TGFpl may help overcome their substrate 
dependent effects on enhanced cell migration. Further studies to characterise the effects of 
transient over-expression of these growth factors in articular cartilage chondrocytes may 
provide a means of delivering anabolic factors to a defect site and aid the process of 
chondrocyte migration and matrix production for the development of a biomechanically 
stable repair tissue that is well integrated with the pre-existing cartilage.
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A ppendix 1
1.1 DNA Molecular Weight Standard
1.1.1 1 OObp Molecular Weight Ladder (Promega, UK)
B ’-
wo
*00wo
1.2 Protein Molecular Weight Standard
1.2.1 Rainbow Molecular Weight Ladder (GE Healthcare Ltd., UK)
    220KDa
« 97KDa
  66KDa
 45K D a
 30KDa
«------20.1KDa
* 14.3KDa
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A ppendix 2
2.1 Vector Maps and Multiple Cloning Sites
2.1.1 pGEM®-T Vector (Promega, UK)
Xmn 11994
Nae I 
2692Sea 11875
f1 ori
Apa I
Aat II
Amp pGEM*-T
Vector
(3000bp)
/acZ
SstZI
Psfl
Sa/IA/del
Sac I
BstX
Nsi I
ori
t SP6
1 start 
14 
20 
26 
31 
37 
46
55
62
62
73
75
82
94
103
112
126
T7 Transcription Start
I *
5' . . .  TGTAA TACGA CTCAC TATAG GGCGA ATTGG GCCCG ACGTC GCATG CTCCC GGCCG 
3' . . .  ACATT ATGCT GAGTG ATATC CCGCT TAACC CGGGC TGCAG CGTAC GAGGG CCGGC
T7 Promoter II
Apa  I Aaf II Sp/ji fiafZl
GGTAC CGGCG CCCTA ^cloned insert^,TTAGTG ATCAC GCCGG CGGAC GTCCA GCTGG TATAC
Nco I Sac II Spe  I Not\ Pst I Sa/I Nde\
BstZ  I
SP6 Transcription Start
"  I
GGAGA GCTCC CAACG CGTTG GATGC ATAGC TTGAG TATTC TATAG TGTCA CCTAA AT. . . 3' 
CCTCT CGAGG GTTGC GCAAC CTACG TATCG AACTC ATAAG ATATC ACAGT GGATT TA.. . 5'
Sac  I BstX  i MW I
SP6 Promoter
2 d  I
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2.1.2 pSecTag2 Vector (Invitrogen Ltd., UK)
lg k Leader co ^  I  ^  Sroo in uj o. uj m : m yc  epitope 6xHis TAA
Comments for pSecTag2 A:
5159 nucleotides
CMV promoter: bases 209-863 
T7 promoter/priming site: bases 863-882 
Murine Ig K-chain V-J2-C signal peptide: bases 905-967 
Multiple cloning site: bases 970-1081 
c-myc epitope: bases 1082-1114 
Polyhistidine tag: bases 1127-1144 
BGH reverse priming site: bases 1167-1184 
BGH polyadenylation sequence: bases 1166-1380 
fl origin: bases 1443-1856 
SV40 promoter and origin: bases 1924-2245 
EM-7 promoter: bases 2261-2327 
Zeocin™ resistance gene: bases 2328-2702 
SV40 polyadenylation sequence: bases 2832-2961 
pUC origin: bases 3345-4018 
Ampicillin resistance gene: bases 4163-5023 (C)
* The Sfi 1 site is located 
before the variable region.
tFrame-dependent variations: 
Asc I is only found in version A.
6 9 9
8 7 9
1 0 4 1
1 1 4 6
enhancer region (3* end)- ] 
AATGGGAGTT TG TT TTG G C A
, CAAT .
CCAAAATCAA CG G G A C TTTC CAAAATGTCG TAACAACTCC
3' end o f hCMV
7 5  9  GCCCCATTGA CGCAAATGGG
TATA <
CG GTAG G CGT G TACGGTGGG A G G TC T A T A T AAGCAGAGCT
putative transcriptional startr
8 1 9  CTCTGG CTA A  CTAGAGAACC
T7 promoter primer binding sitel---------------------
C A C TG C TTA C  TG G C T T A T C G  A A A TTA A TA C G A CTCACTAT
___________________ lg K-chain leader sequence_____________
AGGGAGACCC AAG CTG G CTA  G CCA CC A TG  GAG ACA GAC ACA
M e t  G l u  T h r  A s p  T h r
GTA CTG 
V a l  L e u
CTG
L e u
CTC  TGG G T T  
L e u  T r p  V a l
CTC CTG CTA TGG 
L e u  L e u  L e u  T r p
£ t l
CCA G GT T C C  A C T G GT GAC GCG GCC CAGCCG 
P r o  G l y  S e r  T h r  G l y ^ A s p
Signal cleavage site 
Hind  III A spl 18 I K p n \ Ram H I BslX I*
9 8  0  GCCAGGCGC IQCOCGCCGI TACGAAG CTTG G TA CCG  A G CTCG G A TC CACTCCA GTG  TGGTGGA
Pst I EcoK. V BslX  I* Not I Xho  1 DraW  Apa
A T T C T G C a 'g A  T A T C C A G C A C  A G TG G C <3G C C  G c t c G A G G A G ' G G C C C  G A A  CA A AA A  C T C
G l u  G i n  L y s  L e u
____________myc  epitope______________   Polyhistidine tag______
ATC TCA  GAA GAG GAT CTG  A AT AGC GCC G TC GAC CA T CA T CAT CAT CAT 
l i e  S e r  G l u  G l u  A s p  L e u  A s n  S e r  A l a  V a l  A s p  H i s  H i s  H i s  H i s  H i s
BGH reverse priming site
CA T TGA G TTT A A A C C C  G CTG A TCA G C C TC G A C TG TG  C C T T C T A G T T  GCCAGCCATC 
H i s  * * *
1 2 0 2  T G T T G T T T G C  C C C TC C C C C G  T G C C T T C C T T  G ACCCTGG A A  G G TG CCA CTC CCA CTG TCCT
BGH poly (A) addition site I-------- 1
1 2 6  2  TT C C TA A T A A  AATGAGGAAA TTG CA TCG CA  T T G T C T G A G T  A GG TG T
•Note that there are two Bs/X  I sites in the polylinker.
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3.1 Media Recipes for Bacterial Growth
3.1.1 Stock Solutions
1. Ampicillin -  Amp Tabs™ (Stratagene, CA, USA), at 2.5mg/tablet of ampicillin, 
were dissolved directly into the LB agar or broth to a final concentration of 100 
pg/ml.
2. isopropyl-p-D-thiogalactopyranoside (IPTG) -  1.2g of IPTG powder (Promega, 
UK) was dissolved in 50ml of distilled water and to give a stock concentration of 
0.1M. The solution was filter sterilised and stored at 4°C.
3. 5-bromo-4-chloro-3-indolyl-p-D-galactopyranoside (X-Gal) -  50 mg/ml stock 
concentration in N, N-dimethylformamide (DMF) was stored at -20°C (Promega, 
UK).
4. SOC media -  2% tryptone, 0.5% yeast extract, lOmM NaCl, 2.5mM KC1, lOmM 
MgCL, lOmM MgS04 , 20mM glucose (Invitrogen Ltd., UK)
3.1.2 Luria Broth (LB) Agar Plates
One LB agar tablet was dissolved per 50ml of distilled water and autoclaved at 121°C for
11 minutes. The agar was allowed to cool to temperate before the addition of supplements.
Plates were poured aseptically and allowed to set before storing at 4°C until use. Plates
were allowed to warm to room temperature before use.
3.1.3 Supplements Added to LB Agar
pGEM®-T Vector Selection -  Ampicillin (100pg/ml)
IPTG (0.5mM)
X-Gal (80pg/ml)
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LB broth tablets were dissolved, 1 per 50ml of distilled water and autoclaved at 121°C for 
11 minutes. Both were allowed to cool to temperate before the addition of ampicillin 
(lOOpg/ml) and storage at 4°C. Broth was stored for up to 2 weeks at 4°C.
Appendix 4
4.1 Sequencing Oligonucleotide Primers
T7 5’ TAA TAC GAC TCA CTA TAG GG 3’
M l3 Forward 5’ CGC CAG GGT TTT CCC AGT CAC GAC 3’
M l3 Reverse 5’ AGC GGA TAA CAA TTT CAC ACA GGA 3’
IGF-1 BamR I Forward 5’GCG GGA TCC AGG ACC CGA GAC 3’
IGF-1 Not I Reverse 5’CGC GCG GCC GCG GCC GAC TT 3’
TGFpl BamH I Forward 5’GCG GGA TCC GCC CTG GAC ACC AAC TAC TGC 
TTC AGC TCC 3’
TGFpi Not I Reverse 5’CGC GCG GCC GCG CTG CAC TTG CAG G 3’
Appendix 5
5.1 Buffer Recipes
5.1.1 Phosphate Buffered Saline (PBS) pH 7.4
A lOx stock was made up for storage at room temperature containing: 
87g Sodium Chloride 
2g Potassium Chloride 
2.72g Potassium hydrogen phosphate
11.36g Sodium hydrogen phosphate
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The lOx stock was diluted to 1 x using distilled water and the pH adjusted to 7.4 using 
hydrochloric acid before autoclaving at 121°C for 11 minutes and storing at room 
temperature.
5.1.2 PBS and Tween 20™
A lx working concentration of PBS was made up and the pH adjusted as previously 
described. Tween 20™ was added to a working concentration of 0.001%.
5.1.3 Laemmli Buffer
A lOx stock was made up for storage at room temperature containing:
lOOg SDS 
300g Tris 
1440g Glycine
The above reagents were dissolved in 10 litres of distilled water.
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